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Abstract
This thesis tackles the problem of T-cell receptor (TCR) diversity, from two
different points of view. On one hand, the observed TCR diversity is studied
from a mathematical perspective, concentrating on the probability of a sample
to reproduce a certain percentage of the total TCR diversity. On the other
hand, biological samples are considered, focusing on statistical analysis of the
observed VDJ gene segments. To conclude, a stochastic model is developed
to explore the population dynamics of a simulated TCR repertoire. Com-
puter simulations complete this multidisciplinary approach, helping verifying
the different mathematical theories behind the stochastic models.
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Chapter 1
Biological Introduction
Immunology is the study of the different mechanisms of defense of the body against in-
fections. The disease-causing agents can be divided into viruses, bacteria, parasites and
fungi. Our body is constantly in contact with millions of them but only few represent a
real threat for it. The human body has three possible layers of defense against pathogens:
physical and chemical barriers, the innate immune system and the adaptive immune sys-
tem. Physical and chemical barriers, such as skin and mucosal epithelial lining of the
airways and gut, prevent pathogens from entering the body [113, 80]. When these barriers
are not sufficient for a certain pathogen, the innate immune system comes into play.
Before going further into the details of the innate part of the immune system, it is
worth clarifying that the immune system has four general main functions. The first one,
called immunological recognition, defines the very first step of defense after the physical
barriers have been overcome [28]. This task requires the ability of recognizing an infection
in the shortest possible time. The second important task includes all the so called immune
effector functions, such as the T-cell and B-cell activities. As for the third task, the immune
system has to have the capacity of self-regulation. This function is extremely important
and, in case of failure, it could bring to autoimmune diseases, allergies or over reactions
to pathogens [76]. Immunological memory is the last of the four tasks: once the body has
been exposed to a certain pathogen, a class of cells of the immune system, called memory
cells, are generated and remain in the circulation and tissues patrolling the environment
inside the body [1]. These cells will be the first reacting to a second possible entrance of
the same pathogen in the body, generating a much stronger and faster response than the
first one [113].
The innate immune system (or non-specific immune system) [3, 123], mainly composed
by cells that recognize and respond to pathogens in a generic way such as macrophages
[15], is able to set up a quick response (within hours) to microbial infections. The main
goal is to delay the growth of pathogen numbers in the body as much as possible, while the
adaptive immune response gets ready for action. This process is initiated when antigens,
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that is molecules or microbial components capable of inducing an immune response, reach
the secondary lymphoid organs such as lymph nodes, tonsils and spleen. Dendritic cells
[18], usually present in those tissues that are in contact with the environment such as skin,
play a critical role in the immune system activation. They are the main carriers of these
antigens from peripheral tissues to secondary lymphoid organs, where antigens will be
presented to T-cells and B-cells [19]. Macrophages, the mature form of monocytes (bone
marrow derived cells), are also a fundamental part of the innate response. Their role is to
kill microbes ingesting them [72]. During this process, macrophages secrete chemokines
and general cytokines [96], small molecules that cause inflammation and attract cells of
the adaptive immune system [114]. It is in fact this last mentioned property that gives the
name to chemokines, chemotactic cytokines. It refers to the ability to induce chemotaxis
(the movement of an organism in response to a chemical stimulus) in nearby responsive
cells. In this way, cells like monocytes or neutrophils are recruited from the bloodstream
into the infected tissue.
The inflammation process has now begun. Some pathogens have, unfortunately for us,
evolved in such a way to be able to evade these first two barriers. When this happens,
an action far more specific than the ones before is evoked: the activation of the adaptive
immune system. Its action is highly specific for a particular pathogen and takes longer
(maybe days) to be started. The main steps are the recognition of specific non-self antigens
among millions of self antigens, the generation of a response that is tailored to the specific
pathogen and the development of immunological memory [113, 23]. This capillary and
specific response is obtained thanks to specialized antigen receptors present on the surface
of the adaptive immune system cells [51]. Billions of cells are part of this system, generating
a vast repertoire of different antigen receptors and allowing the body to respond to ideally
every possible pathogen it could be exposed to [113, 172, 46]. Lymphocytes are the main
cells of the adaptive response, grouped in B-cells, T-cells, and natural killer cells (NK
cells) [10].
As previously said, the effectiveness of this response relies on the accuracy with which
the antigen is presented to these cells. Basically all cells in the body are able to present
a certain antigen on their cell surface, thanks to a biological complex called MHC (Ma-
jor Histocompatibility Complex) [87]. Some cells are more specialized than others in
the presentation process, being equipped with specific co-stimulatory ligands that can be
recognized by the co-stimulatory receptors on the surface of the T-cells [98]. These spe-
cialized cells are mainly B-cells and dendritic cells, and are known by the name of antigen
presenting cells (APCs). Next section will describe the T-cells, the main focus of this
thesis.
2
1.1 T cells
1.1 T cells
T cells are a type of lymphocyte that play a central role in the adaptive immune system
response. They can be distinguished from other lymphocytes, such as B-cells and natural
killer cells (NK cells), by the presence of a T-cell receptor (TCR) on their cell surface, a
molecule responsible for recognizing antigens [152]. The co-evolution of TCR and MHC
complexes is the basis of an impressive recognition system, thanks to which minor changes
in the binding site (between MHC complex and the peptide) may lead to many different
coordinated T-cell responses [37].
Their name “T-cells” is due to their maturation process in the thymus [4, 113], an
organ in the upper chest. In fact, like B cells, they derive from multi-potent hematopoietic
stem cells in the bone marrow and, only after, they migrate to the thymus via the blood.
Here they undergo a strict selection process with thymic cells, shaping the mature T-cell
repertoire in the body. At this stage, they enter the bloodstream as mature na¨ıve T cells.
Their main task is now to circulate through the peripheral lymphoid tissues looking for
their corresponding antigens. From these encounters the adaptive immune response will
be initiated against the particular pathogen.
There are two different groups of T cells, each with a distinct function. The first group
represents CD4+ T cells. Their name is due to the expression of the CD4 (Cluster of
Differentiation 4) glycoprotein on their cell surface [174]. The second one is constituted
by CD8+ T cells, expressing the CD8 (Cluster of Differentiation 8) glycoprotein [113, 127].
CD4+ T cells can be further split into helper T cells TH [122], T follicular helper cells
(TFH) [39] and regulatory T cells (Treg) [158, 22]. T helper cells (TH cells) assist (therefore
the name “helper”) other white blood cells during different immunologic processes, such as
the maturation of B cells and activation of cytotoxic T-cells and macrophages. They can be
further subdivided in different functional classes, mainly TH1, TH2 and TH17. The former,
TH1, produce a particular kind of cytokines called interferon gamma (IFNγ), capable to
activate macrophages [60]. TH2 produce other cytokines, IL-4, IL-5 and IL-13, helping
the recruitment of eosinophils and basophils [169]. TH17, so called from the cytokine
IL-17 that they produce, induce the arrival of neutrophils to the sites of infection. TFH
cells focus on helping B-cells in the lymphoid follicles, while Treg cells have the important
function of suppressing other T-cells responses when needed, helping to prevent negative
outcomes such as autoimmune diseases.
The activation of CD4+ T cells begins with the presentation and recognition processes
of peptide antigens between TCRs and MHC class II molecules, molecules expressed on
the surface of APCs [55]. Thanks to this, CD4+ T cells become activated starting to divide
rapidly and to secrete cytokines that regulate or assist the active immune response [4, 127].
Cytotoxic T-cells (CTLs or T-killer cells) are involved in the destruction of virally infected
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cells, tumor cells or cells that have been exposed to DNA damage for different reasons [20].
In order for the TCR to bind to the class I MHC molecule, a molecule expressed on the
surface of nearly all host cells, the former must be accompanied by a glycoprotein called
CD8, which is able to bind to the constant region of the class I MHC molecule. Once
being exposed to infected or nonfunctional host cells, CTLs release the cytotoxins that
enhance apoptosis (programmed cell death) in the infected cell.
Thanks to molecules secreted by other T cells called regulatory T cells, the CD8+ cells
can be inactivated to an anergic state, which prevents autoimmune diseases [4, 127]. It is
worth noticing that, as explained above, TCR is incomplete by itself. Its need to encounter
the stimulating ligand through the help of another cell is the main difference between a
TCR and antibodies, that can bind to antigens in absence of other structures [37]. Under
normal conditions of absence of any infection, the majority of the lymphocytes circulate
in the body (blood and limph) as small inactive cells with few cytoplasmatic organelles.
In this form they are referred to as na¨ıve lymphocytes and all together they create the
na¨ıve repertoire. A lymphocyte is then activated, by binding to an APC through the TCR
[65, 67]. Following activation, T cells undergo clonal expansions and their daughter cells
start differentiating into different functional classes [112, 33].
1.2 T-cells and repertoire development
As already outlined before, T cells develop from progenitors (same progenitors of the B
cells) that derive from pluripotent hematopoietic stem cells in the bone marrow. Their
maturation journey starts with the migration of these progenitors to the thymus, the
organ situated in the upper anterior thorax, above the heart. It is lobulated on its surface
and each of these lobules contains cortical and medullary regions. Once the progenitors
arrive in the thymus, they receive a strong signal from stromal cells directly through one
of their receptor called Notch1. This is the sign for the progenitors, to switch on specific
genes that induce the commitment to undergo the T-cell lineage rather than the B-cell
one. Once in the thymus, T-cell precursors start differentiating for up to a week before
undergoing a phase of massive proliferation. These developing thymocytes have to pass
through different steps before being able to leave the thymus. The first stage for this
population is called double negative (DN), reflecting the absence of both CD4 and CD8
molecules on their cell surface [114].
This phase can be further subdivided into four different passages, known as DN1, DN2,
DN3 and DN4. DN1 cells express the CD44 glycoprotein, typically used to track early
T-cell development. At this point the genes encoding for both chains of the TCR are still
in the germline configuration. Following with the maturation process, these lymphocytes
start expressing the alpha chain of the IL-2 receptor, known as CD25. This is step DN2,
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while the DN3 step is characterized by the decrease of CD44 expression. The somatic
recombination of the beta chain of the TCR starts in the DN2 phase and continues until
the DN3 one. Here the beta chain is coupled with a pre-T-cell alpha chain (pTα), form-
ing the pre-TCR. This immature TCR pairs with the CD3 (cluster of differentiation 3)
protein complex, inducing cell proliferation, the end of the β-chain rearrangement and the
expression of both CD8 and CD4. This step is the interface between DN4 and the first
step of the double-positive (DP) phase [69].
From this stage we have two different lineages: γ/δ and α/β T cells. The lineage α/β
represents the majority of the lymphocytes in the body and it is the only one presenting
the CD4 or CD8 molecules. The DP stage is characterized by cells that enlarge and start
dividing, reaching a following resting state after some divisions. The rearrangement of the
alpha chain of the TCR takes place now. These resting cells express low levels of TCR
and are now tested for their ability to recognize self-peptide: self-MHC complexes. Only
the ones that recognize these self-complexes are positively selected, and go on to mature
and express high levels of TCR. At the same time, they stop the expression of either CD4
or CD8, becoming single-positive T cells (SP) [53].
The other hard examination for these lymphocytes is the so called negative selection,
in which all the T-cells responding to self-peptides with high affinity are eliminated. This
is the main process that avoids possible autoimmune diseases. It has been clear for the
past 20 years that only 5% of the total DP lymphocytes are actually able to survive
this double-check, maturing as single positive and entering the blood stream [69, 162].
In these studies it was found that nearly 90% of developing thymocites die for neglect
(process killing those T cells which would not be functional due to their inability to bind
MHC), while a further 5% die for deletion. When we add this small survival percentage
to the thymic involution due to aging, it is clear that much more effort is needed in order
to understand the functional relationship between diversity and immune robustness.
An interesting fact is that thymic involution cannot be considered, by itself, the cause
of observed loss in diversity of the repertoire. In particular, a study [82] argues the im-
portance of future experimental capabilities, mathematical modeling and data analysis in
unraveling the interconnections among thymic involution and clonal expansions due to
virus infections or genetic mutations. On this matter, another study found challenging
results [130]. A part from confirming the fact that thymic involution does not imply a low
diversity in the repertoire, they found that age had an important impact on the inequality
of clonal sizes. In particular, the results were indicating an uneven homeostatic prolifera-
tion in elderly individuals, where this unevenness was not related to clonal expansions in
the memory sub-population. Most remarkably, the authors clearly state their opinion on
the difference between human and animals repertoires, comparing their results to those
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of a similar study [52] :“Conclusions for the human repertoire from animal models are
unreliable because the size of the T-cell compartment and mechanisms and kinetics of
T-cell homeostasis are fundamentally different in humans and mice”. The author of this
manuscript fully agrees with this particular point of view.
Many studies have been focusing on the impact of positive and negative selection on
repertoire diversity. Some of them, have particularly focused on the impact that the
self-peptides sampling process deployed by APCs has on the repertoire diversity both in
the thymus and in the periphery [88]. In particular, these authors recall the importance
of maintaining the well established affinity model to understand selection in the thymus
[2], which proposes that selection outcome is established by the affinity of the TCR for a
pMHC complex, but they also emphasize how important it would be, for a coherent model
of thymocyte selection, to consider also the spatial and temporal aspects of self recogni-
tion in different micro-environments within the thymus itself. The molecular mechanism
that distinguishes positive and negative selection and their impact on repertoire diversity
remains nowadays a complex system not fully understood, and it is striking to think that
nearly 20 years ago we were already starting thinking about this unresolved problem [144].
The problem of repertoire diversity in the periphery has been studied for a long time,
and a “flight for survival” was suggested for lymphocytes in the periphery [64]. The
authors discuss the importance of considering a continuous selective pressure throughout
the entire lymphocyte life story, due to the constant need to acquire selective advantage
on their competitors. The importance of different life stages is also underlined, as well as
the presence of specific survival niches to which different lymphocytes belong in different
stages of their cell differentiation.
1.3 Biological terminology
• AIRE: The autoimmune regulator (AIRE) is a protein encoded by the AIRE gene
in humans. It is a transcription factor mainly present in a part of the thymus called
medulla and it controls the mechanism underlying the prevention of autoimmune
diseases. T cells recognise epitopes presented on a MHC molecule complex, and
those T cells that attack the body’s own proteins are eliminated in the thymus.
The main goal of AIRE is to induce transcription of a wide selection self genes that
creates proteins which a T cell could only usually encounter in peripheral tissues,
creating what has been defined as an “immunological self-shadow” in the thymus
[11]. These proteins, called “tissue-specific self-antigens” (TSAs), are then expressed
by medullary thymic epithelial cells (mTECs) or general stromal cells, and T cells
that respond to those proteins are eliminated through cell death (apoptosis). This
is the reason why AIRE it is thought to drive negative selection [114].
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• Antibody: Also known as immunoglobulin (Ig), it is a protein produced by plasma
cells, a type of white blood cells. They recognize a unique part of the foreign target,
called antigen [99]. Antibodies can either be secreted from the cell, having a soluble
form, or they can be bound to the B cell surface. In this case, they are known as B
cell receptors (BCRs)[114].
• Antigen: An antigen (Ag) is any molecule that serves as target for the T or B cell
receptors and antibodies. The name is an abbreviation of antibody generator [114].
• Apoptosis: Apoptosis is the process of programmed cell death (PCD). It is a
complex set of activation mechanisms that, once started, inevitably lead to cell
death. Apoptosis should not be confused with necrosis, that is the death of a cell
caused by external factors [58].
• Artemis: One of the key enzymes involved in V(D)J recombination process [50].
This is the process by which T cell or B cell receptors are created by recombining
gene segments known as variable (V), diversity (D) and joining (J). The joining of
a V and D segment starts with the RAG (recombination activating gene) nuclease
cutting both DNA strands besides the V segment and the D segment. A hairpin
structure is formed at the two remaining ends, called the coding ends. Here is when
Artemis nuclease comes into play, together with the DNA-dependent protein kinase
(DNAPK), binding to these DNA ends and making a single cut near the center of
the hairpin. Further processing is applied to the exposed 3’ termini, mainly deletion
and addition of nucleotides, before the V and D segments are ligated to restore the
integrity of the chromosome. The exact cutting point for Artemis is variable and this
variability, combined with random nucleotide deletion and addition, is the source of
extreme diversity in the resulting antibody or T cell receptor genes [114].
• ATP hydrolysis: Reaction in which chemical energy is released from the high-
energy phosphoanhydride bonds in adenosine triphosphate (ATP) where it is usually
stored. This reaction produces mechanical energy. Adenosine diphosphate (ADP)
and an inorganic phosphate, orthophosphate (Pi), are the two main products. A fur-
ther hydrolyzation process can then occur on the ADP to produce energy, adenosine
monophosphate (AMP), and another orthophosphate (Pi) [105].
• Autophosphorylation: Modification of proteins occurring after the translation
process. A phosphate group is added to serine, threonine or tyrosine residues within
protein kinases, normally to regulate the catalytic activity [149].
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• Blunt end: Blunt end refers to the simplest DNA end of a double stranded molecule.
In a blunt-ended molecule both strands terminate in a base pair, leaving no overhangs
or unpaired bases.
• DNA-PK: DNA-dependent protein kinase is an enzyme very important for the
V(D)J recombination process. DNA-PKcs is the catalytic subunit of DNA-PK. The
second component is the enzyme Ku [73].
• Hairpin: Also known as stem-loop, it is an intramolecular structure. It consists of
a single-strand DNA (or just a RNA molecule) in which two complimentary regions
come together, forming a double-helix that ends with a non-pairing base sequences,
leaving the end open in a loop [43].
• In-frame: See ORF and Reading frame.
• Ku: Ku is an important enzyme for the V(D)J recombination process. It is a het-
erodimer of two polypeptides, Ku70 (XRCC6) and Ku80 (XRCC5). In humans, Ku
forms a complex with the DNA-dependent protein kinase catalytic subunit (DNA-
PKcs) to form the full DNA-dependent protein kinase, DNA-PK [110].
• Locus: In genetics, a locus is the specific location of a gene, DNA sequence, or
position on a chromosome.
• ORF: An open reading frame (ORF) is the part of a reading frame that has the
potential to code for a protein or peptide. It is a continuous stretch of DNA typically
starting with the a methionine sequence (ATG), and ending with a stop codon (TAA,
TAG or TGA in most genomes).
• RAGs: The recombination-activating genes (RAGs) encode enzymes that play an
important role in the VDJ recombination process. There are two recombination-
activating gene products known as RAG-1 and RAG-2, whose cellular expression is
restricted to lymphocytes during their developmental stages [139, 114].
• Reading frame: A reading frame is a way of dividing the sequence of nucleotides
in a nucleic acid (DNA or RNA) molecule into a set of consecutive, non-overlapping
triplets. In particular, these triplets are called codons if they represent amino acids
or stop signals during translation.
• RSSs: Recombination signal sequences (RSSs) are short stretches of DNA flank-
ing the V, D and J gene segments of the V(D)J recombination process. They are
composed of seven conserved nucleotides (a heptamer) that reside next to the gene
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Figure 1.1: Sequential rearrangement of TCR αβ genes.
encoding sequence followed by a spacer (containing either 12 or 23 variable nu-
cleotides) followed by a conserved nonamer (9 base pairs). Only a pair of dissimilar
spacer RSSs are efficiently recombined (i.e. one with a spacer of 12 nucleotides will
be recombined with one that has a spacer containing 23 nucleotides). This is known
as the 12/23 rule of recombination (or the one-turn/two-turn rule) [21, 114].
• TdT: Terminal deoxynucleotidyl transferase (TdT) is a specialized DNA polymerase
heavily involved in the V(D)J recombination process. It adds N-nucleotides to the
V,D, and J exons during gene recombination, enabling the phenomenon of junctional
diversity [25].
• Transcription factor: Protein that binds to specific DNA sequences, thereby con-
trolling the rate of transcription of genetic information from DNA to messenger RNA
[34].
The reader might want to refer to Figure 1.1 to better understand the following sections.
1.4 V(D)J recombination
The adaptive immune system has to constantly cope with millions of possible pathogens
and, in order to recognize them all, it requires an enormous diversity in its lymphocytes
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repertoire. This high level of diversity would not be possible without a unique genetic
mechanism called V(D)J recombination process, also known as somatic recombination.
The entire process, occurring only in developing lymphocytes during their early stage
of maturation, aims at rearranging different gene segments and it occurs in both B cells
and T cells, generating a wide repertoire of antibodies/immunoglobulins (Igs) and T cell
receptors (TCRs) respectively. The question of whether the recognition system in T cells
and B cells differs and, if so, how, has been present from the very beginning of the studies
on V(D)J recombination [42].
The lymphatic system of a human being comprises lymphatic organs, lymphatic vessels
and the circulating lymph. Thymus and bone marrow are known to be the two primary
lymphoid organs. They represent, respectively, the maturation centers for T-cells and
B-cells. As previously said, somatic recombination occurs in these organs and its ultimate
results are new antigen-binding regions of Igs and TCRs, allowing for the recognition of
antigens from nearly all pathogens.
This incredible process was first discovered in 1987 by Susumu Tonegawa, Ph.D. who
has then been awarded the Nobel Prize in Physiology or Medicine [159].
1.4.1 Recombination in T cell receptors
T-cell receptors (TCRs) are heterodimers built of two different protein chains. In humans,
the great majority of TCRs consist of an alpha (α) and a beta (β) chain, while only a
minority is built from two different chains: gamma (γ) and delta (δ). We focus here on
α/β TCRs, although the recombination process for the γ/δ ones is very similar. Both
TCR α and β chains consist of a variable (V ) protein region (Vα and Vβ) and a constant
(C) region (Cα and Cβ) [114].
The DNA sequence of the human Vα region (TCRα locus, chromosome 14) contains
∼ 70 variable (V) segments and 61 joining (J) segments, followed by a single constant
(C) gene which contains separate exons for the different parts of the constant region of
the protein chain. The human TCRβ locus (chromosome 7) has a different organization:
52 V segments, 1 diversity (D) segment (Dβ1), 6 J segments (Jβ1), 1 constant gene, 1 D
segment (Dβ2), 7 J segments (Jβ2) and another final constant gene [127]. Different from
humans, the mice TCRβ locus (chromosome 6) contains 35 V segments, 2 D segments and
12 J segments [95]. The mice Vα region contains instead ∼ 132 V segments and ∼ 60 J
segments [66, 95].
The variable regions in both chains contain three hyper-variable regions, also called
complementarity determining regions (CDR1, CDR2, CDR3). The first two regions are
only encoded by V segments, while the CDR3 region is the main focus of the entire V(D)J
recombination [166]. The recombination process starts with the joining of a D segment to
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a J segment in the β chain, which can involve either the joining of the Dβ1 gene segment
to one of the six Jβ1 segments or the joining of the Dβ2 gene segment to one of the
seven Jβ2 segments. The next step is the joining of a V segment to the newly formed DJ
complex, followed by deletion of all other gene segments among them. At this stage, the
incorporation of the constant domain gene (Vβ −Dβ − Jβ − Cβ) occurs, followed by the
synthetisation of the primary transcript. Transcription of the mRNA brings to the full
length protein for the TCRβ chain. The α-chain undergoes the same process, differing
only in the lack of the D segments. The β- and α- chains are then assembled, resulting in
the formation of the αβ-TCR that is expressed on the majority of T lymphosytes. In the
next section we will focus on the main joining process that gives rise to any D-J, V-DJ or
V-J coupling.
1.4.2 V(D)J recombination process
The V(D)J recombination process starts with the binding of the recombination activating
gene 1 and 2 enzymes (RAG1 and RAG2) to a recombination signal sequence (RSS) flank-
ing a coding gene segment (V, D, or J). These 2 genes were first discovered in the late 80s
[142] but it was not clear from the very beginning whether these genes could only encode
tissue-specific components of the main structure governing the somatic recombination pro-
cess, the V(D)J recombinase [7]. The recognition of RSS by the RAG complex is fairly
straightforward given the very conservative shape of RSSs. There are three important
elements that help this recognition: a heptamer of seven conserved nucleotides, a spacer
region of 12 or 23 basepairs in length, and a nonamer of nine conserved nucleotides. These
consensus heptamer and nonamer are highly conserved (CACAGTG and ACAAAAACC).
On the other hand, the spacer region is highly variable but with a highly conserved length
[38].
Gene segments that have to be recombined are usually adjacent to RSSs of different
spacer lengths, that is one has a “12RSS” and one has a “23RSS” [160], following what
is well known as the 12/23 Rule. Once two RAG complexes have bound to two different
RSS, the two complexes are brought together and, once close to each other, they create
a single-strand notch in the DNA between the two first bases of the two RSSs (just
before the heptamers) and the respective coding segments attached to these two RSSs
(e.g. V and D segments) [114]. The presence of these breaks introduced at these junctures
was demonstrated early during the studies on somatic recombination [140] but a proper
understanding on the type of notches was not immediately clear [7].
Two different DNA ends are thus created: a hairpin (stem-loop) on the coding segment
and a blunt end on the signal segment [143]. The two double stranded breaks at the
blunt end are then ligated together by the action of a heterodymer protein called Ku
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(Ku70:Ku80) in association with X-ray repair cross-complementing protein 4 (XRCC4),
producing a circular piece of DNA containing the material between the coding segments,
known as signal joint. It is still not clear whether this signal joint is discarded or then
reused in different ways. On the hairpin side, the coding ends are processed prior to their
ligation, leading eventually to junctional diversity [126].
A Ku protein also binds on this side, followed by the DNA-dependent protein kinase
(DNA-PK) and Artemis nuclease complex. Artemis usually has an exonuclease activity,
but it can gain endonuclease activity once bound to the DNA-PK complex, enabling the
opening of the hairpins. Artemis is activated and opens the coding end hairpins [101]. If
the cleavage is in the center of the hairpin, a blunt end is created. If the cleavage is not
centered, the result is an overhang of extrabases on one of the two ends. These bases are
called palindromic (P) nucleotides.
Next, DNA ligase IV, XRCC4, Ku, and DNA-PK align the DNA ends (from the two
different gene segments) and recruit the template-independent DNA polymerase (TdT) in
order to add, in a 5’ to 3’ direction, non-templated (N) nucleotides to the coding end. This
enzyme was immediately designated, from its very discovery, as one (if not the only one)
of the tissue-specific enzymes capable of modifying the V(D)J junctions [6, 7]. Although
it is thought that the addition is random, there have been signs of TdT exhibiting a G/C
preference for the added nucleotides [126].
As last stage, exonucleolytic activity takes place, removing bases to adjust the process
and finally pair the two ends, eventually ligated by DNA ligase IV in association with
XRCC4. The result of this process is a highly variable TCR binding region, allowing the
adaptive immune response to be almost always ready for novel pathogens. The entire pro-
cess requires a high amount of energy, which needs to be strictly regulated and controlled.
As it is now clear, somatic recombination is a highly complex process involving highly
specific procedures.
This mechanism is essential to our survival, being the only process capable of creating
such a diversity against the nearly infinite pathogens possibilities. Being so specific, it has,
unfortunately, the potential to generate aberrant DNA damage in developing lymphocites
[138]. Although the study of these negative effects is not the goal of this thesis, we thought
it was necessary to at least cite the problem for the awareness of the reader [173, 125].
1.5 Studies on T-cell repertoire diversity
Numerous studies examined the T-cell repertoire diversity during the last 30 years, many
of them focusing on the impact of viral infections on the diversity itself [124, 69, 151, 89].
In particular, some studies focused on the stability of the diversity of the TCR repertoire
during and following a viral infection [97]; the authors showed how the Lymphocytic
12
1.5 Studies on T-cell repertoire diversity
Choriomeningitis Virus (LCMV) induced repertoire changes following the clearance of
the viral antigens. The authors also realized the T-cell repertoire skewing properties of
LCMV infections at the memory level. Another interesting result was the generation,
by genetically identical mice, of different T cell responses to the same peptides. Other
authors studied the dynamics of the CD8+ TCR repertoire in response to LCMV infection,
identifying differences of the order of 101 − 102 in the expansion of the T-cell population
in response to two different peptides of the same virus [44]. Thanks to the usage of
mathematical models, they show how this difference in expansion could be due to an
actual difference in proliferation rates or in the proliferation period. Following studies
aimed at determining the main differences among acute and chronic LCMV infections [9],
where mathematical modelling was able to detect the immunodominance effect caused
by chronic infection, as previously showed by [171]. The impact of different epitopes on
CD8+ T-cell response gave even more insights [141], indicating that the magnitude of the
response might be influenced by the epitope specificity but the same does not seem to hold
for the TCR β chain repertoire diversity (in mice). In fact, the β-repertoires showed very
little difference in response to three different infections. The main goal of the authors was
to address the question on whether or not it would be possible to modify the diversity and
specificity of the CD8+ repertoire by changing the vector used to deliver the particular
epitope taken into consideration.
A different aspect of the T-cell repertoire diversity has also been studied during the
years: the bias present at the very first steps of the TCR repertoire creation, that is
the unbalanced process of the somatic recombination. An important result was shown
[136], and for the first time it was clarified that the V(D)J recombination process is
biased towards some specific V-D-J combinations, contrarily to what was believed until
that moment. The authors proved this striking result thanks to an analysis of the size
of the V-D-J overlap in unrelated adult humans. As previously described, the positive
and negative selections play a main role in shaping the repertoire. It becomes even more
important when considering the possibility that T cells could escape negative selection
even though presenting the potential to express two different functional TCR α chains
[41]. The results from this study came from a new PCR technique for the simultaneous
analysis of both α and β chains from single cells experiments, developed by the same
authors. The authors discuss the importance of these findings, suggesting the possibility
of triggering autoimmunity as a consequence of infection, in case one of these special
double-TCR T cells were to be the respondent to some infection. Other authors have
discussed the problem of autoimmunity related to the cross-reactivity concept [120]. The
focus was on the possibility, for an incompletely deleted na¨ıve T cell population specific for
a tissue-restricted self peptide, to be triggered by systemic production of self-peptides and
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cause autoimmune problems. Studies on CD8+ and CD8− TCR repertoire in troutes were
carried with some interesting results [32]: different regulatory patterns for the diversity
of TCR β chains by CD8+ and CD8− in trout and mammals could exist. The authors
in fact found out that the CDR3 region for the different β chains had much more regular
profiles after the viral infection, suggesting a mechanism for which the infection itself lead
to multiple expansions of CD8− T cell clonotypes, possibly reducing the importance of the
large peaks otherwise observed in the uninfected troutes. The authors argue that precisely
this finding could favor the idea of different impact of infections on CD8− and CD8+, in
both trout and mice.
TCR diversity was also studied in relation to T-cell subsets, such as effector, cen-
tral/effector memory and na¨ıve cells, in both CD8+ and CD4+ populations [27]. TCR
expansions were found in the effector subpopulations as opposed to na¨ıve or memory ones.
Following these findings, the authors argued the importance of including subset analysis in
TCR repertoire studies and suggest the idea of a more polyclonal-oriented antigen-driven
expansion in long-lived T central memory cells as opposed to a more oligoclonal expan-
sion in short-lived T effector cells. The importance of T-cell subsets was also the focus
of other authors [119]. T-cell precursor frequencies were found not to be correlated with
immunodominance hierarchies induced by pathogen presentation; public clonotypes were
found to be rare in the precursor pool while the memory pool presented narrower TCR
repertoire diversity. A broad analysis of CDR3β from healthy mice was carried out in 2014
[103]. An extensive number of publicly shared sequences was found and it was suggested
that despite the random generation process of TCR repertoires, a sort of uniformity was
present in the mice repertoires’ diversity, suggesting ongoing selection tends to modify
the initial ranomized diversity. A different study suggested instead a possible connection
between T-cell precursors and immunodominance hierarchies [132]: in fact the authors
suggest that the age-related modifications in T-cell immunodominace hierarchies may be
driven by changes in numbers of T-cell precursors.
A deeper insight into the mechanism of somatic recombination and TCR repertoire
diversity was given by a study aiming at assessing the impact of individual genetic factors
on the immune diversity [175]. Exciting discoveries emerged from this study: first, the
overlap between TCR repertoires of monozygous twins was not that different to the overlap
of unrelated individuals. Second, and possibly even more striking, the authors discuss
results in which the TCR V genes choice for recombination in the thymus is strictly related
to genetic traits, as already shown in a previous study [109], while the choice of TCR J
genes seems to be completely random. They also discuss the preference, in subsequent
selection in the thymus, of some α J segments as opposed to β J segments.
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The potential of bioinformatics to detect the immunological status of a patient was
studied in a very interesting piece of work [75]. Here the authors introduce a bioinformatics
framework working on Hill-based diversity profiles enabling quantification of immunolog-
ical information enclosed in immune repertoires. A broad range of immunological states
such as healthy or transplantation recipient were able to be predicted with high accuracy,
instilling the idea that, in the near future, repertoire profiling could help recovering a
great amount of what they define as immunodiagnostic fingerprints. In a similar way,
other authors reviewed different biotechnological methodologies (mainly high-throughput
sequencing HTC) for the study of TCR repertoire diversity, highlighting the profound
effect of these techniques on our knowledge of the immune system dynamics during health
or diseases [78]. Going back on the topic of the importance of bioinformatics on immune
repertoire analyses, it is worth mentioning a recently developed computational model
called TraCeR [154]. This method is able to reconstruct full-length, paired TCR sequences
from single-cell analysis.
The first analysis of both the na¨ıve and the epitope-specific TCR αβ repertoires was
developed only recently [40]. The authors argue the scarce and not accurate information
carried on by studies of subsets of cells or of single TCR chains. They claim in fact that
TCRα usage is at least as diverse as TCRβ usage. Before concluding this section, we
would like to give a quick overview of the different clonal size estimations that have been
given during the years, in order to give a taste of the difficulty of this research area. From
bulk studies on mouse, TCRβ uniquess was said to be around 10% [30], 28% [31], 55%
[128] and 68% [131] of the total sequences analyzed. In humans the situation is not much
better, as the number of distinct clonotype classes was estimated to be between 106 and
2× 107 [13, 130, 135].
So far, we have given an overview of the general understanding of the biology behind
those immunological complex systems that somatic recombination and diversity mainte-
nance are. More could be said, especially from the point of view of the quantitative efforts
made during the last 30 years to broaden the knowledge in this area, but we will leave
these themes for the next chapter, in a specific section dedicated exactly to the evolution
of quantitative methods in this research area.
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Chapter 2
Mathematical Introduction
This section focuses on the definition of the basic probability concepts generally used
in this thesis. Firstly we will introduce the general concepts of a probability space,
which will help defining a general random variable X, together with some of their main
properties, such as its expected value E(X), its variance Var(X) and probability generating
function φX(z). We will then focus on some important general properties of the pgf, before
introducing different examples of both discrete and continuous distributions. Finally,
we will move the attention to stochastic processes and Markov chains, introducing basic
results.
2.1 Probability spaces
In probability theory probability space (Ω,F,P) is defined as a mathematical construct
[77]. The first part of a probability space is the sample space Ω, defined as the set of all
possible outcomes of the considered random process. We define now the other two parts:
F and P.
2.1.1 The set of events F
Let Ω and 2Ω be respectively a set and its power set, where the power set 2Ω is defined
as the set of all possible subsets of Ω including the empty set Ø and Ω itself. The set
of events F ∈ 2Ω is mathematically defined as a σ-algebra [77], that is a subset of 2Ω
satisfying three important properties:
• Ω ∈ F;
• F is said to be closed under complementation, that is if f ∈ F, then Ω \ f ∈ F;
• F is said to be closed under countable unions, that is if f1, f2, f3, · · · ∈ F, then
f = f1 ∪ f2 ∪ f3 ∪ · · · ∈ F.
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It is important to notice that the term event must be seen as a set of zero, one or multiple
outcomes, that is a subset of the sample space.
2.1.2 The probability measure P
Let us consider a set of events F in a probability space (Ω,F,P). A probability measure
P is defined as a real-valued function P(f) on F satisfying two main requirements:
• P(f) ∈ [0, 1], with P(Ø) = 0 and P(Ω) = 1;
• Countable additivity property i.e., for all countable collections {fk} of pairwise dis-
joints sets, P
(⋃
k∈K
fk
)
=
∑
k∈K
P(fk).
2.2 Random variables
A real-valued random variable X is a real-valued function X : Ω → R = (−∞,∞). In
this probability space, the probability P(X ≤ k) represents the probability of the set of
outcomes {ω ∈ Ω : X(ω) ≤ k}. From now on P(X ≤ k) will be indicated by Pr(X ≤ k).
Real-valued random variables can be divided in two distinct cathegories: discrete and
continuous random variables. Discrete random variables may only take a countable number
of values, such as {0, 1, 2, · · · }, while a continuous random variable takes an uncountable
(infinite) number of possible values. Examples of both kinds will be given in the next
sections. We are now defining the cumulative distribution function for a generic random
variable, which will allow us to define the probability mass function for a discrete random
variable and the probability density function for a continuous random variable. We will
also introduce the expected value, variance of a general random variable, distinguishing
between the discrete and the continuous case. Finally, we will introduce the concept of
probability generating function for a discrete random variable.
2.2.1 Cumulative distribution function (cdf)
Given a random variable X : Ω → E(E ⊆ R), the cumulative distribution function (cdf)
FX(x) : E → [0, 1] for the random variable X is the function defined as
FX(x) = Pr(X ≤ x) = Pr({ω ∈ Ω : X(ω) ≤ x}).
2.2.2 Probability mass function (pmf)
Given a discrete random variable X : Ω→ E(E ⊆ R), the probability mass function (pmf)
fX(x) : E → [0, 1] for the random variable X is the function defined as
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fX(x) = Pr(X = x) = Pr({ω ∈ Ω : X(ω) = x}).
2.2.3 Probability density function (pdf)
Given a continuous random variable X with cdf FX , and assuming the existence of a
non-negative, integrable function fX(x) : E → [0,∞) such that
FX(x) =
∫ x
−∞
fX(y)dy,
then the function fX(x) is called the probability density function (pdf) for the random
variable X.
2.2.4 Independent random variables
Consider two continuous random variables X and Y , with probability density functions
fX(x) and fY (y) respectively. Let their joint probability distribution be f(x, y). The
random variables X and Y are said to be independent if and only if
f(x, y) = fX(x)fY (y) ∀(x, y) ∈ Ωx × Ωy.
If we consider discrete random variables, the same holds considering probability mass
functions instead of probability density functions.
2.2.5 Expected value and variance
Given a discrete random variable X taking values x1, x2, x3, · · · with probabilities p1, p2, p3, · · · ,
its expected value E(X) is defined as
E(X) =
∞∑
i=1
pixi,
while its variance Var(X) is defined as
Var(X) =
∞∑
i=1
pi(xi − E(X))2.
Given a continuous random variable X taking values in A ⊆ R with pdf fX(x), its expected
value E(X) is defined as
E(X) =
∫
A
xfX(x)dx,
while its variance Var(X) is defined as
Var(X) =
∫
A
(x− E(X))2fX(x)dx.
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2.2.6 Conditional probability
Consider two random variables X and Y . The conditional probability that X = x given
that Y = y is defined as
Pr(X = x|Y = y) = Pr(X = x and Y = y)
Pr(Y = y)
.
2.2.7 Probability generating function (pgf)
Let X ≥ 0 be a discrete random variable with probability mass function fX(x). The
probability generating function (pgf) of X is defined as
φX(z) = E(zX) =
∞∑
x=0
fX(x)z
x. (2.1)
Some important basic properties of pgf are now given. The reader is directed to any uni-
versity textbook on probability theory for the proof of these properties. A good reference
book for stochastic processes applied to biology where these properties can be found is [5].
The first property is the relation between the pmf fX(x) and the pgf, given by
fX(k) = Pr(X = k) =
φ
(k)
X (0)
k!
, (2.2)
where k! indicates the factorial of k while, for a general function g(x), g(k)(0) indicates
the kth derivative of the function g calculated at x = 0.
The second important property is
φX(1
−) =
∞∑
x=0
f(x) = 1, (2.3)
where φX(1
−) = limz→1−φX(z) and z is going to 1 from below.
A third important property of the pgf is as follows:
E(X) = φ(1)X (1
−). (2.4)
Finally, we cite the following useful property: let X1, X2, · · · , Xn be a set of indepen-
dent random variables. Define Sn =
n∑
i=1
Xn. The pgf of Sn is
φSn(z) = φX1(z)φX2(z) · · ·φXn(z). (2.5)
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2.3 Discrete random variables
In this section we give a quick overview of the main discrete distributions that will be used
in different chapters of this manuscript. We briefly recall that a discrete random variable
takes values on a finite (or countable) list of possible values with certain probabilities
described by the probability mass function.
2.3.1 Bernoulli distribution
Probability distribution of a random variable X taking value 1 with probability p ∈ (0, 1)
and value 0 with probability q = 1− p. We have
• Pr(X = k) =
{
p for k = 1
q for k = 0
,
• E(X) = p,
• Var(X) = pq,
• φX(z) = q + pz.
2.3.2 Binomial distribution
Probability distribution of a random variable X representing the number of successes in a
sequence of n independent Bernoulli trials, where each trial has a probability p of success.
The special case n = 1 represents the Bernoulli distribution. We have
• Pr(X = k) =
(
n
k
)
pk(1− p)n−k,
• E(X) = np,
• Var(X) = np(1− p),
• φX(z) = (1− p+ pz)n.
2.3.3 Geometric distribution
Probability distribution of the number X of Bernoulli trials needed to get the first success,
where each trial has a probability p of success. We have
• Pr(X = k) = p(1− p)k−1, k = 1, 2, ...
• E(X) = 1
p
,
• Var(X) = 1− p
p2
,
• φX(z) = pz
1− (1− p)z .
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2.3.4 Poisson distribution
Probability distribution of the number X of events occurring in a fixed interval of time,
knowing that these events occur independently and with a fixed average rate λ. We have
• Pr(X = k) = λ
ke−λ
k!
, k = 0, 1, 2, ...
• E(X) = λ,
• Var(X) = λ,
• φX(z) = eλ(z−1).
2.3.5 Logarithmic distribution
Probability distribution originally used for the modelling of species abundance. The only
parameter is p. We have
• Pr(X = k) = −1
log(1− p)
pk
k
, k = 1, 2, ...
• E(X) = −1
log(1− p)
1
1− p ,
• Var(X) = −p p+ log(1− p)
(1− p)2log2(1− p) ,
• φX(z) = log(1− pz)
log(1− p) .
2.3.6 Hypergeometric distribution
Probability distribution of the number of successes X in n draws without replacement,
where the draws are taken from a finite population of size N that contains exactly K
successes. It is similar to the Binomial distribution, with the exception that the draws are
taken without replacement. We have
• Pr(X = k) =
(
K
k
)(
N−K
n−k
)(
N
n
) , k = 0, ... min(n,k)
• E(X) = nK
N
,
• Var(X) = nK
N
N − n
N − 1
N −K
N
,
• φX(z) =
(
N−K
n
)
2F1 (−n,−K;N −K − n+ 1; z)(
N
n
) ,
where 2F1 (−n,−K;N −K − n+ 1; z) represents the ordinary hypergeometric function.
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2.4 Continuous random variables
In this section we give a quick overview of the main continuous distributions that will be
used in different chapters of this manuscript. We briefly recall that a continuous random
variable takes values on an uncountable list of possible values with certain probabilities
described by the probability density function.
2.4.1 Exponential distribution
Probability distribution describing the time between events in a process where events
occur in a continuous way, independently from each other, and at a constant average rate
(known as Poisson process). It can be seen as the continuous analogue of the geometric
distribution. We have
• f(x) = λe−λx, x ≥ 0
• E(X) = 1
λ
,
• V ar(X) = 1
λ2
.
2.4.2 Gamma distribution
This probability distribution can be parametrized by a shape parameter α and a rate
parameter β. Different parametrizations are possible. We have
• f(x) = β
αxα−1e−xβ
Γ(α)
, x ≥ 0
• E(X) = α
β
,
• V ar(X) = α
β2
,
where Γ(z) represents the Gamma function defined as
Γ(z) =

(z − 1)! for z positive integer number
∫ ∞
0
tz−1e−tdt for z complex number with positive real part
2.4.3 Beta distribution
This probability distribution is parametrized by two shape parameters α and β. We have
• f(x) = x
α−1(1− x)β−1e−xβ
B(α, β)
, 0 ≤ x ≤ 1
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• E(X) = α
α+ β
,
• V ar(X) = αβ
(α+ β)2(α+ β + 1)
,
where B(x, y) represents the Beta function defined as
B(x, y) =

(x− 1)!(y − 1)!
(x+ y − 1)! for x, y positive integer numbers
∫ 1
0
tx−1(1− t)y−1dt for x, y complex numbers with positive real part
2.5 Stochastic processes
Consider a subset T of [0,∞). Consider a family of random variables {Xt(s) : t ∈ T, s ∈
Ω}. This family is called a stochastic process. Depending on whether T is countable or
uncountable, and depending on whether Xt(s) are discrete or continuous random variables,
{Xt(s) : t ∈ T, s ∈ Ω} needs different techniques to be analyzed. For a countable T , we
have a discrete-time stochastic process; when instead we have an uncountable T , the
process is defined as continuous-time stochastic process. The literature and knowledge
on stochastic processes are very broad but, for the purposes of this thesis, the following
sections will only briefly introduce a special class of stochastic processes, the Markov
processes.
2.5.1 Markov processes and Markov chains
Briefly speaking, a stochastic process has the Markov property if its future behaviour
depends on the present state only, and not on all the previous ones. In particular we
are interested in expressing this property for a discrete-time stochastic process where
T = {0, 1, 2, . . .}. We say that the process {Xt}t∈T has the Markov property if
Pr(Xt = xt|Xt−1 = xt−1, . . . , X0 = x0) = Pr(Xt = xt|Xt−1 = xt−1).
In particular, the probabilities Pr(Xt = xt|Xt−1 = xt−1) are called transition probabilities.
Given the set T being discrete, we define this Markov process as discrete-time Markov
chain. The natural extension of this property to the continuous-time case can be stated in
the following way. Consider T uncountable. A continuous-time stochastic process {Xt}t∈T
with space of states S is a continuous-time Markov chain if
Pr(X(t) = j|X(tn) = in, . . . , X(t1) = i1) = Pr(X(t) = j|X(tn) = in)
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where 0 ≤ t1 ≤ · · · ≤ tn ≤ t is any non-decreasing sequence of n+1 times and i1, . . . , in, j ∈
S are any n+ 1 states in the space of states, for any integer n ≥ 1.
2.6 Mathematical analyses of repertoire diversity
Species diversity has been the focus of a broad amount of work for more than 70 years
now. A great amount of literature has been produced during these years, but an overview
of this literature is not the goal of this section. Here we aim at reviewing mathematical
models and species diversity similarity measures, as well as statistical methods, applied
to the study of T-cell receptor repertoire diversity. An enormous effort has been made
by scientists from all over the world in the last 20 years to deepen the knowledge of the
mathematical bases of V(D)J recombination process, TCR repertoire diversity, immune
sampling diversity and immunenodiversity-related problems. We here review the main
steps of this journey, trying to maintain a certain historical continuity.
One of the first contributions in this sense focused on the development of a probabilis-
tic model trying to explain the connection between repertoire diversity, self antigens and
foreign antigens [46]. The authors basically address the question of how diverse the reper-
toire should be in order to be able to recognize all the theoretically possible pathogens.
The importance of the diversity of self antigens that the immune system needs to avoid
reactivity with is established, showing that the number of these particular peptides is the
main driver of repertoire diversity, rather than the number of foreign antigens. A few years
later, similar work was carried out focusing specifically on the immunological feature of
cross-reactivity [106]. In this study, the necessity of a wide cross-reactive ability of T cells
were analysed, leading to the well known problem of the lymphoid system of an hypothet-
ical mouse with one clonotype for each possible MHC-associated peptide: such a mouse,
even considering the best case in which it had only one cell in each clone, would need a
lymphoid system 100 times larger than the mouse body itself. In 1999, interesting work
was done on affinity-driven TCR repertoire selection and the problem of alloreactivity
[53], the problem of T cells responding to foreign MHC entering the body, for example
following an organ transplant [116]. The authors simplify the structural complexity of a
TCR to a digit string representation, claiming the advantage of such a formalism, over
previously proposed bit strings approaches [45], in order to control the resolution of affinity
distribution.
A different interesting problem was also studied in those years: the requirement for
regulatory T cells (Tregs) [107]. The existence of Tregs had already been experimentally
established, but the reasons behind their presence in the immune system were not clear.
Apart from preventing autoimmunity problems, the authors suggest that Tregs may be a
subset directly generated in the thymus with the goal of controlling inflammatory responses
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induced by enteric organisms. In 2003 a very interesting article was published, suggesting
the possibility for the repertoire to have fractal properties [118]. The main striking result
concerned the possibility to describe not only the population of ranked clonotypes, but
also the clonal frequencies of many different subsets of the repertoire, by a power law-like
distribution.
A quantitative model of thymic selection, involving structural differences within the
thymus, was developed in those years [59]; the main goal of the model was to estimate the
fractions of T cells positively (and negatively) selected in both main areas of the thymus,
namely the cortex and the medulla. Results indicated that the majority of the thymocytes
die due to neglect selection in the cortex, and that the negative selection might happen
with a higher probability in the medulla. During those years, another important research
area was being explored: mathematical methods to compare the diversity of samples drawn
from a given TCR repertoire. Facing this problem means facing the same problems that
mathematical ecology had been facing (and was still facing) in trying to estimate species
diversities from selected samples, but in a much more hostile mathematical environment.
In fact, as the reader will be able to appreciate in this manuscript, the number of lym-
phocytes in a human body is of the order of 1012 while the estimated number of different
clonotype classes is approximately 108. Established methods for comparing sample di-
versity were discussed in a work of 2007 [164]. In particular, one method was discussed
(applied in this manuscript in Section 4.3.2): the use of a non-parametric statistical test
called randomization test, based on a test statistic called Simpson’s diversity index.
Stochastic models were used to study TCR repertoire diversity [153]. The authors built
a stochastic model incorporating competition for survival signals among competitors. In
particular, they built on the concept of niche overlap previously introduced by [47, 48, 49]
and defined the concept of robust repertoire as one in which the loss of some classes
wouldn’t affect its capabilities that much, but at the same time with the least possible
overlap in the coverage of the epitope space. The main result was, for a robust repertoire,
the biological property for which the majority of the clonotype classes clusters around
a mean value of niche overlap ν = 1. The authors avoided to include other types of
competition in the model, such as the non-TCR specific one for cytokines previously
studied in [26], arguing that this non-TCR specific competition impact the total number
of T cells, and not repertoire diversity, as discussed in [104].
Different Poisson abundance models (PAMs) were presented in [145], where the authors
discussed the statistical incompleteness of previous studies on TCR diversity estimates
comparing the repertoires of T-cell subsets [62, 170, 92]. In particular, the PAMs were
used to study the clonal size distributions of mice with limited TCR diversity. The ex-
ponential distribution is among those theoretical distributions obtained as possible clonal
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size distributions. Although we believe that discrete distribution would better fit the
modelling of clonal size distributions, an interesting point of discussion was proposed in
1957: the broken stick model of [102]. In particular, the authors argue that, even though
the exponential distribution can be derived by this model, this model itself might not be
well representative for the TCR repertoire given the time-dependent changes of thymic
micro-environments, described as structural niche, together with signal niche as described
above. To overcome this problem, they recall a similar model, the sequential broken stick
model [155]. This model would be a better representative of the time dependent structural
properties of the thymic niches, and would bring to the hypothesis of a Lognormal clonal
size distribution. The application of the analytical solution to the unseen species problem
given by [63] to the problem of TCR diversity was followed by [135], with the main result
being a much higher diversity (∼ 4-fold) than what reported in the previous studies [13].
A mathematical model taking into account both intra- and inter-clonal competition
was developed to evaluate the different impacts of TCR-specific and TCR-nonspecific reg-
ulatory signals over T cells coming from a transplanted thymus in patients affected by
DiGeorge Anomaly [35]. The main result of this stochastic model was the little impor-
tance of TCR-specific regulatory signals if a homeostatic case was considered. As previ-
ously said, there are many statistical measures developed by ecological studies on species
richness or species overlap. Many of these non-parametric models have been used in TCR
repertoire diversity with many limitations and very little insight. To possibly overcome
these problems, a parametric model, based on a multivariate Poisson-lognormal distribu-
tion, was suggested and tested on transgenic mice populations [134]. The particular idea
of Poisson-lognormal was based on previous studies indicating that mixtures of Lognormal
distributions might be good estimation of clonal size distributions [145]. A follow up on
similar ideas has been made some years later (2013) by [74], where the observed receptor
counts were modelled by a multivariate Poisson abundance mixture (mPAM). The new
idea proposed was a Bayesian parameter fitting model not based, as in previous studies,
on the conditional posterior likelihood (conditioned on the number of observed species)
but on the complete one, showing this technique to be more effective in modelling TCR
count data. On a very different line of reasoning, a work for the statistical inference of the
generation probability of TCRs was carried out [115]. The authors built a model capable
of predicting the probability of being generated, for a given CDR3 region, by the primitive
recombination process. The typical CDR3 sequence could be produced by something like
30 different recombination events, suggesting that a deterministic approach would cause
great systematic biases and correlation in the model which could not be overcome. In
particular, they focused on nonproductive CDR3 sequences, allowing the description of
the generation probability of the CDR3 sequences before any kind of functional selection.
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A remarkable result is the importance of insertions in the enhancement of the diversity
level: around 60% of the total diversity is due to insertions.
Following the interesting idea of 2003 explained above, some authors described the
fractal properties of the human TCR repertoire in both health and after stem cell trans-
plantation conditions [108]. In particular, they find a diminished (but still present) fractal
distribution of TCR gene segments in patients after stem cell transplantation.
In 2013, a comprehensive overview of the existing technological and mathematical
analysis for repertoire diversity studies was carried out by [148]. From the mathematical
point of view, the authors drew a sketch of the recent mathematical efforts to unravel TCR
repertoire diversity, in particularly the ones inspired by the advances in sequencing tech-
nologies such as [135, 168]. They cite anyway some recent works on population dynamics
based on differential equations [129, 12], while for the various systems-biology approaches
to signal processing and population survival, they refer to [68, 8].
A fascinating biological hypothesis, especially for its simplicity, accounting for the
great difference between potential and actual TCR repertoire diversity was named as
“evolutionary sloppiness” by [172]. The authors suggests that the theoretical potential
diversity of the thymus could be attributed to a simple fact: reducing the amount of
potential diversity could require much more energy-consuming check in the recombination
process, energy that evolution simply decided not to waste. The authors also argue for
the idea that cross-reactivity in response to different pathogens is indeed a rare event in
na¨ıve repertoires, but that it can become much less than rare in repertoires subject to
successive infections. A different attempt to study the immune system has been made by
bioinformatics. In particular, a review on immunological profiling and computational tools
to analyse high-dimensional data was published in 2014 [86]. The main goal of the paper
is to highlight the need of a more general framework able to integrate different data sets,
and they achieve this goal while describing some of the main analysis and visualization
tools for systems immunology.
The different shortcomings of recent mathematical methods for the diversity estimation
that had been applied to TCR studies were discussed again in 2015 [93]. One of the main
problems brought to light is the well-known “unseen species” problem. Some estimators
were shown to be biased by sample sizes, as well as by what they define as the problem
of “under-sampling”. Parametric statistical methods were argued to be based on the
need of an a priori frequency distribution which we actually do not know. In response
to this, the authors developed a new estimator (DivE) which does not require any a
priori assumption. DivE had been previously tested, against five different non-parametric
estimators, on three independent datasets [94]. DivE was proved to be much more efficient
in estimating diversity with different sample sizes. In particular, the other estimators
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tended to increase the estimated diversity with the increase of sample sizes, while DivE
was able to maintain an accurate estimate for all datasets. On the same line of [115], a
second paper was published to infer somatic recombination processes of B cells [57]. The
resulting similarities with the previous work on T cells were expected to be very common,
given the existence of a unique underlying recombination process for both T and B cells.
A very interesting aspect of these studies is given by the authors’ suggestion for a sort of
evolutionary adaptation of the generation process, due to the main results indicating that
sequences with higher probability to be produced are also the ones with higher probability
to pass the selection process in the thymus. Besides the many similarities, there was an
important difference between T- and B-cell repertoires: the former are much less diverse
than the latter ones, due to the lower number of insertions in the T-cell recombination
machinery.
A different study, defined by its authors as the first of its kind, focused on in-depth
analysis of CD8+ T-cell repertoire at the single level lineages [54]. In particular the
authors aimed at a deeper understanding of the dynamics of CD8+ T-cell repertoire upon
vaccination of a particular attenuated yellow fever virus vaccine. High-throughput data
and an algorithm based on the well-known Fisher exact statistical test were the basis for
this study. Thanks to these techniques, the authors were able to identify 2000 different
clones, 12% of which was then detected in the long-term memory compartment. Different
authors also focused on long-term maintenance of human T cells, with a particular focus
to the na¨ıve repertoire [157]. The study aimed at assessing the spatial distribution of
diversity in different lymphoid tissue sites. Results revealed an interesting tendency of the
repertoire diversity: for individuals forty years old (or older), site-specific clonal expansions
were detected and a minimal overlap among the different lymphoid tissues. These main
results were suggested by the use of Simpson’s diversity index, Shannon entropy and
Jensen-Shannon divergence measure. In 2016 two papers were published, proving once
more the increasing importance of bioinformatics and data-driven modelling in solving
immunological problems [83, 165]. From the creation of a statistical method (Recon), based
on maximum-likelihood theory, to the perspectives emerging from a particular workshop of
the National Institute of Allergy and Infectious Diseases, the importance of computational
data-driven modelling which enhance the quality of immune studies is becoming clearer
and clearer.
A different mathematical approach to the study of clonotype diversity in the repertoire
was used by [14]. The authors apply the idea of stochastic descriptors to a previous work
[153], aiming at a deeper understanding of the survival probability distribution of a single
clonotype emigrating from the thymus into the repertoire. In particular, two possible fates
are shown, the first being extinction of the clone in the short-term in case of a too hostile
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environment, while the second representing its long-term survival in the periphery. The
authors also showed that the probability distribution of the maximum size obtained by
the clonotype in the second case is bi-modal.
Finally, to conclude this journey through mathematics applied to the study of TCR
repertoire diversity, and to give the reader the possibility to have a more general glance
at the broad use of mathematics in immunology, it is important and necessary to cite
the beautifully-written, latest review on the area of mathematical immunology [56]. Even
though its focus on TCR diversity is very restricted, citing only a few of the latest contri-
butions in this area such as [153, 17, 100], this review range over an incredible number of
mathematical techniques, from agent-based modelling to eco-immunology, passing through
Gillespie and Monte-Carlo algorithms, besides cellular automata, ordinary, partially and
stochastic differential equations (ODEs, PDEs and SDEs), sensitivity analysis and prin-
cipal component analysis (PCA). Model validation and parameter estimation are deeply
discussed, and the literature review is organized by levels, from the molecular to the pop-
ulation one. As a mathematician and PhD student in systems immunology, I believe this
review can be easily defined as a goldmine for whomever is researching in the area of
mathematical and systems immunology.
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Mathematics for T-cell sampling
3.1 Abstract
Modern next generation sequencing (NGS) technologies allow us to sequence DNA or
RNA from single cells. In particular, single-cell sequencing techniques enable the study
of the DNA or RNA sequences of T-cell receptors (TCRs) from a sample, one cell at a
time. The upscaling of fundamental properties from the sample to the whole repertoire
remains one of the biggest mathematical challenges in systems immunology. This chapter
focuses on the distribution of number of repeats of any particular TCR clonotype in a
sample of T cells, trying to give some insights on the true clonal size distribution of a
repertoire. We compute the mean number of T-cell extractions needed to find a repeat
with a given probability. We give insights on the mathematical relation that binds the
clonal size distribution in a repertoire with the one observed in a sample. Equal clonal sizes
in the repertoire is the first hypothesis that we consider, although not biologically relevant.
We then consider a different case where the number of T cells per clonotype class in the
repertoire is a random variable with a geometric, Poisson or logarithmic distribution. A
repertoire in which a small fraction of clones are expanded is also considered.
3.2 Introduction
The number of T cells circulating in an adult human body has been estimated to be
approximately 4× 1011 [81]. Each one of these T cells is able to express on its cell surface
something like 30,000 T-cell receptors (TCRs), usually all being a clone of each other
[163]. In the thymus, T cells are constantly accurately selected, based on their ability
to bind with self-peptides expressed in association with major histocompatibility complex
molecules (self-pMHC) [137], [81], [16], [161]. More details regarding this selection process
can be found in Section 1.2. If we could arrange all the T cells in classes based on their
TCR, the result would be a repertoire of classes, each one defined as “clonotype class”. T
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cells follow two different paths for peptide recognition depending on whether they belong
to the CD8+ type or to the CD4+ one. The former type recognises peptides bound to
MHC class I molecules while the second one, CD4+ type, recognises peptides bound to
MHC class II molecules [163], [150], [114]. Once TCR clonotypes have been defined,
some very important questions naturally come up, such as how many TCR clonotypes are
actually present in a human, mouse or other mammal immune systems? How many T
cells does a clonotype class maintain? And what kind of clonal size distribution does a
body maitain? [91], [24], [36], [156]. Nowadays, sequencing technologies do not allow us to
directly answer these questions. Both chains (α and β) of each single TCR are created by
a complex semi-random process called somatic recombination or VDJ recombination (see
Section 1.4). Some estimates of the total possible number of different TCRs that could, in
principle, be produced by this process are about 1015 [146], [121], [172], [115]. However,
it is well known the paper showing how these estimates could never be achieved, as 1015
T cells would weigh about 500 kg [106]. We define here the number of distinct TCR
clonotypes, N , as the total number of T cells divided by the mean number of cells per
clonotype class. Equivalently, N can be seen as the product of the rate of release of new
clonotypes from the thymus to the periphery, θ, times the mean lifetime of a clonotype
in the periphery [100]. Some lower limits on the number of distinct TCR β chains in the
repertoire have been given in the literature 4 × 106 [13], [85], [135], [168]. If each TCR
β chain can combine with 25 α chains, then the number of possible distinct clonotypes
in a human immune system should be at least 108 [130]. Even though direct estimates
of TCR diversity have been made by PCR amplification of mRNA from pools of cells,
it is necessary to keep in mind that numbers of mRNA vary from cell to cell and PCR
amplification may depend on the particular TCR sequence. This problem makes PCR
amplification a questionable technique for the measurement of clonal size distributions. A
possibility to overcome this problem, therefore avoiding TCR-related biases, is given by
single-cell measurements, where PCR and sequencing are performed on one cell at a time.
However, these experiments are very expensive, allowing us to sequence only hundreds of
cells from a single individual. This is the point where mathematical analyses can help,
allowing estimates of diversity based on samples of small sizes [164], [135], [145], [93]. We
consider the number of T cells per clonotype class to be a random variable with a given
distribution. Once a random sample has been extracted from the repertoire, we want to
study the random variable representing the number of copies, actually found in the sample,
of a particular TCR. We approach this problem by making use of probability generating
functions. The absence of most of the clonotypes in a small sample it is not surprising,
given the enormous size of the repertoire itself. Besides, the majority of clonotypes that are
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in the sample present no repeats. We show the subtle relationship between the observed
distribution of clonal sizes in the sample and the theoretical distribution in the repertoire.
3.3 Sampling from a repertoire
What can be deduced from a sample of m cells taken from a repertoire of T cells if the total
number of cells in the repertoire, S, is very large? Let us begin by describing the structure
of the repertoire, which is divided into N subsets, called TCR clonotypes. Denote by ni
the number of cells of a clonotype labeled i. The index i runs from 1 to N , and
∑
i ni = S
(see Figure 3.1). Typically S is known, but N and the ni are not.
Figure 3.1: The repertoire contains S cells, divided up into N TCR clonotypes. Here, cells
are represented by small coloured circles, a TCR clonotype is the set of cells of one colour,
and a random sample of cells is represented by those circles inside the black square.
When the number of cells in the sample, m, is much smaller than the number of cells
in the repertoire, S, and much smaller even than the number of TCR clonotypes, N , it
is not obvious how to draw direct conclusions. On the other hand, some mathematical
simplifications can be made. Let us consider one TCR clonotype, with label i. If mni  S
then, instead of the full expressions involving multivariate hypergeometric distributions,
we can use the binomial approximations that
1. the probability that none of the m cells in the sample are of clonotype i is
(
1− niS
)m
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2. the probability that exactly one of the m cells in the sample is of clonotype i is
mniS
(
1− niS
)m−1
.
3. the probability that exactly two of the m cells in the sample are of clonotype i is
1
2m(m− 1)niS ni−1S
(
1− niS
)m−2
.
It is worth noting that here we use the quantity ni(ni − 1) rather then n2i (as it would be
expected from a binomial distribution) due to the small general values of ni. In fact, this is
trying to reproduce the sampling without replacement of the hypergeometric distribution
that is not present in the binomial one. If m 1 but mni/S  1 then we can approximate
the last expression by ri, where
ri =
1
2
(m
S
)2
ni(ni − 1). (3.1)
We say there is a repeat in the sample if two (or more) of the m cells are of the same
clonotype. Let us consider a group of M identified clonotypes in the repertoire, with
numbers of cells n1, n2, . . . , nM . How many repeats, of clonotypes in this group, will we
see in our sample? If
ri  1 ∀i = 1, . . . ,M ,
so that the occurrences of repeats in distinct clonotypes can be taken as independent
events, then
E(number of repeats of identified clonotypes) =
M∑
i=1
ri =
1
2
(m
S
)2 M∑
i=1
ni(ni − 1).
That is,
E(number of repeats of identified clonotypes) =
1
2
m2
S2
M E(ni(ni − 1)) , (3.2)
where the expectation is taken over the M clonotypes:
E(ni(ni − 1)) = M−1
M∑
i=1
ni(ni − 1) .
Repertoires can be constructed and sampled inside a simple computer program, where
each clonotype is assigned a label i and values of ni are assigned according to a probability
distribution. We have constructed repertoires with uniform, geometric, Poisson, logarith-
mic and heterogeneous distributions of clonal sizes to verify the conclusions presented
here.
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Figure 3.2: Mean number of repeats as a function of the number of cells in the sample,
from a repertoire of N = 105 clonotypes and a geometric distribution of clonal sizes, with
n¯ = 10.
3.4 The mean number of repeats
To find the mean number of repeats of any clonotype from the repertoire in the sample,
we put M = N in (3.2) and write S = N E(ni), to obtain
E(number of repeats) =
N∑
i=1
ri =
m2
2N
E(ni(ni − 1))
E(ni)2
. (3.3)
The expression (3.3) is the product of the factor m
2
2N , that does not depend on the distri-
bution of clonal sizes, and the factor E(ni(ni−1))E(ni)2 , that does. The latter can be written
E(ni(ni − 1))
E(ni)2
=
E(n2i )
E(ni)2
− 1
E(ni)
.
• If ni = n¯ for every i then
E(n2i )
E(ni)2
= 1 and
E(ni(ni − 1))
E(ni)2
= 1− 1
n¯
.
• If ni has a geometric distribution with mean n¯ (that is, Pr(ni ≤ k) = 1−
(
1− 1n¯
)k
,
k = 1, 2, . . .) then
E(n2i )
E(ni)2
= 2− 1
n¯
and
E(ni(ni − 1))
E(ni)2
= 2
(
1− 1
n¯
)
.
See Figure 3.2.
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3.5 Number of draws to find the first repeat
Let us consider the probability of finding no repeats in a sample of m cells. With ri defined
in (3.1), we approximate by 1− ri the probability that fewer than two cells of clonotype i
are found in the sample, so that
Pr(no repeat in a sample of m cells) =
N∏
i=1
(1− ri) . (3.4)
We can then write
log (Pr(no repeat in a sample of m cells)) =
N∑
i=1
log(1− ri) (3.5)
' −
N∑
i=1
ri , (3.6)
assuming ri  1 for every i and applying Taylor approximation log(1 + x) = x + O(x2).
Thus, we have
Pr(no repeat in a sample of m cells) = exp (−λ) , (3.7)
where
λ =
N∑
i=1
ri =
m2
2N
E(ni(ni − 1))
E(ni)2
(3.8)
is the mean number of repeats in a sample of m cells, as seen in Eq. 3.3.
How many cells do we need to sample in order to have a 50 percent chance of finding
a repeat? Let this number be m0.5. This implies λ = log 2. Then, using (3.8),
m20.5 =
E(ni)2
E(ni(ni − 1)) 2N log 2 . (3.9)
In the simplest case, when all clonotypes have the same number of cells, n¯, we find
Pr(no repeats) = exp(−m22N (1− 1n¯)) and
m0.5 =
√√√√(2N log 2
1− 1n¯
)
.
When the distribution of the number of cells per clonotype is geometric with mean n¯, and
the desired number is
m0.5 =
√√√√(N log 2
1− 1n¯
)
.
See Figure 3.3. For a more general case, if we want to answer the question on how many
cells we need to sample in order to have a certain probability p of finding a repeat, we
should use the relationship
1− p = e−λ ⇒ λ = log
(
1
1− p
)
.
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Figure 3.3: Mean number of cells that need to be sampled in order to have a 50 percent
chance of one repeat, from a repertoire of N clonotypes and a geometric distribution of
clonal sizes, with n¯ = 10.
3.6 Poisson distribution of number of repeats in a sample
Let k be the total number of repeats in a sample of m cells. For example, if 96 sequences
are found once and 2 sequences are found twice, then m = 100 and k = 2. We have already
seen Pr(k = 0) in (3.7). Let us consider the case k = 1:
Pr(k = 1) =
N∑
i=1
ri
N∏
j=1
j 6=i
(1− rj).
If ri  1 for every i then, from (3.4) and (3.7), we have
N∏
j=1
j 6=i
(1 − rj) '
N∏
i=1
(1 − ri) = e−λ
and, from (3.8),
Pr(k = 1) = λe−λ .
The same argument works for all k  m, so that the number of repeats in a sample has
approximately a Poisson distribution:
Pr(number of repeats is k) =
λk
k!
e−λ .
3.7 Estimating the size of the repertoire from one repeat
Suppose there is one repeat in a sample of m cells. We then use (3.8) to estimate N .
Putting λ = 1 and, assuming a geometric distribution of clonal sizes, we conclude that
N = m2
n− 1
n
' m2 .
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If we find one repeat per 100 cells, we estimate the number of distinct clonotype classes
to be around 104. If we find one repeat per 1000 cells, we estimate that the size of the
repertoire is 106. In practice, the estimate m2 is likely to be conservative, because any
clonal expansion will increase the number of observed repeats.
3.8 The observed distribution of clonal sizes
In this section, our goal is to find the probability distribution of the number of instances
of k copies of a TCR in a random sample of m cells. Firstly, consider the point of view of
one cell in the total of S cells in the repertoire. The probability, which we denote q, that
this cell is one of the m cells in the sample is
q =
combinations of S − 1 elements in m− 1 places
combinations of S elements in m places
=
(
S−1
m−1
)(
S
m
) = m
S
. (3.10)
Next, let us define the Bernoulli random variable B:
Pr(B = 0) = 1− q and Pr(B = 1) = q, where q = m
S
.
The probability generating function of B is
φB(z) =
∞∑
k=0
Pr(B = k)zk = 1− q + qz . (3.11)
If ni is the number of cells of a clonotype labeled i, then the number of cells of type i in
the sample is the random variable Yi, which can be written
Yi = B1 + · · ·+Bni , (3.12)
where Bj , j = 1, . . . , ni are random variables with the same distribution as B. With the
approximation that the Bj are independent random variables, the probability generating
function of Yi is (See Sec. 2.2.7)
φYi(z) = φB(z)
ni = (1− q + qz)ni . (3.13)
In Appendix A we show that the random variable Yi can be approximated as a binomial
distribution with parameters ni and q = m/S. Here we use though a slightly different
approximation, for which the random variable Yi is approximated with a binomial distri-
bution with parameters ni and q = m/S. It is easy to simulate these distributions and
check that they overlap for large enough values of the parameter S. Now, let Y be the
number of copies of a randomly-chosen clonotype found in the sample of m cells, which
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can be 0 or any integer greater than 0 (up to min{m,ni}). To find the probability distri-
bution of Y , we must take the distribution of values of ni into account. Suppose that the
probability generating function of the random variable ni is φn(z). Then
φY (z) =
∑
k
Pr(ni = k)(1− q + qz)k = φn(1− q + qz). (3.14)
Let us recall the Taylor expansion of a function f(x) around the point x = 0, defined as
f(x) =
∞∑
k=0
f (k)(0)
k!
xk
where f (k)(0) represents the kth derivative of the function calculated in x = 0. Therefore,
the Taylor expansion of the general φY (z) is
φY (z) =
∞∑
k=0
φ
(k)
Y (0)
k!
zk.
By definition of probability generating function, we can write
φY (z) =
∞∑
k=0
Pr(Y = k)zk,
which results in
Pr(Y = k) =
φ
(k)
Y (0)
k!
. (3.15)
It is important to notice that the random variable Y describes the probability, for a general
clonotype in the repertoire, of being present (k ≥ 1) or not being present (k = 0) in the
sample. What is interesting, especially from an experimental point of view, is to rescale
these probabilities so that they can describe the observed clonal size distribution. In other
words, we want to focus on the probability that a certain clonotype is present in the
sample with a certain number of copies k ≥ 1, given that this clonotype has been seen in
the sample. Let us define pk = Pr(Y = k) and sk = Pr(Y = k|Y 6= 0). It follows that, for
k ≥ 1, we have
sk =
Pr(Y 6= 0|Y = k ≥ 1) Pr(Y = k)
Pr(Y 6= 0) =
Pr(Y = k)
Pr(Y 6= 0) =
pk
1− p0 . (3.16)
These probabilities represent the observed distribution of clonal sizes; that is, the his-
togram that is obtained by plotting number of TCRs versus number of cells in the sample.
We can consider them as the probabilities of the random variable Y obs, defined as the
number of copies of a randomly-chosen clonotype actually seen in the sample. It is also
of interest to try to say something about the probability generating function of Y obs.
Dividing φY (z) by 1− p0 we obtain
φY (z)
1− p0 =
p0
1− p0 +
p1
1− p0 z +
p2
1− p0 z
2 + · · · = s0 + s1z + s2z2 + · · ·
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where sk are defined in (3.16) for k ≥ 1. What we want though, for our random variable
Y obs, is s0 = 0. Therefore, we obtain
φY obs(z) =
φY (z)
1− p0 − s0 =
φn(1− q + qz)− φn(1− q)
1− φn(1− q) . (3.17)
Since φn(1 − q) is a constant, this last result shows that the distribution of a generic
clonotype class in the repertoire is transferred, with different parameters, to the distribu-
tion of the same clonotype class in the sample. We will validate this general result in the
following sections based on specific cases of clonal size distributions. In particular, the
general property E(X) =
[
φ
(1)
X (z)
]
z=1
for any general r.v. X brings us to
E(Y obs) =
[
φ
(1)
Y obs
(z)
]
z=1
=
[
φ
(1)
n (1− q + qz)
1− φn(1− q)
]
z=1
=
qE(ni)
1− φn(1− q) . (3.18)
Let us try to give now a different interpretation of (3.15). Recalling (3.14), we can prove
that
φ
(k)
Y (z) = q
k φ(k)n (1− q + qz).
In particular, we obtain
φ
(k)
Y (0) = q
k φ(k)n (1− q).
This gives us a different interpretation of (3.15)
Pr(Y = k) =
qkφ
(k)
n (1− q)
k!
, (3.19)
in particular when we are dealing with q  1. In fact, in this case, we can write
φ(k)n (1− q) ' φ(k)n (1) = E [(ni)k] ,
where E [(ni)k] represents the kth factorial moment of the random variable ni. In order to
check the validity of the last equation, let us consider a general random variable X. Its
probability generating function φX(z) = E(zX) can be differentiated k times obtaining
φ
(k)
X (z) = E[X(X − 1) . . . (X − k + 1)zX−k],
resulting in
φ
(k)
X (1) = E[X(X − 1) . . . (X − k + 1)] = E [(ni)k] . (3.20)
To conclude, (3.19) can be written as a function of the raw moments of the random variable
ni as
Pr(Y = k) ' q
k
∑k
t=0 S(k, t)E(nti)
k!
, (3.21)
where the coefficients S(k, t) represent the Stirling numbers of the first kind, that is the
coefficients in the expansion
(x)n =
n∑
k=0
S(n, k)xk,
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where (x)n denotes the falling factorial (x)n = x(x− 1)(x− 2) . . . (x− n+ 1).
Using (3.19), we can then observe the following relationship
sk+1
sk
=
pk+1
pk
' q
k + 1
φ
(k+1)
n (1− q)
φkn(1− q)
' q
k + 1
E [(ni)k+1]
E [(ni)k]
. (3.22)
In particular, (3.22) can be further simplified in cases such as Poisson and geometric
distributions for ni. In fact, (3.22) would become
q
k + 1
λ and
q
k + 1
(k + 1)(n− 1) for the
two cases respectively. As a last observation, we can use (3.19) to obtain
sk =
qkφ
(k)
n (1− q)
k!
[1− φn(1− q)]−1. (3.23)
3.9 Homogeneous cases
In this section we will consider a consistant clonal size distribution in the repertoire.
We analyze four different distributions: constant, geometric, Poisson and logarithmic
clonal size distribution. The constant case is somehow the basic type of possible discrete
clonal size distributions, although unrealistic. The Poisson distribution has been chosen
for its well-known ability in representing count data. The geometric and logarithmic
distributions were chosen as being different discrete distributions from the Poisson one,
and also for a different reason. In a work published in 2011 [111], the authors firstly
consider a general birth and death process and discuss two possible approximations for
the limiting conditional probability distribution (LCD) of the process, deriving them from
a previous work [117]. Defining λn and µn as the birth and death rates of the process, the
first approximation is given by
pi
(1)
1 =
1
1+
∑∞
n=2
λ1λ2...λn−1
µ2µ3...µn
,
pi
(1)
n =
λ1λ2...λn−1
µ2µ3...µn
pi
(1)
1 for n ≥ 2.
(3.24)
The second approximation is given instead by
pi
(2)
1 =
1
1+
∑∞
n=2
λ1λ2...λn−1
µ1µ2...µn−1
,
pi
(2)
n =
λ1λ2...λn−1
µ1µ3...µn−1pi
(2)
1 for n ≥ 2.
(3.25)
The authors apply then these approximations to a specific birth and death process. Here
we focus on the process with birth and death rates λn = λn
k and µn = µn
k. It is easy to
show that the first approximation for these rates can be written as
pi
(1)
1 = [Lik(λ/µ)]
−1 ,
pi
(1)
n = (λ/µ)n−1
[
nkLik(λ/µ)
]−1
for n ≥ 2,
(3.26)
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where Lik(z) represents the polylogarithmic function of order k defined as
Lik(z) =
+∞∑
i=1
zi
ik
.
The second approximation can be written as
pi
(2)
1 = 1− (λ/µ),
pi
(2)
n = (λ/µ)n−1[1− (λ/µ)] for n ≥ 2.
(3.27)
As can be seen, the second approximation suggests that a birth and death process with
rates of the kind λn = λn
k and µn = µn
k would reach an LCD closely related to geometric
distribution, which could be seen as the distribution of the clonal size of a particular
clonotype subject to the previously explained process. From here, and from the relation
between the logarithmic distribution and the polylogarithmic one, we decided to explore
geometric and logarithmic clonal size distributions.
3.9.1 Constant clonal size distribution
Let us consider a repertoire of N different clonotype classes and let us suppose that
ni ≡ n ∀i ∈ {1, 2, . . . N}. It follows that
φn(z) = z
n, (3.28)
so that
φY (z) = (1− q + qz)n. (3.29)
Considering the known property of probability generating functions, for which
E(Y ) = φ
′
Y (1), (3.30)
we obtain that E(Y ) = nq. Moreover, applying (3.15) we obtain
Pr(Y = k) =

(1− q)n, for k = 0
(n)kq
k(1− q)n−k
k!
=
(
n
k
)
qk(1− q)n−k, for k ≥ 1
where (n)k = n(n− 1) . . . (n− k + 1).
3.9.2 Geometric clonal size distribution
Let us now consider the case in which ni has a geometric distribution with mean n. It is
worth noting that we have to consider the geometric distribution with support on the set
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{k = 1, 2, 3, . . .} given that we are working on clones which are present in the repertoire
(that is k > 0). Thus
Pr(ni = k) =
1
n
(1− 1
n
)k−1.
It follows that
φn(z) =
z
n− (n− 1)z , (3.31)
so that
φY (z) =
1− q + qz
n− (n− 1)(1− q + qz) =
1− q + qz
1 + (n− 1)q(1− z) . (3.32)
Applying (3.15) we obtain
Pr(Y = k) =

1− q
1 + q(n− 1) , for k = 0
(n− 1)k−1nqk
(1 + q(n− 1))k+1 , for k ≥ 1
The following recursive formula holds
pk = p1γ
k−1 k ≥ 1, (3.33)
where
γ =
(n− 1)q
1 + q(n− 1) . (3.34)
To understand the distribution of Y , let us factorize p1 as
p1 = θp,
where p = (1 + q(n− 1))−1 and
θ =
nq
1 + q(n− 1) .
Therefore γ = 1− p, resulting in
pk = θp(1− p)k−1 k ≥ 1. (3.35)
Being q < 1, it follows that θ < 1. An important observation comes from (3.30) for which,
in this case too, the expected value of the random variable Y is E(Y ) = nq.
Applying (3.16), we obtain
sk =
θp(1− p)k−1
1− p0 = p(1− p)
k−1. (3.36)
We conclude that the observed distribution of clonal sizes (the histogram that is obtained
by plotting number of TCRs versus number of cells) is geometric with parameter p, result-
ing in a mean of 1 + (n− 1)q. This validate, as previously discussed, the relation (3.17),
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that is the property for which the distribution of a generic clonotype class in the repertoire
is transferred, with different parameters, to the same clonotype class found in the sample.
It is worth noting the following relation:
sk+1 = γsk. (3.37)
This is a particular property of all positive geometric distributions. See Figure 3.4 for
a particular case of this relation. For both constant and geometric unimodal cases, see
Figure 3.5.
0 0.2 0.4 0.6 0.8 1
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Figure 3.4: Relation between sk+1 and sk, with q = 0.0001 and n = 10. See (3.37).
3.9.3 Poisson clonal size distribution
Let us now consider the case in which ni has a Zero-Truncated Poisson distribution (ZTP)
with mean n. It is worth noting that we have to consider this distribution because of its
support on the set {k = 1, 2, 3, ...} given that we are working on clones which are present
in the repertoire (that is a Poisson distribution with k > 0). Thus, we have
Pr(ni = k) =
λk
(ek − 1) k! .
We need the expected value of the ZTP(λ) to be equal to n:
n =
λeλ
eλ − 1 . (3.38)
In order to find an expression for our parameter λ, we rearrange (3.38) and we multiply
both sides by e−n, in order to obtain
−ne−n = eλ−n(λ− n),
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Figure 3.5: Observed clonal size distribution in a sample of 1000 cells, from repertoires
containing different numbers of clones, N . A “constant” repertoire means that there are 10
cells of each clonotype. In a “geometric” repertoire, the number of cells in each clonotype
is drawn from a geometric distribution with mean 10.
that in turn gives the solution
λ = n+W
(
− n
en
)
, (3.39)
where W (·) represents the Lambert W function, defined as the set of functions for which
the solution of zez = f(z) is x = W (f(z)). In particular, here we have
eλ−n(λ− n) = f(λ− n), with f(λ− n) = −ne−n.
It is important to notice that for −1
e
< x < 0 the function W (·) is double-valued taking
two possible branches: W0(·) or W−1(·). Therefore, we need to understand which one to
use so that we can obtain uniqueness for the solution (3.39). For −1
e
< x < 0, we have
−1 < W0(·) < 0 and −∞ < W−1(·) < −1. Substituting (not inside the W function) (3.38)
in (3.39), we obtain
W
(
− n
en
)
= − λ
eλ − 1 .
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For λ > 0, we have −1 < − λ
eλ − 1 < 0, indicating W0(·) as the right branch to be chosen.
Thus,
Pr(ni = k) =
λk
k! (ek − 1) , (3.40)
and
φni(z) =
eλz − 1
eλ − 1 , (3.41)
with λ given by (3.39). We can then find φY (z) a
φY (z) =
eλ(1−q+qz) − 1
eλ − 1 . (3.42)
It follows that
Pr(Y = 0) =
eλ(1−q) − 1
eλ − 1
and
Pr(Y = k) ≡ pk = λ
kqkeλ(1−q)
k! (eλ − 1) k = 0, 1, 2, ...
The observed distribution is then defined by
sk =
(λq)k
k! (eλq − 1) k = 1, 2, ... (3.43)
showing that the observed distribution is also a ZTP distribution with parameter λ
′
=
qλ. This confirms the previously shown relation (3.17). It is worth noting the following
relation:
sk+1 =
λq
k + 1
sk. (3.44)
This is a particular property of all ZTP distributions.
3.9.4 Logarithmic clonal size distribution
Let us now consider the case in which ni has a logarithmic distribution with mean n.
Thus, we need the expected value of the Log(p) to be equal to n:
− 1
ln(1− p)
p
1− p = n. (3.45)
In order to find an expression for our parameter p, we define x = 1− p and we rearrange
(3.45), obtaining
x ln(x) +
1− x
n
= 0.
This gives
1 + nx
[
ln(x)− 1n
]
n
= 0,
which in turns can be seen as
x ln(xe−
1
n ) = − 1
n
.
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Multiplying both sides by e−
1
n , we obtain
xe−
1
n ln(xe−
1
n ) = − 1
n
e−
1
n ,
that can be written as
eln(xe
− 1n ) ln(xe−
1
n ) = − 1
n
e−
1
n .
The solution of this equation is given by
ln(xe−
1
n ) = W
(
− 1
n
e−
1
n
)
,
where W (·) represents the Lambert W function, defined as the function for which the
solution of xex = a is x = W (a). In particular, we obtain
x = e
1
n
+W
(
− 1
n
e−
1
n
)
,
that gives us the final relation
p = 1− e
1
n
+W
(
− 1
n
e−
1
n
)
. (3.46)
As previously stated in Section 3.9.3, for −1
e
< x < 0 the function W (·) is double-valued
taking two possible branches: W0(·) or W−1(·). Therefore, we need to understand which
one to use so that we can obtain uniqueness for the solution (3.46). For −1
e
< x < 0, we
have −1 < W0(·) < 0 and −∞ < W−1(·) < −1. Substituting (not inside the W function)
(3.45) in (3.46), we obtain
W
(
− 1
n
e−
1
n
)
=
ln(1− p)
p
.
For 0 < p < 1, we have
ln(1− p)
p
< −1, indicating W−1(·) as the right branch to be
chosen. Thus,
Pr(ni = k) =
−1
ln(1− p)
pk
k
, (3.47)
and
φni(z) =
ln(1− pz)
ln(1− p) , (3.48)
with p given by (3.46). Using (3.23), we can then find
sk =
−1
ln(1− a)
ak
k
with a =
pq
1− p(1− q) k = 1, 2, ... (3.49)
showing that the observed distribution is also a logarithmic distribution with parameter
a =
pq
1− p(1− q) . This confirms the previously shown relation (3.17). It is worth noting
the following relation:
sk+1 =
ak
k + 1
sk. (3.50)
This is a particular property of all logarithmic distributions.
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3.10 Heterogeneous cases: expansion of a subset of the reper-
toire
In this section we assume that a fraction f  1 of clones undergoes expansion following
an immune response to a certain infection. We call E the expanded part and U the
unexpanded one. We consider two special cases: constant and geometric repertoire.
3.10.1 Constant clonal size distribution: expansion case
Let us consider the case in which the random variable ni of T cells of type i is
ni ≡

n, if clone i is in the unexpanded part U
nα, if clone i is in expanded part E.
Recalling (3.14), we need to focus on finding the probability generating function φn of the
random variable ni. By definition,
φn(z) =
∞∑
k=0
Pr(ni = k)z
k. (3.51)
Thus we have to find Pr(ni = k). From the theory we have that
Pr(ni = k) = Pr(ni = k i ∈ E) Pr(i ∈ E) + Pr(ni = k i ∈ U) Pr(i ∈ U).
In our case, we have
Pr(ni = k | i ∈ D) =

1, for {D = E and k = nα} or for {D = U and k = n}
0, otherwise
and
Pr(i ∈ D) =

f, for D = E
1− f, for D = U.
At this point, we can write (3.51) as
φn(z) = (1− f)zn + fznα. (3.52)
Therefore, the probability generating function of the random variable Y is
φY (z) = φn(1− q + qz) = (1− f)(1− q + qz)n + f(1− q + qz)nα. (3.53)
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Following the same procedure as in Section 3.9.2, we can find that
pk =
(
n
k
)
(1− f)qk(1− q)n−k +
(
nα
k
)
fqk(1− q)nα−k k ≥ 0 (3.54)
and
sk =
pk
1− p0 k ≥ 1.
The E(Y ) can be easily found following (3.30), obtaining E(Y ) = nq[1 + (α− 1)f ]. There-
fore,
E(Y obs) =
nq(1 + (α− 1)f)
1− p0 . (3.55)
3.10.2 Geometric clonal size distribuion: expansion case
We consider the case in which the random variable ni of T cells of type i is:
ni ∼

Geom( 1n), if clone i is in the unexpanded part U
Geom( 1nα), if clone i is in expanded part E.
We now follow the same procedure as in Section 3.10.1. In this case, we have
Pr(ni = k | i ∈ D) =

(
1− 1nα
)k−1 ( 1
nα
)
, for D = E
(
1− 1n
)k−1 ( 1
n
)
, for D = U
and
Pr(i ∈ D) =

f, for D = E
1− f, for D = U.
Therefore we obtain
Pr(ni = k) = f
(
1− 1
nα
)k−1( 1
nα
)
+ (1− f)
(
1− 1
n
)k−1( 1
n
)
.
At this point, we have
φn(z) = f
∞∑
k=1
(
1− 1
nα
)k−1( 1
nα
)
zk + (1− f)
∞∑
k=1
(
1− 1
n
)k−1( 1
n
)
zk .
We see now that
φn(z) = f φe(z) + (1− f) φu(z), (3.56)
where e and u are random variables with a geometric distribution with parameters 1nα and
1
n respectively.
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Therefore, the probability generating function of the random variable Y is
φY (z) = φn(1− q + qz) = f φe(1− q + qz) + (1− f) φu(1− q + qz) (3.57)
where
φe(1− q + qz) = 1− q + qz
nα− (nα− 1)(1− q + qz) =
1− q + qz
1− q(nα− 1)(z − 1)
and
φu(1− q + qz) = 1− q + qz
n− (n− 1)(1− q + qz) =
1− q + qz
1− q(n− 1)(z − 1) .
Following the main ideas of Section 3.9.2, we find
Pr(Y = k) =

f
1− q
1 + q(nα− 1) + (1− f)
1− q
1 + q(n− 1) , for k = 0
f
(nα− 1)k−1 nα qk
(1 + q(nα− 1))k+1 + (1− f)
(n− 1)k−1 n qk
(1 + q(n− 1))k+1 , for k ≥ 1.
We can find sk as defined in (3.16). Moreover, applying (3.30), we find
E(Y ) = nq(1 + (α− 1)f). (3.58)
Therefore,
E(Y obs) =
nq(1 + (α− 1)f)
1− p0 . (3.59)
Case q 1
Let us consider the case in which S  m, that is q  1. In this case, excluding all the
parts proportional to q2, the quantity 1− p0 can be approximated by
1− p0 ' 1 + q(n(α+ 1)− 2)− [f(1− q) + fq(n− 1) + (1− f)(1− q)q(1− f)(nα− 1)]
1 + q(n(α+ 1)− 2) ,
which turns out to be
1− p0 ' nq(1 + (α− 1)f)
1 + q(n(α+ 1)− 2) .
Therefore,
E(Y obs) ' 1 + q(n(α+ 1)− 2) ' 1 + qnα. (3.60)
It is interesting to notice that this quantity does not depend on the fraction f of expanded
clones in the repertoire. In fact, this quantity is a good estimation of E(Y obs) for f ≥ 0.1.
See Figure 3.6.
50
3.11 Analysis of the TCRβ repertoire of naive CD8+ T cells
Figure 3.6: Expansion case with geometric clonal size distributions. Independence of
E(Y obs) from f for f ≥ 0.1. S = 106.
3.11 Analysis of the TCRβ repertoire of naive CD8+ T cells
Suppose the repertoire, from which cells are sampled, contains a total of S cells that are
shared among N TCRβ clones. That is, N is equal to the total number of distinct TCRβ
sequences in the repertoire.
We use the letter i to denote a clone in the repertoire that consists of ni cells. Thus
i = 1, 2, . . . , N and n1 + n2 + · · · + nN = S. The mean clonal size is denoted by n¯. It
is equal to S/N , the mean number of cells per clone. Three types of hypothesis are as
follows:
(i) that each individual clone has the same number of cells;
(ii) that the clonal sizes follow a simple geometric distribution, where the probability of
finding clones with small size is higher than that of finding large clones;
(iii) that there are two types of clones in the repertoire, the majority of clones made up
of only a few cells, and a small minority of clones that contain many cells.
Suppose that a sample ofm cells is taken and the TCRβ of each of the cells is sequenced.
We define q (as in Section 3.8) to be the probability that one cell, randomly-chosen from
the total of S cells, is part of the sample of size m:
q =
m
S
.
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Let m0 be the number of distinct sequences found in the sample, and let m1 be the number
of sequences found only once in the sample. If mk, k = 1, 2, · · · is the number of sequences
found once, twice, ... then
m0 = m1 +m2 +m3 + · · · and m = m1 + 2m2 + 3m3 + · · ·
3.11.1 The mean clonal size of the CD8+ GP33+ subset
Here we analyse the single cell data from our QuanTI collaborators on the CD8+ GP33+
subset, where GP33+ is a specific LCMV (Lymphocytic Choriomeningitis Virus) epitope.
The value of S is the total number of GP33+ cells, estimated to be 441 (BM) or 2293
(SP+LN). Thus, with sample sizes m between 94 and 271, the value of q is between 0.04
and 0.12. Hypothesis (i) is not consistent with the data: if n = 1 then m is always equal to
m0; if n = 2 or larger, the predicted values of the ratio
m
m0
are larger than those observed.
In fact, defining Y obs as in Section 3.8, we can write
E(Y obs) =
∞∑
k=1
kPr(Y obs = k) ≈
∞∑
k=1
k
mk
m0
=
m
m0
.
That is, the mean of the ratio
m
m0
is
nq
nq + 12n(n− 1)q2
. Thus, we consider hypothesis (ii).
Geometric
We first consider the geometric distribution of values of number of cells per clone, ni. The
statement that ni has a geometric distribution with mean n¯ is that
Pr(ni = k) =
1
n¯
(
1− 1
n¯
)k−1
, k = 1, 2, . . . .
Note that n¯ ≥ 1. The fraction of clones that consist of only one cell is
Pr(ni = 1) =
1
n¯
.
If the distribution of values of ni is geometric, then the distribution of the number of
copies of each Tcrb sequence found in a sample of m cells is also geometric, with mean
equal to 1 + (n¯− 1)q (as shown in Section 3.9.2). Defining Y obs as in Section 3.8, we can
write
E(Y obs) =
∞∑
k=1
kPr(Y obs = k) =
∞∑
k=1
k
mk
m0
=
m
m0
.
That is, the mean of the ratio mm0 is 1 + (n¯ − 1)q. Because the values of S and m are
known, we obtain one estimate of n¯ from each measured value of m0:
n¯ = 1 + S
(
1
m0
− 1
m
)
. (3.61)
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We use (3.61) to estimate n¯ in the GP33+ repertoire, where S = 2300. There are five
independent measurements, summarised:
Mouse 5: 271 sequences, 268 unique, so estimate n¯ = 1.09.
Mouse 6: 188 sequences, 186 unique, so estimate n¯ = 1.13.
Mouse 7: 128 sequences, 127 unique, so estimate n¯ = 1.14.
Mouse 10: 244 sequences, 240 unique, so estimate n¯ = 1.16.
Mouse 11: 165 sequences, 165 unique, so estimate n¯ = 1.00.
The mean of the estimated values of n¯ is 1.10, with standard deviation 0.05.
Poisson
We next consider the hypothesis that the number of cells per clone, in the repertoire, has
a Poisson distribution. The statement that ni has a positive Poisson distribution with
mean n¯ is that
Pr(ni = k) =
1
eλ − 1
λk
k!
k = 1, 2, . . . , and n¯ =
λeλ
eλ − 1 . (3.62)
In this case, the distribution of the number of copies yi of each TCR sequence found in a
sample of m cells is also positive Poisson, with
Pr(yi = k) =
1
eλq − 1
(λq)k
k!
k = 1, 2, . . . .
The mean value of mm0 is
λqeλq
eλq−1 which, because λq  1, we can write as mm0 = 1 + 12λq +
1
4(λq)
2 + · · · .. Retaining up to first order in λq,
λ = 2S
(
1
m0
− 1
m
)
. (3.63)
For each mouse, we estimate λ using (3.63), then calculate n¯ using (3.62).
Mouse 5: 271 sequences, 268 unique, so estimate n¯ = 1.10.
Mouse 6: 188 sequences, 186 unique, so estimate n¯ = 1.14.
Mouse 7: 128 sequences, 127 unique, so estimate n¯ = 1.15.
Mouse 10: 244 sequences, 240 unique, so estimate n¯ = 1.17.
Mouse 11: 165 sequences, 165 unique, so estimate n¯ = 1.00.
The mean of the estimated values of n¯ is 1.11, with standard deviation 0.05.
We also estimate n¯ from one sample of the GP33+CD44+ repertoire, where S = 441.
Mouse 12: 94 sequences, 93 unique, so estimate n¯ = 1.05.
Thus the two cases, based on distributions of different shapes, give similar estimates
of the mean number of cells per clone, corresponding to a repertoire in which 91% ± 4%
of clones consist of one cell only.
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3.12 Discussion
The study of TCRs repertoire is of great importance nowadays. A very diverse repertoire
could imply a much higher probability, for the immune system, of being able to properly
react to certain foreign peptides. As discussed in the biological introduction, single-cell
sequencing techniques allow us to obtain small samples from the totality of the repertoire
of a particular individual. As it has been shown in this chapter, estimates of TCR diversity
depend on the clonal size distribution in the repertoire, though small samples allow the
simplifying approximation that random variables describing quantities of interest, such as
the numbers of cells of different types in the sample, are independent. We have proved
that the probability generating function of the distribution of clonal sizes in the sample
can be seen as the composition of that of a Bernoulli random variable (that takes values 0
or 1) and that of the true distribution of clonal sizes in the repertoire that is being sampled
from. In particular, we have expressed the relation between the clonal size distribution
in the repertoire and the one in the sample for different distribution cases. Our work
is motivated by studies of the repertoire of T cells in humans and mice. As previously
discussed in the introduction, in this type of experiment, where mRNA is extracted from
a pool of cells, it is difficult to obtain statistics of the number of cells of each clonotype
(abundance data) that is free from biases. Single-cell TCR sequencing can eliminate biases
but can, at present, only be carried out on a few hundred cells from one individual. This
is, though, a great opportunity to apply mathematical techniques to such an important
research area related to human health.
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Chapter 4
VDJ recombination & Data
analysis
4.1 Abstract and Introduction
Single-cell sequencing techniques probably represent the most reliable way to study the
DNA or RNA sequences of T-cell receptors (TCRs) from a sample, one cell at a time. In
the previous chapter we focused on the relation between the true clonal size distribution
(i.e., the distribution of the repertoire) and the observed clonal size distribution (i.e., the
distribution of the sample). This chapter focuses on a slightly different question, which can
be expressed as follows: given the observed clonal size of a specific TCR clonotype class,
what can we deduced about the true clonal size distribution of that particular clonotype
class? As we will see, this question will provide new insights on the study of the diversity
of a repertoire.
4.2 Data
The data considered in this study are part of a broader study on TCR diversity on na¨ıve
and LCMV (lymphocytic choriomeningitis virus) infected mice, of which only the na¨ıve
part has been published so far [71]. Samples from 10 specific-pathogen-free (SPF) B6 mice
were analysed; five were not infected (na¨ıve) and labelled as BA1, BA2, BA3, BA4 and
BA5; the other five mice were subdivided in two subgroups, two being only immunized,
labelled EF1 and EF2, and three being infected with LCMV and labelled EF3, EF4 and
EF5. In particular, EF1 and EF2 were immunized with the epitope GP33 (from here their
alternative label GP33i1 and GP33i2). The mice were obtained from breeding colonies
at the Centre de Distribution, Typage et Archivage (CDTA, Orleans, France), and all
the experiments were performed in accordance with the National European Commission
guidelines for the care and handling of laboratory animals and were approved by the site
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etichal review committee. In this section we present the data related only to V and J
distributions and only related to GP33-specific repertoire. For each mouse, both 2D and
3D plots were created representing the V-J distribution. Tables with the actual data can
also be found in Appendix B.
Figure 4.1: V-J plot for the uninfected mouse BA1.
56
4.2 Data
Figure 4.2: V-J plot for the uninfected mouse BA2.
Figure 4.3: V-J plot for the uninfected mouse BA3.
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Figure 4.4: V-J plot for the uninfected mouse BA4.
Figure 4.5: V-J plot for the uninfected mouse BA5.
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Figure 4.6: V-J plot for the infected mouse EF1.
Figure 4.7: V-J plot for the infected mouse EF2.
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Figure 4.8: V-J plot for the infected mouse EF3.
Figure 4.9: V-J plot for the infected mouse EF4.
60
4.2 Data
Figure 4.10: V-J plot for the infected mouse EF5.
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4.3 Statistics
This statistical section will serve as a reference for the entire chapter in which we will try
to answer some biological questions related to diversity inter (and intra) groups of infected
and uninfected mice. The analyses will focus on the V-J repertoire of the data collected
from our QuanTI collaborators Prof. Benedita Rocha and Dr. Pedro Filipe Fernandes
Goncalves [71]. The goal will be to apply some of the techniques of [164], in particular
the technique known as Randomization Test, to the data. Other analyses for public and
private V-J repertoires will also follow.
4.3.1 Statistical terms
We recall here the definition of two important statistical terms:
• test statistic: A test statistic is a single measure of some attribute of a sample
(i.e. a statistic) and it’s used in statistical hypothesis testing. The main idea behind
the test statistic is to summarize the data to a single value, that will be ultimately
used to perform an hypothesis test. The test statistic, together with the p-value
associated to the hypothesis test, allow to determine whether to accept or reject the
null hypothesis (H0) of the hypothesis test.
• p-value: The p-value is defined as the probability of obtaining a result equal to
or more extreme than the result that was actually observed. It is a function of the
observed sample and it is used for testing a statistical hypothesis. Before the test
is performed, a threshold value is chosen, called the significance level of the test,
traditionally 5% or 1%. A small p-value (≤ 0.05) indicates strong evidence against
the null hypothesis, that is the data suggest to reject the null hypothesis. A large
p-value (> 0.05) indicates weak evidence against the null hypothesis, that is the data
are not sufficient to reject the null hypothesis.
4.3.2 Randomization Test
The Randomization test is a statistical test to determine the significance of some observed
test statistic aimed at assessing a particular hypothesis. The assessment is achieved thanks
to the generation of a distribution of the test statistic assuming the null hypothesis. The
proportion of the distribution that is at least as extreme in absolute value as the observed
test statistic is then determined. This proportion is a good estimate of the p-value and
represents the probability that the observed test statistic could have been achieved by the
distribution of the test statistic under the null hypothesis. See [164] for an illustration of
the methodology of the randomization tests (in particular Fig. 4.11).
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Figure 4.11: The randomization test for comparing the diversity of TCR samples. A
schematic of the randomization test method for determining the statistical significance
of the difference in a diversity measure (DB − DA) between two TCR sets, A and B.
The method involves first pooling all sequences from Set A and Set B and then randomly
drawing two new sets (of the same sizes as the original Set A and Set B), and calculating the
difference in diversity that arose from this random sampling. This procedure is repeated
multiple times (i.e.: repeat steps 3 and 4 multiple times) to obtain a distribution of the
difference in diversity measures assuming the null hypothesis that both samples are drawn
from the same distribution. The p-value for the difference in diversity (DB −DA) is the
proportion of the distribution (highlighted in red) from the random draws for which the
difference in diversity was greater than that observed experimentally (i.e.: (DB −DA)).
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4.3.3 Simpson’s diversity index
The Simpson’s diversity index is a measure of the degree of concentration of a sample
when individuals are classified into types, and it is defined as
DS = 1−
∑c
i=1 ni(ni − 1)
n(n− 1) , (4.1)
where ni is the number of individuals of the i-th type (or class) in the sample, c is the
number of different types in the sample, and n is the total number of individuals in the
sample. This index ranges between 0 (all individuals of the sample belong to the same
type) and 1 (each individual in the sample belongs to a different type or class) representing
minimal and maximal diversity (within the sample) respectively [147].
4.3.4 Jaccard distance
The Jaccard distance between two sets A and B is a measure of overlapping dissimilarity
between sample sets. It is defined as
dJ(A,B) = 1− J(A,B) ,
where J(A,B) is the Jaccard index and it is defined as
J(A,B) =
|A ∩B|
|A ∪B| .
This index ranges between 0 (the two sets share everything) and 1 (the two set share
nothing) representing minimal and maximal dissimilarity respectively [79, 133].
4.3.5 Wilcoxon-Mann-Whitney U test
The Wilcoxon-Mann-Whitney U test is a non-parametric statistical test, that is a statis-
tical hypothesis testing test which make no a priori assumptions on the variables taken
into consideration. As opposed to parametric tests, the parameters are present but they
are determined by the data rather than by the model assumptions. Consider two different
independent samples X and Y . Consider also generic observations x from sample X and
y from sample Y . The hypotheses associated to the test are as follows:
• H0: Pr(x > y) = Pr(y > x);
• H1: Pr(x > y) 6= Pr(y > x).
The test is based upon a statistics called U which, under H0 and considering samples
with size greater or equal than 20, can be approximated with a normal distribution. For
smaller samples, tables for the exact distribution of U exist. To compute the statistic U ,
an easy and intuitive way is as follows:
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• Consider an observation x and define nx the number of times an observation in
sample X is greater than any other observation y in sample Y ;
• Start with nx = 0 and increase nx of 1 each time x is greater than y, while increase
it of 0.5 each time x meets a tie;
• Define UX =
∑
x∈X nx;
• Define UY with the contrary procedure.
4.3.6 Pearson’s χ2 test
The χ2 test is is a statistical test in which the sampling distribution of the test statistic
follows a chi-squared distribution when the null hypothesis is true. It is commonly used to
assess independence of unpaired observations of two different random variables X and Y ,
where in general the random variables are expressed in contingency tables. Before giving
the mains steps for the computation of this statistical test, we define the Pearson’s χ2 test
statistic (which asymptotically approaches the χ2 distribution) as follows:
χ2 =
∑
i,j
(ni,j − ei,j)2
ei,j
,
where
ei,j =
(∑
j ni,j
)
(
∑
i ni,j)∑
i,j ni,j
represents the expected frequency of type (i, j) if the occurrences were distributed ran-
domly over the contingency table. The test is structured in 5 different steps, as follows:
• Compute the Pearson’s χ2 test statistic as specified above;
• Determine the number of degrees of freedom, df = (r − 1)× (c− 1), where r and c
represent the number of rows and columns in the contingency table respectively;
• Define the confidence level for the test result (i.e. significance level of the test);
• Compare the χ2 (computed in the first point) with the tabulated values of the χ2
distribution (critical value) with degrees of freedom computed in the second point
and with selected level of confidence chosen in the third point;
• If the test statistic exceeds the critical value of the fourth point, reject the null
hypothesis H0 for which the two random variables X and Y are independent.
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4.4 Js and Vs frequency plots
We show here the plots for the fraction of all V and J gene segments in the data for
both na¨ıve, infected and immunized mice. Single V and J plots per mouse can be found
with greater resolution in Appendix B. Figure 4.12 shows a clear preference for V13−1,
V13−2 and V13−3 in na¨ıve mice. It also shows a preference for J2 genes rather than for J1
genes. Figure 4.13 shows instead the importance of V29 for infected and immunized mice.
Different exploratory plots for the marginal distributions are shown in Figures 4.14, 4.15,
4.16 and 4.17, while plots for the joint distributions are shown in Figures 4.18 to 4.27. It
is important to notice that the results for na¨ıve mice are in concordance with previous
studies, for both V [84] and J [29] segments.
Figure 4.12: V-J frequency plots for the na¨ıve mice BAs.
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Figure 4.13: V-J frequency plots for the infected mice EFs.
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Figure 4.14: V frequency plots for each na¨ıve mouse compared to average frequencies of
na¨ıve mice.
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Figure 4.15: J frequency plots for each na¨ıve mouse compared to average frequencies of
na¨ıve mice.
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Figure 4.16: V frequency plots for each infected mouse compared to average frequencies
of infected mice.
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Figure 4.17: J frequency plots for each infected mouse compared to average frequencies of
infected mice.
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Figure 4.18: VJ plot for the na¨ıve mouse BA1.
Figure 4.19: VJ plot for the na¨ıve mouse BA2.
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Figure 4.20: VJ plot for the na¨ıve mouse BA3.
Figure 4.21: VJ plot for the na¨ıve mouse BA4.
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Figure 4.22: VJ plot for the na¨ıve mouse BA5.
Figure 4.23: VJ plot for the infected mouse EF1.
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Figure 4.24: VJ plot for the infected mouse EF2.
Figure 4.25: VJ plot for the infected mouse EF3.
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Figure 4.26: VJ plot for the infected mouse EF4.
Figure 4.27: VJ plot for the infected mouse EF5.
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4.5 Js and Vs Simpson’s diversity
This section presents the plots for Simpson’s indices for na¨ıve and infected mice. It is
worth noting that the two immunized mice (EF1 and EF2) have higher diversity index with
respect to the infected ones, probably suggesting that infection induce a higher skewness in
the diversity distribution with respect to immunization. Figure 4.28 indicates a minimum
in the Vs diversity of mouse EF3. This agrees with Figure 4.13, where the V distribution
in mouse EF3 is shown to be have low diversity. More interestingly, Figure 4.28 shows
how important the diversity of the J component is for the general diversity of VJs, as it
can be seen in the case of mouse BA3. Here, the V diversity is low with respect to the
other mice, but a value of J diversity similar to the other mice implies a level of total VJ
diversity comparable to that of other mice.
Figure 4.28: V-J-VJ Simpson’s indices for na¨ıve and infected mice.
4.5.1 Wilcoxon-Mann-Whitney U test
Three Wilcoxon-Mann-Whitney U tests were performed on the data representing na¨ıve
and infected mice. The first test was performed between the two sets
• SBA,V = {DBA1,V , DBA2,V , DBA3,V , DBA4,V , DBA5,V }
• SEF,V = {DEF1,V , DEF2,V , DEF3,V , DEF4,V , DEF5,V },
where the generic DBAn,V represents the Simpson’s diversity index of the na¨ıve mouse
BAn with respect to the V segments distribution. Similar reasoning holds for DEFn,V .
The second test was performed between the two sets
• SBA,J = {DBA1,J , DBA2,J , DBA3,J , DBA4,J , DBA5,J}
• SEF,J = {DEF1,J , DEF2,J , DEF3,J , DEF4,J , DEF5,J},
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where the generic DBAn,J represents the Simpson’s diversity index of the na¨ıve mouse
BAn with respect to the J segments distribution. Similar reasoning holds for DEFn,J .
The third and last test was performed between the two sets
• SBA,V J = {DBA1,V J , DBA2,V J , DBA3,V J , DBA4,V J , DBA5,V J}
• SEF,V J = {DEF1,V J , DEF2,V J , DEF3,V J , DEF4,V J , DEF5,V J},
where the generic DBAn,V J represents the Simpson’s diversity index of the na¨ıve mouse
BAn with respect to the V J combination distribution. Similar reasoning holds forDEFn,V J .
The result are shown here:
• BAV and EFV: U = 18, p-value = 0.3095
• BAJ and EFJ: U = 12, p-value = 1
• BAVJ and EFVJ: U = 23, p-value = 0.03175
Given the high p-values for the first two tests, we cannot consider the results as conclusive.
The third test though, has a p-value lower than 0.05, suggesting that Simpson’s diversity
index is statistically higher in na¨ıve mice with respect to infected mice.
4.6 Randomization tests for VJ’s diversity
This section focuses on the distribution of diversity, using Simpson’s diversity index as
a test statistic. In other words, the study of this section focuses on how much a single
mouse CD8+ TCR V-J repertoire differs from a flat CD8+ TCR V-J repertoire (case
Simpson’s index equal to 1) and how much these differences vary among mice and within
groups. It is important to understand that we are not focusing on the actual V-J profile
of a repertoire. This means that two different V-J profiles could have the same Simpson’s
diversity index. As an example, let us imagine that mouse X has the same V-J repertoire
of mouse Y except for the fact that the number of sequences of class {V1J1−1} and the
number of sequences of class {V1J1−2} are inverted. In this case, the two mice would
have two different V-J profiles but the same Simpson’s diversity index. Thus, this section
focuses on the “amount” of V-J diversity.
Randomization tests based on Simpson’s index were applied to each possible pair of
mice (within the na¨ıve group and within the infected group), resulting in a series of p-
values plotted in Figure 4.29. The tested hypotheses are
H0 : the two samples come from the same diversity distribution
H1 : the two samples do not come from the same clonal size diversity distribution.
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Figure 4.29: p-values for the randomization test based on Simpson’s index, for both na¨ıve
and infected mice.
Figure 4.29 implies that we can exclude the null hypothesis (i.e. coming from the same
diversity distribution) for the pairs of mice BA3-BA1, BA3-BA2, BA3-BA4, BA3-BA5,
EF1-EF3, EF1-EF4, EF1-EF5, EF2-EF3, EF2-EF5, EF3-EF4, EF3-EF5. The EF1-EF2
pair is particularly interesting cause it represents the two previously immunized mice; see
Tables 4.1 and 4.2.
BA1 X
BA2 0.07011 X
BA3 0.00578 0.00031 X
BA4 0.08240 0.91210 0.00003 X
BA5 0.29003 0.68246 0.00323 0.74695 X
BA1 BA2 BA3 BA4 BA5
Table 4.1: p-values for the randomization test (105 simulations) based on Simpson’s index
for na¨ıve mice.
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EF1 X
EF2 0.59052 X
EF3 0.00000 0.00004 X
EF4 0.04211 0.07309 0.00000 X
EF5 0.00000 0.00211 0.03837 0.0000 X
EF1 EF2 EF3 EF4 EF5
Table 4.2: p-values for the randomization test (105 simulations) based on Simpson’s index
for infected mice.
4.6.1 χ2 test
Two Pearson’s χ2 tests were performed on the data. The first test was performed between
the two categorical variables X1 = V segments and Y1 = na¨ıve mice, with a number of
degrees of freedom of (23− 1)× (5− 1). The second test was performed between the two
categorical variables X2 = Jsegments and Y2 = na¨ıve mice, with a number of degrees of
freedom of (12− 1)× (5− 1). We show here the results
• Result for test 1: χ2 = 126.06, df = 88, p-value = 0.004872
• Result for test 2: χ2 = 47.655, df = 44, p-value = 0.3264.
Considering a confidence level of 0.05, we see that the results from test 1 allow us to reject
H0, that is the two variables X1 and Y1 are not independent. Test 2 does not allow to
reject H0 instead. The same procedure was applied to immunised/infected mice. The
results were
• Result for test 1: χ2 = NaN, df = 88, p-value = NA
• Result for test 2: χ2 = 224.94, df = 44, p-value < 2.2e− 16.
Considering a confidence level of 0.05, we see that the results from test 2 allow us to reject
H0, that is the two variables X2 and Y2 = infected mice are not independent. Test 1 did
not work because three of the columns of the contingency table (precisely the columns
related to V21, V23 and V24) were full of 0s (each line represents a particular mouse),
not allowing the computation of the ei,j described in 4.3.6. To overcome this issue, and to
try to understand the relationship between the non-zero columns and the mice, the three
columns were removed from the contingency table and the test was repeated (Test 3). The
result was
• Result for test 3: χ2 = 456.19, df = 76, p-value < 2.2e− 16.
This last result shows how the different V segments are not independent on the different
immunized/infected mice.
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4.7 Public & Private VJ repertoire
A map of shared and not shared V-J repertoires among na¨ıve and infected mice has been
computed and plotted. Results are shown in Fig. 4.30 and Fig. 4.31.
Figure 4.30: V-J repertoires sharing plot for naive mice.
The Jaccard distance was applied in order to vizualize the diversity in public and
private V-J repertoires. It is immediately clear from the analysis that the average Jaccard
distance for na¨ıve mice is lower than the one for infected or immunised ones, suggesting
that infected or immunized mice share less among each other than the na¨ıve ones. See
Figures 4.32 and 4.33.
4.8 Sample and repertoire frequencies
In this section we find a general result on the relation between frequencies in the repertoire
and frequencies in a sample. We recall Chapter 3 and, in particular, (3.10)
q =
combinations of S − 1 elements in m− 1 places
combinations of S elements in m places
=
(
S−1
m−1
)(
S
m
) = m
S
. (4.2)
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Figure 4.31: V-J repertoires sharing plot for infected mice.
Figure 4.32: Jaccard indices among na¨ıve mice.
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Figure 4.33: Jaccard indices among infected mice.
and (3.13)
φYi(z) = (1− q + qz)ni , (4.3)
where ni is the number of T cells in the clonotype class i in the repertoire. If we define
pk = Pr(Yi = k), we have φYi(z) = p0 + p1z + p2z
2 + · · · and if we want to consider Y obsi ,
that is the number of observed T cells of clonotype i in the sample, then we have to
consider
Pr(Y obsi = k) = Pr(Yi = k|Yi 6= 0) =
Pr(Yi = k)
Pr(Yi 6= 0) =
pk
1− p0 . (4.4)
If we divide φYi(z) by 1− p0 though, what we obtain is not exactly φY obsi (z). In fact, we
obtain
φYi(z)
1− p0 =
p0
1− p0 +
p1
1− p0 z +
p2
1− p0 z
2 + · · ·
Defining qk =
pk
1− p0 , we have that q0 6= 0, which is not what we want, given that we
expect q0 = Pr(Y
obs
i = 0) = 0. Therefore, we need
φY obsi
(z) =
φYi(z)
1− p0 − q0 =
(1− q + qz)ni − (1− q)ni
1− (1− q)ni . (4.5)
Defining fi = ni/S as the frequency of clonotype i in the repertoire, it is easy to compute
E(Y obsi ) =
E(Yi)
1− p0 =
niq
1− (1− q)ni =
mfi
1− (S−mS )Sfi , (4.6)
and
Var(Y obsi ) =
Var(Yi)
(1− p0)2 =
niq(1− q)
[1− (1− q)ni ]2 =
mfi(S −m)
S
[
1− (S−mS )Sfi]2 . (4.7)
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Defining gi as the frequency of clonotype i in a sample of m cells, we can write E(Y obsi ) =
mE(gi). Therefore, from (4.6) we obtain
E(gi) =
fi
1− (S−mS )Sfi . (4.8)
4.8.1 General solution of (4.8)
Equation (4.8) can be written as
E(gi) =
fi
1− αfi where α = (1− q)
S . (4.9)
This allows us to write
αfi = 1− 1
E(gi)
fi. (4.10)
We focus now on the solution of the general equation pax+b = cx+ d, where p > 0 and
a, c 6= 0. Using the substitution −t = ax+ ad
c
, which can be seen as x = −d
c
− t
a
, this
equation can be transformed into
tpt = R = −a
c
pb−
ad
c .
This can be seen as
tet ln(p) = R and, therefore, t ln(p)et ln(p) = R ln(p),
which gives
t =
W (R ln(p))
ln(p)
where W represents the Lambert W function.
Thus, we have the general solution
x = −
W
(
−a ln(p)c pb−
ad
c
)
a ln(p)
− d
c
. (4.11)
We can now see (4.10) as a special case of this general case, where p = α, a = d = 1, b = 0
and c = −E(gi)−1. Thus, we obtain the solution
fi = E(gi)−
W
(
E(gi) ln(α)αE(gi)
)
ln(α)
. (4.12)
This solution, as can also be seen in (4.10), strongly depends on the value of E(gi) or fi.
In fact, no matter how small α could be, if raised to the fi (See Eq. (4.10)) or to the
E(gi) (See Eq. (4.12)), it can still range between 0 and 1. For example, α = 10−20 can
still become α0.001 = 0.95. On the other hand, α = 10−20 becomes α0.1 = 0.01. For this
reason, in the next section we try to give some approximation for fi.
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4.8.2 Approximation of (4.8)
Using Laurent expansion at fi ' 0, we can approximate (4.8) as
E(gi) ' − 1
S ln
(
1− mS
) + fi
2
+ O(f2i ), (4.13)
which gives us
fi ' 2
(
E(gi) +
1
S ln
(
S−m
S
)) . (4.14)
Applying Taylor expansion, we obtain
1
ln
(
1− mS
) ' − S
m
+ O(1/2), (4.15)
and therefore
E(gi) ' 1
m
+
fi
2
. (4.16)
On the other side, it is clear from (4.9) that if fi is not small enough, then we have α
fi ' 0
and, therefore,
E(gi) ' fi. (4.17)
It is interesting to notice that (4.16) and (4.17) have only one point in common, which is
fi =
2
m
. This value of fi represents also the point in which both (4.16) and (4.17) have
maximum distance from the real trajectory (4.8). This distance (or error) is the difference
between (4.8) in fi =
2
m
and (4.17) in fi =
2
m
:
2
m
1− (1− q) 2q
− 2
m
=
2
m
[
(1− q) 2q
1− (1− q) 2q
]
.
Using Taylor approximation, we can write
(1− q) 2q
1− (1− q) 2q
' 1
e2 − 1 + O(q).
This allows us to give a definitive answer to our approximation problem:
• For fi ∈
(
0,
2
m
]
, we use (4.16) to approximate (4.8);
• For fi ∈
(
2
m
, 1
]
, we use (4.17);
• The maximum error produced is erri = 0.3
m
at frequency fi =
2
m
.
Thus, we have
fi '
{
2
(
E(gi)− 1m
)
for E(gi) ∈
(
1
m ,
2
m
]
E(gi) for E(gi) ∈
(
2
m , 1
]
.
(4.18)
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Figure 4.34: Test of goodness of (4.17), (4.16) and (4.20) for (4.8). Parameters are S =
1000 and m = 100.
As we can see from (4.18), the case E(gi) = 1m would give us no information at all about
fi. The reason behind this comes from the approximation (4.15). Therefore, we consider
a better Taylor approximation
− 1
S ln
(
1− mS
) ' − 1
S
1[
−q − q22
] = 2
m(2 + q)
. (4.19)
Thus, we can write
E(gi) ' 2
m(2 + q)
+
fi
2
, (4.20)
eventually obtaining
fi '
{
2
(
E(gi)− 2m(2+q)
)
for E(gi) ∈
[
1
m ,
2
m
]
E(gi) for E(gi) ∈
(
2
m , 1
]
.
(4.21)
In Figure 4.34 we can see a plot of these results.
4.8.3 Approximation of Var(gi)
Similar steps can be done to approximate Var(Y obsi ). In fact, applying Taylor expansion
to Eq. (4.7), we have
Var(Y obsi ) '
m(S −m)
S
[
1
fiS2 ln
2
(
1− mS
) − 1
S ln
(
1− mS
) + O(fi)] . (4.22)
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If we consider now (4.15) and the other Laurent expansion
1
ln2
(
1− mS
) ' S2
m2
− S
m
+ O(1/12),
we obtain
Var(Y obsi ) '
(S −m)
S
[
1
fim
− 1
Sfi
+ 1
]
, (4.23)
and
Var(gi) ' (S −m)
m2S
[
1
fim
− 1
Sfi
+ 1
]
:= α(fi), (4.24)
which in turn gives
σgi '
√
α(fi). (4.25)
4.8.4 Standard error of g¯i
Let us imagine to extract K independent samples and to observe the quantities Y
(1)
i , Y
(2)
i ,
· · · , Y (K)i , where Y (j)i represents the number of T cells of clonotype i found in the jth
sample of size m. Let us define the sample mean of {Y (j)i , j = 1, 2, · · · ,K} as Y¯i. In the
same way, we define the sample mean of {g(j)i , j = 1, 2, · · · ,K} as g¯i.
Given the relations expressed in (4.21), we want now to focus on the standard error of
g¯i. We want to do this to understand how much g¯i differs from E(gi) with a small number
of samples K and, in turn, how good is the estimate in (4.14).
Let us now focus on the standard error of g¯i. We know from statistical theory that
SEg¯i =
s√
K
, where s =
√√√√ 1
K − 1
K∑
j=1
(
g
(j)
i − g¯i
)2
. (4.26)
We know that SEg¯i is an estimate of how far the sample mean g¯i is likely to be from the
population mean E(gi), giving us an idea of the goodness of using g¯i in place of the general
E(gi) in (4.18).
We would like now to find an upper bound for SEg¯i which could be expressed as a
function of the only variable K. The following steps show our upper bound:
• Kg¯i =
∑K
k=i g
(k)
i ;
• g¯i − g(j)i = 1K
∑
k 6=j g
(k)
i − (K−1)g
(j)
i
K ≤ K−1K
[
1− g(j)i
]
≤ K−1K ;
•
∣∣∣g(j)i − g¯i∣∣∣ ≤ K−1K ∀j ∈ {1, 2, · · · ,K};
•
(
g
(j)
i − g¯i
)2 ≤ (K−1)2
K2
∀j ∈ {1, 2, · · · ,K};
•
√∑K
j=1
(
g
(j)
i − g¯i
)2
< K−1√
K
;
87
4. VDJ RECOMBINATION & DATA ANALYSIS
which gives us the upper bound
SEg¯i <
√
K − 1
K
. (4.27)
Figure 4.35 shows numerical simulations of frequencies in the repertoire and their relative
frequencies in the samples (average values over 100 samples). Other simulations, showing
sampling from different kind of clonal size distributions, are shown in Figures 4.36-4.53. In
particular, for each kind of distribution (e.g., geometric distribution with mean 3), three
different plots are shown, for three different sampling and plotting procedures: (i) extrac-
tion of one single sample and plotting of all of the classes in the sample, (ii) extraction of
five samples and plotting of all of the classes in the five samples, and (iii) extraction of
five samples and plotting of the classes that are present in all of the samples. The third
kind is the reason why some plots do not show any point. Each figure also plots (4.8) ±
(4.25).
Figure 4.35: Simulation of frequencies in the repertoire and related frequences of observed
classes in the sample. Average values over 100 samples.
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Figure 4.36: Geometric repertoire with mean 3. One sample of size 100 is taken. Param-
eters: S = 104, N = 3250.
Figure 4.37: Geometric repertoire with mean 3. Five samples of size 100 are taken.
Parameters: S = 104, N = 3307.
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Figure 4.38: Geometric repertoire with mean 3. Five samples of size 100 are taken and
only the common classes (common to all samples) are displayed. Parameters: S = 104,
N = 3274.
Figure 4.39: Geometric repertoire with mean 10. One sample of size 100 is taken. Param-
eters: S = 104, N = 1029.
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Figure 4.40: Geometric repertoire with mean 10. Five samples of size 100 are taken.
Parameters: S = 104, N = 991.
Figure 4.41: Geometric repertoire with mean 10. Five samples of size 100 are taken and
only the common classes (common to all samples) are displayed. Parameters: S = 104,
N = 1002.
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Figure 4.42: Poisson repertoire with mean 3. One sample of size 100 is taken. Parameters:
S = 104, N = 3118.
Figure 4.43: Poisson repertoire with mean 3. Five samples of size 100 are taken. Param-
eters: S = 104, N = 3202.
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Figure 4.44: Poisson repertoire with mean 3. Five samples of size 100 are taken and
only the common classes (common to all samples) are displayed. Parameters: S = 104,
N = 3166.
Figure 4.45: Poisson repertoire with mean 10. One sample of size 100 is taken. Parameters:
S = 104, N = 995.
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Figure 4.46: Poisson repertoire with mean 10. Five samples of size 100 are taken. Param-
eters: S = 104, N = 991.
Figure 4.47: Poisson repertoire with mean 10. Five samples of size 100 are taken and
only the common classes (common to all samples) are displayed. Parameters: S = 104,
N = 1019.
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Figure 4.48: Heterogeneous repertoire: unexpanded part geometric with mean 3 and
expanded part (0.01 of total clones) constant with mean 75. One sample of size 100 is
taken. Parameters: S = 104, N = 2688.
Figure 4.49: Heterogeneous repertoire: unexpanded part geometric with mean 3 and
expanded part (0.01 of total clones) constant with mean 75. Five samples of size 100 are
taken. Parameters: S = 104, N = 2687.
95
4. VDJ RECOMBINATION & DATA ANALYSIS
Figure 4.50: Heterogeneous repertoire: unexpanded part geometric with mean 3 and
expanded part (0.01 of total clones) constant with mean 75. Five samples of size 100 are
taken and only the common classes (common to all samples) are displayed. Parameters:
S = 104, N = 2677.
Figure 4.51: Heterogeneous repertoire: unexpanded part geometric with mean 10 and
expanded part (0.01 of total clones) constant with mean 250. One sample of size 100 is
taken. Parameters: S = 104, N = 806.
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Figure 4.52: Heterogeneous repertoire: unexpanded part geometric with mean 10 and
expanded part (0.01 of total clones) constant with mean 250. Five samples of size 100 are
taken. Parameters: S = 104, N = 806.
Figure 4.53: Heterogeneous repertoire: unexpanded part geometric with mean 10 and
expanded part (0.01 of total clones) constant with mean 10*25. Five samples of size 100
are taken and only the common classes (common to all samples) are displayed. Parameters:
S = 104, N = 807.
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4.9 Data frequencies and implications on frequencies in reper-
toire
This section presents the frequencies for all V and J segments in the 10 different mice. If the
samples were of the same sizes, the reader could directly apply the techniques developed
in Section 4.8 to obtain an estimate of the respective frequencies in the repertoire. In fact,
the expected value (4.8), representing the mean of the random variable Y obsi , has to be
considered over samples of the same size m. Our data do not follow this criterion, as we
have different sample sizes for each mouse. There might be a way out of this situation
though, considering the following reasoning. Define m1 and m2 as two different sample
sizes, and S as the repertoire size. As long as m1 ≈ m2 and m1,m2  S, we can easily
verify (even just by simulations) that a binomial distribution with parameters ni and m1/S
would not be distinguishable from another binomial distribution with parameters ni and
m2/S. This is in fact our current situation, as we have different similar sample sizes mj
for j = 1, . . . , 5 and a binomial distribution for the random variable Yi, representing the
number of T cells of type i in the sample. Similar reasoning holds for the random variable
Y obsi , represented by the zero-truncated Yi. For this reason, we apply here the analyses
of Section 4.8 to obtain some estimates of the V and J segments in the GP33-specific
repertoire of na¨ıve, immunized and infected mice. We start by plotting the frequencies in
Figures 4.54 to 4.61. See Appendix C for more details.
Figure 4.54: V frequencies for na¨ıve mice.
In order to apply the techniques of Section 4.8, we need to use a unique value for the
sample size, which we define as the mean over the different values. In particular, we will
98
4.9 Data frequencies and implications on frequencies in repertoire
Figure 4.55: V frequencies for na¨ıve mice and mean V frequency.
Figure 4.56: J frequencies for na¨ıve mice.
use mBA = 205 and mEF = 208 for the na¨ıve and infected respectively.
Mean frequencies for both V and J segments are displayed in Tables 4.3 and 4.4, sub-
divided in the two groups of mice (na¨ıve and immunized/infected). It can be immediately
seen that the V segments V21 V23 and V24 are never found in immunized/infected mice. All
the other average values are above zero, wrongly suggesting that we could substitute these
values in (4.21) in place of E(gi) to approximate fi. In fact, gi represents the frequency of
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Figure 4.57: J frequencies for na¨ıve mice and mean J frequency.
Figure 4.58: V frequencies for immunized and infected mice.
a particular type i (V or J particular segment in our case) which is actually observed in
the samples. Therefore, before applying (4.21), we need to understand if and which are
the V and J segments absent in one or more mice. In these cases, we won’t be able to
estimate the respective frequency in the repertoire. Of course, one could apply the same
equation only to those mice with actually these particular V or J segments missing from
the other mice, but we decided not to do it here, given the low number of available samples.
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Figure 4.59: V frequencies for immunized and infected mice and mean V frequency.
Figure 4.60: J frequencies for immunized and infected mice.
Looking at the data, we realize that all J segments are present in all mice. Regarding the
V segments, here the result of what is missing for each mouse:
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Figure 4.61: J frequencies for immunized and infected mice and mean J frequency.
V segment BA1 BA2 BA3 BA4 BA5 EF1 EF2 EF3 EF4 EF5
V1 X
V2 X X X X
V15 X
V20 X X
V21 X X X X X X X X X
V23 X X X X X X X X
V24 X X X X X X X X
V26 X
V30 X X X X
We now give an example of how we would apply (4.21) to the described experimental
data, and in particular to the estimation of the frequency of the V1 gene segment in the
repertoire. As previously shown, the V1 gene segment is present in all 5 samples from
the 5 na¨ıve mice. Therefore, its average frequency (i.e., E(gi) = 0.0547) shown in Table
4.3 in the BAs column is free from interference due to mice without that particular gene
segment. Considering mBA = 205, we obtain [1/mBA, 2/mBA] = [0.0048, 0.0097]. E(gi)
falls out of this interval, therefore suggesting that we should use the second part of (4.21).
Thus, we believe that the percentage of V1 gene segments in the whole repertoire of the
na¨ıve mice is around 5.47%.
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BAs EFs
V1 5.47 · 10−2 2.07 · 10−2
V2 2.71 · 10−2 5.98 · 10−3
V3 3.21 · 10−2 2.76 · 10−2
V4 2.83 · 10−2 2.61 · 10−2
V5 4.23 · 10−2 1.77 · 10−2
V12−1 4.85 · 10−2 2.27 · 10−2
V12−2 3.48 · 10−2 5.41 · 10−2
V13−1 0.11 0.12
V13−2 0.15 6.05 · 10−2
V13−3 0.13 7.49 · 10−2
V14 5.43 · 10−2 3.45 · 10−2
V15 2.46 · 10−2 2.68 · 10−2
V16 7.59 · 10−2 0.13
V17 2.52 · 10−2 5.05 · 10−2
V19 6.22 · 10−2 8.67 · 10−2
V20 1.58 · 10−2 1.73 · 10−2
V21 1.03 · 10−3 0
V23 1.93 · 10−3 0
V24 3.91 · 10−3 0
V26 1.96 · 10−2 1.66 · 10−2
V29 4.54 · 10−2 0.18
V30 4.05 · 10−3 9.43 · 10−4
V31 1.29 · 10−2 2.57 · 10−2
Table 4.3: V means over the five na¨ıve and five immunized/infected mice, that is including
mice without some V genes.
BAs EFs
J1−1 0.1 0.14
J1−2 6.74 · 10−2 5.14 · 10−2
J1−3 2.82 · 10−2 2.98 · 10−2
J1−4 5.42 · 10−2 6.21 · 10−2
J1−5 2.17 · 10−2 2.93 · 10−2
J1−6 3.2 · 10−2 4.75 · 10−2
J2−1 0.14 0.13
J2−2 5.72 · 10−2 3.83 · 10−2
J2−3 7.42 · 10−2 6.82 · 10−2
J2−4 9.62 · 10−2 5.89 · 10−2
J2−5 0.13 0.15
J2−7 0.2 0.19
Table 4.4: J means over the five na¨ıve and five immunized/infected mice, that is including
mice without some J genes.
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4.10 Discussion
This chapter focused on exploratory analyses of the data described in Section 4.2 and
on some probabilistic results connecting a particular frequency in the repertoire with
frequencies in different samples. A clear preference for V13−1, V13−2 and V13−3 in na¨ıve
mice was shown in Figure 4.12. The same figure also shows a preference for J2 genes in
na¨ıve mice with respect to J1 genes. This result can be also seen in Figure 4.30. The
importance of V19 for infected mice is shown in Figure 4.13. Interestingly, Figure 4.28
shows how important the diversity of the J component is for the general diversity of VJs.
The V diversity of mouse BA3 is low with respect to the other mice, but a value of J
diversity similar to the other mice implies a level of total VJ diversity comparable to all
the mice. Figure 4.29 shows the p-values for the randomization test on different mice.
The data exclude the hypothesis of similar diversity distribution for all the couples of
mice a part from the couples BA2-BA3, BA3-BA4, BA3-BA5, EF1-EF2, and EF2-EF4.
The last pair is particularly interesting, representing the two previously immunized mice.
This could indicate that these two mice have reached a similar diversity distribution due
to immunization. A higher level of clonal sharing among na¨ıve mice rather than among
infected mice is shown in Figures 4.32 and 4.33. The major innovative point of this
chapter is represented by (4.21). The importance of this formula depends on the kind
of data we would like to use it for. In fact, E(gi) represents the average of gi taken
over all those samples where the clonotype i was actually observed. This means that to
estimate the frequency fi of a clonotype with this equation, we should first observe the
clonotype in all of our samples (or at least 2 samples). This could be very challenging
for a general clonotype but could become much easier if we considered V, J or even VJ
classes, rather than clonotype classes. It is worth noting that the formula is perfectly able
to work at different levels of diversity, clonotype classes included, although the currently
available single-cell technologies are not developed yet to produce enough frequency data
for clonotype classes. To properly understand the level of diversity on which our formula
can work nowadays, see Figure 4.62.
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V s
Js
V1J1
clonotype class i
fi approximation
Figure 4.62: Example of the level of diversity (VJs) where (4.21) could work rather than
at the clonotype class level.
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Chapter 5
Markov chains and TCR
repertoire renewal
5.1 Abstract and Introduction
Let us consider a TCR repertoire at a given time t with N distinct clonotype classes.
It is well known that the thymus is constantly producing new clonotypes, while in the
periphery a certain diversity is maintained due to a balanced birth and death process based
on competition among classes for biological signal. The biological questions we address
concern the time evolution of diversity in the repertoire. In particular, we first explore
(i) the random variable describing the average time at which a given percentage of the
original N clonotype classes have disappeared from the repertoire due to competition or
natural death, (ii) the size of the repertoire at such time, and (iii) the maximum repertoire
diversity achieved in this time interval. We believe that these questions are of foremost
importance in order to understand the real value of sampling from a repertoire and try
to estimate its diversity at a given point in time. These three points will be described as
specific stochastic descriptors, in connection to the Markov model that will be explained
in the following section.
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5.2 Mathematical model
We present here an unidimensional continuous-time Markov chain (CTMC) representing
the dynamical process of competition among clonotype classes. In particular, we consider
the CTMC X = {X(t) : t ≥ 0} defined over the space of states S = {0, 1, 2, . . .} and with
initial condition X(0) = N , where X(t) represents the number of distinct clonotype classes
present in the repertoire at time t ≥ 0. The birth rate λn represents thymic production
of new clonotypes in the repertoire, and it is described by a constant thymic output rate
λn ≡ θ, as defined in [100]. The extinction of a given clonotype, in reality dependent on
reception of survival stimuli from the environment and on competition among classes [64],
is represented here by a rate µn of transition of process X from state n to state n − 1;
see Figure 5.1. In the following sections, we propose two different choices for µn, denoted
µ
(1)
n and µ
(2)
n , which incorporate clonotype competition in two different ways. According
to the choice of µn, we will label the process X as X(1) or X(2).
n+ 1 · · ·nn− 1· · ·210
λ0 λ1 λ2
µn+2µn+1µnµn−1
λn−2 λn+1λnλn−1
µ3µ2µ1
Figure 5.1: Continuous-time birth-and-death process X.
5.2.1 Implicit competition
We consider the process X(1) with a linear death rate µ
(1)
n = µ˜n, where µ˜−1 is defined as
the average survival time of a clonotype in the repertoire, where clonotypes are assumed
to act independently from each other. This average survival time was previously evaluated
in [100] as
T (α, nθ) =
1
αµ
(γE − eαnθ · Ei(−αnθ) + log(αnθ)), (5.1)
where γE represents the Euler-Mascheroni constant, Ei(x) represents the exponential in-
tegral defined as
Ei(x) =
∫ x
−∞
et
t
dt
and α =
θnθ
γM
represents the strength of the thymic production relative to the peripheral
division. Moreover, the main assumptions in [100] are that: (i) each clonotype comes out
of the thymus at a rate θ and a fixed size nθ, and (ii) the environment is populated by M
distinct self pMHC subsets. The parameter µ in (5.1) represents the single cell death rate,
while γ represents the single cell division rate. The dependence of (5.1) on parameters nθ,
M , γ, θ, µ is shown in Appendix D.
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We are therefore expressing competition among clonotypes intrinsically through the
rate µ˜. T (α, nθ) is in fact defined as the mean time until the stochastic process Xt, where
Xt is defined as the diffusion process on the real line approximating the number of T cells
ni(t) of clonotype class i. The process Xt satisfies the stochastic differential equation (15)
in [100]
dXt = −αµXtdXt +
√
2µXtdWt,
where Wt represents a Wiener process. The term −αµ in this stochastic differential
equation is the term including competition among clonotypes in the general scenario,
therefore inducing implicit competition in the time T (α, nθ).
Thus, we set µ˜−1 = T (α, nθ), where the values of the parameters in (5.1) will be
chosen for our numerical results according to Table 1 in [100], and to the rescaling process
described in Section 5.7, with µn = µ
(1)
n = µ˜n for process X(1).
5.2.2 Explicit competition
We consider here a second alternative for the choice of µn, defining the process X(2) with
death rate µn = µ
(2)
n = n(β1 + β2p(n − 1)). In process X(2), parameter β1n represents a
linear contribution, while parameter β2pn
2 is used to model clonotype competition in a
similar way to Mathematical Ecology models [90]. In particular, the parameter p = 10−6 is
defined in [100] as the probability that any given self pMHC is recognised by a randomly-
selected T-cell clonotype. This quadratic term can be seen as the environmental pressure
a single clonotype is subject from that fraction p of clonotypes with which it competes. In
order to give biological meaning to the parameters β1 and β2, we need to find two different
equations relating β1 and β2. We start by recalling that in Section 5.2.1 the death rate was
defined as µ
(1)
n = µ˜n, where µ˜ = [T (α, nθ)]
−1. We notice that the authors in [100] compute
the time T (α, nθ) as the average extinction time of a single clonotype in a repertoire of
an average number of clonotypes N∗. Thus, we assume µ(1)n to be equal to µ
(2)
n for the
particular case n = N∗. This allows us to write the first equation
µ
(1)
N∗ = µ
(2)
N∗ ⇒ β2 =
µ˜− β1
p(N∗ − 1) . (5.2)
We choose µ˜ > β1 so that β2 > 0. This condition comes naturally from the definitions of
β2 and β1. In fact they represent the environmental pressure that a clonotype is subject to
when it belongs to an environment with multiple and no competing clonotypes respectively.
We need now to find a second equation to pair with (5.2). We notice µ
(2)
1 = β1, meaning
that β1 represents the death rate of a single clonotype subject to no environmental pressure.
We consider the birth and death process C = {C(t) : t ≥ 0} representing the number of
T cells belonging to this clonotype subject to no competition, where the death rate is µ
(0.5 year−1 for human, 1 month−1 for mouse), the birth rate is γ (10 year−1 for human,
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10−4 month−1 for mouse) and the initial state is C(0) = nθ. The parameters µ, γ and nθ
were defined in [100]. Define T0,nθ as the time until absorption of process C. Therefore we
can assume β1 = [T0,nθ ]
−1. It is clear that, focusing on mice, T0,nθ < +∞ as µ > γ. The
same does not hold for humans as µ < γ. Define η0,nθ = E [T0,nθ |T0,nθ < +∞]. Therefore
for this case we choose
β1 =
Pr(T0,nθ < +∞)
η0,nθ
. (5.3)
It is possible to analyse η0,nθ with a first step argument, considering a maximum number
of T cells S belonging to a clonotype class; see Gillespie simulations for η0,nθ in Figure
5.2, and Figure 5.3 for simulations of Pr(T0,nθ < +∞). Figure 5.4 shows the dependence
of the parameter β2 on β1.
Figure 5.2: Gillespie simulations of η0,nθ . Parameters in accordance with Section 5.7:
µ = 0.5 year−1, γ = 1.25 year−1, and maximum number of T cells allowed in a clonotype
class S = 1000. Number of simulations = 105.
5.3 Certainty of first visit to state 0 in finite mean time
In this section we focus on proving that process X(2) visits the state 0 with probability 1
and in finite mean time. Similar arguments apply to process X(1) and are here omitted.
To this goal, we consider the state 0 to be an absorbing state; see Figure 5.5.
Thus, process X(2) can be seen as a birth-and-death process defined on S = {0}∪C, with
C = {1, 2, . . .} and 0 being the absorbing state; see Chapter 6 in [5]. Our goal is therefore
to prove that for any initial state x, α(x) = limt→+∞ Pr(X(t) = 0|X(0) = x) = 1. This,
accordingly to Theorem 6.2 of [5], occurs if and only if
+∞∑
k=1
µ1µ2 · · ·µk
λ1λ2 · · ·λk = +∞,
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Figure 5.3: Gillespie simulations of Pr(T0,nθ < +∞). Parameters in accordance to Section
5.7: µ = 0.5 year−1, γ = 1.25 year−1, and maximum number of T cells allowed in a
clonotype class S = 1000. Number of simulations = 105.
Figure 5.4: Plot of (5.2). Parameters in accordance to Section 5.7: µ = 0.5 year−1,
γ = 1.25 year−1, θ = 2.5 year−1, nθ = 4, p = 0.05, and N∗ = 50. Number of simulations
= 105.
where λk ≡ θ and µk = k(β1 + β2pk) for k ∈ C. We have
+∞∑
k=1
µ1µ2 · · ·µk
λ1λ2 · · ·λk =
+∞∑
k=1
(β1 + β2p)(2β1 + 4β2p)(3β1 + 9β2p) · · · (kβ1 + k2β2p)
θk
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n+ 1 · · ·nn− 1· · ·210
λ1 λ2
µn+2µn+1µnµn−1
λn−2 λn+1λnλn−1
µ3µ2µ1
Figure 5.5: Continuous-time birth-and-death process X.
which is bounded by the case β2p = 0, that is
+∞∑
k=1
µ1µ2 · · ·µk
λ1λ2 · · ·λk ≥
+∞∑
k=1
βk1k!
θk
= +∞.
The last equality holds because ∀x ∈ R+, ∃k ∈ N such that k! > xk. Thus, α(x) =
1 ∀x ∈ S. We note here that α(x) can be re-expressed as α(x) = Pr(Tx < +∞), where
Tx represents the time until absorption for the initial state X(0) = x. We can prove that
E [Tx] < +∞ by considering Theorem 6.3 of [5]. In particular, E [Tx] < +∞ if and only if
+∞∑
k=2
λ1 · · ·λk−1
µ1 · · ·µk < +∞.
We have
+∞∑
k=2
λ1 · · ·λk−1
µ1 · · ·µk =
+∞∑
k=2
θk−1
(β1 + β2p)(2β1 + 4β2p)(3β1 + 9β2p) · · · (kβ1 + k2β2p)
≤
+∞∑
k=2
θk−1
βk1k!
< +∞,
so that E(Tx) < +∞.
5.4 Time TN(A) from N to A original clonotypes in the reper-
toire
Our interest here is to analyse the random variable TN (A) representing the time to reach for
the first time a number A < X(0) = N of original clonotypes in the repertoire. The main
reason behind the study of this stochastic descriptor is the quest to understand the timings
of regenerative capabilities of a repertoire. We follow here a first step argument. In order
to analyse the random variable TN (A), we need to keep track of the original clonotypes as
the stochastic process evolves. This is due to the fact that TN (A) is not the time of first
visit to state A; that is, TN (A) 6= inf{t ≥ 0 : X(t) = A}, since when process X reaches state
A, the A clonotypes remaining in the repertoire are not necessarily among the original
ones (some of them might be new ones as a result of thymic output). Thus we consider an
auxiliary random variable Y (t) and an augmented process Xaug = {(X(t), Y (t)) : t ≥ 0}
defined on Saug = {(n,m) : m ∈ {0, 1, 2, . . . , X(0)}, n ≥ m}, where Y (t) amounts to the
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number of original clonotypes in the repertoire at time t ≥ 0, which constantly decreases.
Thus we have TN (A) = inf{t ≥ 0 : Y (t) = A}. For process Xaug we define µ(X)n,m and µ(Y )n,m
as the death rates of new and original clonotypes, respectively, accordingly to the original
rate µn; see Figure 5.6. To note that, even though X(t) represents the total number of
clonotypes (original + newly created), we nevertheless use here µ
(X)
n,m to express the death
rate of only the newly created clones. We do this with the only aim to ease the notation.
(n− 1,m)
(n− 1,m− 1)
(n,m) (n+ 1,m)
µ
(X)
n,m θ
µ
(Y )
n,m
Figure 5.6: Transitions diagram for bivariate continuous-time birth-and-death process
Xaug.
5.4.1 Implicit competition
We consider here µ
(X)
n,m = µ
(X,1)
n,m = µ˜(n − m) and µ(Y )n,m = µ(Y,1)n,m = µ˜m, so that µ(X,1)n,m +
µ
(Y,1)
n,m = µ
(1)
n , leading to the analysis of process X
aug
(1) . These rates are directly obtained by
assuming clonotypes going to extinction at a common rate µ˜ in an independent fashion.
We recall that Y (t) is just an auxiliary variable keeping track of original clonotypes without
affecting the dynamics of X(t), so that both variables go necessarily to extinction with
probability one in mean finite time, according to Section 5.3; see Figure 5.7. Moreover,
since every clonotype behaves independently, the process Y = {Y (t) : t ≥ 0} defined on
{0, 1, 2, . . . , X(0)}, is a pure-death linear process with death rate µ˜m; see Figure 5.8.
Thus, TN (A) can be analysed by noting that FTN (A)(t) = Pr(TN (A) ≤ t) = Pr(Y (t) ≤
A) for any initial state X(0) = Y (0) = N . Moreover, from Section 6.4.2 of [5], we can
write
pk(t) = Pr(Y (t) = k|Y (0) = N) =
(
N
k
)
e−kµ˜t(1− e−µ˜t)N−k. (5.4)
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(n− 1,m)
(n− 1,m− 1)
(n,m) (n+ 1,m)
µ˜(n−m) θ
µ˜m
Figure 5.7: Bivariate continuous-time birth-and-death process Xaug(1) with µ
(X)
n,m = µ
(X,1)
n,m =
µ˜(n−m) and µ(Y )n,m = µ(Y,1)n,m = µ˜m.
m · · ·m− 1m− 2m− 3· · ·
m · µ˜(m− 1) · µ˜(m− 2) · µ˜
Figure 5.8: Continuous-time pure-death process Y, representing the death of original clono-
types.
This equation can be seen as the different possible ways of choosing k surviving clonotypes
at time t out of the initial N , where a clonotype survives until time t with probability
e−µ˜t, leading to the binomial formula in (5.4). Given (5.4), we have
FTN (A)(t) = Pr(Y (t) ≤ A) =
A∑
k=0
pk(t) =
A∑
k=0
(
N
k
)
e−kµ˜t(1− e−µ˜t)N−k.
We would like to find a closed form for FTN (A)(t), in order to compute the density function
fT (t) =
d
dt
FTN (A)(t).
We follow now arguments of Section (3-7) in [167] in order to prove the last equality of
1− FTN (A)(t) = 1−
A∑
k=0
pk(t) =
N∑
k=A+1
pk(t) = Ie−µ˜t(A+ 1, N −A), (5.5)
where Ix(a, b) = B(x; a, b)/B(a, b) represents the regularized incomplete beta function,
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with
B(x; a, b) =
∫ x
0
sa−1(1− s)b−1ds
and
B(a, b) =
(a− 1)!(b− 1)!
(a+ b− 1)! .
To prove the last equality of (5.5), we prove a more general case represented by Eq. (3-3)
of Section 3-7 of [167], that is
N∑
k=A+1
(
N
k
)
pk(1− p)N−k =
∫ p
0 y
A(1− y)N−A−1dy∫ 1
0 y
A(1− y)N−A−1dy
= Ip(A+ 1, N −A). (5.6)
We start by defining
QA+1 =
∫ 1
0
yA(1− y)N−A−1dy, (5.7)
SA+1 =
∫ p
0
yA(1− y)N−A−1dy. (5.8)
Recalling the Beta function
B(x, y) =
∫ 1
0
tx−1(1− t)y−1dt, (5.9)
we have QA+1 = B(A+ 1, N −A). The Beta function verifies
B(x, y) =
Γ(x)Γ(y)
Γ(x+ y)
, (5.10)
where Γ(t) is the Gamma function, defined as
Γ(t) =
∫ +∞
0
st−1e−sds (5.11)
or, for any integer n, as
Γ(n) = (n− 1)! . (5.12)
Thus, we can write
QA+1 =
A!(N −A− 1)!
N !
=
[
(A+ 1)
(
N
A+ 1
)]−1
. (5.13)
We focus now on finding an expression for SA+1. The following steps could also be applied
in order to find (5.13). We recall the rule of integration by parts, that is∫ b
a
u dv = [uv]ba −
∫ b
a
v du (5.14)
where u = u(x) and v = v(x) are functions of the variable x. Thus, using (5.14) and
defining the function
q(x) =
px(1− p)N−x
x
, (5.15)
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we can write
SA+1 = q(A+ 1) +
(
N −A− 1
A+ 1
)
SA+2. (5.16)
This relationship can be written for the general case
Sa = q(a) +
(
n− a
a
)
Sa+1 for a = A+ 1, A+ 2, · · · , N − 1 (5.17)
and, for the case a = N , it becomes
SN = q(N). (5.18)
This brings us to the final expression
SA+1 = q(A+ 1) +
N −A− 1
A+ 1
q(A+ 2) +
(N −A− 1)(N − (A+ 2))
A+ 1(A+ 2)
q(A+ 2) + · · ·
+
(N −A− 1)(N − (A+ 1)) · · · (N − (N − 1))
A+ 1(A+ 2) · · · (N − 1) q(N). (5.19)
Is is now sufficient to divide each single term of (5.19) by (5.13) to obtain
N∑
k=A+1
(
N
k
)
pk(1− p)N−k =
∫ p
0 y
A(1− y)N−A−1dy∫ 1
0 y
A(1− y)N−A−1dy
. (5.20)
This gives the relationship
N∑
k=A+1
(
N
k
)
pk(1− p)N−k = Ip(A+ 1, N −A). (5.21)
Thus, using (5.5), we obtain
FTN (A)(t) = I1−e−µ˜t(N −A,A+ 1), (5.22)
using the property of the regularised incomplete beta function for which
Ix(a, b) = 1− I1−x(b, a). (5.23)
To prove this property, we recall that Ix(a, b) = B(x; a, b)/B(a, b), where
B(x; a, b) =
∫ x
0
ta−1(1− t)b−1dt
and
B(a, b) =
∫ 1
0
ta−1(1− t)b−1dt = (a− 1)!(b− 1)!
(a+ b− 1)! ,
and we notice that B(a, b) = B(b, a) for obvious properties of the factorials. Therefore, in
order to prove (5.23), we need to show that
1
B(a, b)
[∫ x
0
ta−1(1− t)b−1dt+
∫ 1−x
0
qb−1(1− q)a−1dq
]
= 1.
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We change the variable in the second integral, introducing the new variable t = 1 − q,
which gives dt = −dq. Thus, we obtain∫ 1−x
0
qb−1(1− q)a−1dq = −
∫ x
1
ta−1(1− t)b−1dt.
Therefore we have
1
B(a, b)
[∫ x
0
ta−1(1− t)b−1dt−
∫ x
1
ta−1(1− t)b−1dt
]
=
1
B(a, b)
[∫ 1
0
ta−1(1− t)b−1dt
]
= 1.
This proves (5.23). Thus, from (5.22) we obtain
FTN (A)(t) = (N −A)
(
N
A
)∫ 1−e−µ˜t
0
sN−A−1(1− s)Ads, (5.24)
and the density function can be obtained as
fTN (A)(t) =
d
dt
FTN (A)(t).
In order to compute this derivative, we need to state the general form of the Leibniz
integral rule:
d
dt
(∫ b(t)
a(t)
g(t, s)ds
)
= g(t, b(t)) · b′(t)− g(t, a(t)) · a′(t) +
∫ b(t)
a(t)
∂
∂t
g(t, s)ds. (5.25)
In our case, we have
a(t) ≡ 0, b(t) = 1− e−µ˜t and g(t, s) ≡ g(s) = (N −A)
(
N
A
)
sN−A−1(1− s)A.
Thus, we obtain
fTN (A)(t) = g(1− e−µ˜t) ·
d
dt
(1− e−µ˜t)
= (N −A)
(
N
A
)
(1− e−µ˜t)N−A−1(e−µ˜t)A · µ˜e−µ˜t
= (N −A)
(
N
A
)
(1− e−µ˜t)N (eµ˜t − 1)−(A+1)µ˜.
(5.26)
We check that the area under fTN (A)(t) is actually 1, as it should be for a probability
density function, that is∫ +∞
0
fTN (A)(t) = (N −A)
(
N
A
)
µ˜
∫ +∞
0
(eµ˜t − 1)N−A−1
eNµ˜t
= 1.
We introduce the new variable p = eµ˜t, which gives dp = µ˜eµ˜tdt. Thus we can write∫ +∞
0
fTN (A)(t) = (N −A)
(
N
A
)∫ +∞
1
(p− 1)K1
pK2
dp,
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where K1 = N −A− 1 and K2 = N + 1. We recall the definition of Gamma function
Γ(z) =
∫ +∞
0
xz−1e−xdx = (z − 1)!
where the first equality holds for any z complex number, while the second equality holds
only if z is a positive integer. We also recall a particular way of defining the Beta function
B(x, y) =
∫ +∞
0
tx−1
(1 + t)x+y
.
With the change of variable t = p− 1 we can write∫ +∞
1
(p− 1)K1
pK2
dp =
∫ +∞
0
tK1
(1 + t)K2
dt = B(K1 + 1,K2 −K1 − 1).
Recalling that
B(x, y) =
Γ(x)Γ(y)
Γ(x+ y)
,
we have ∫ +∞
1
(p− 1)K1
pK2
dp =
Γ(K1 + 1)Γ(K2 −K1 − 1)
Γ(K2)
.
Thus we obtain ∫ +∞
0
fTN (A)(t) = 1.
When considering numerical results in Section 5.7, computation of the function fTN (A)(t)
from (5.26) is practically limited for numerical and computational reasons. In these cases,
we can consider an approximation f˜TN (A)(t) for fTN (A)(t) = e
log(fTN (A)(t)) by using the
approximation
log(fTN (A)(t)) ' N log
(
N
N −A
)
+Alog
(
N −A
A
)
+ log(N −A) + (N −A− 1)log (eµ˜t − 1)
−Nµ˜t+ log(µ˜) + 1
2
log
(
N
2piA(N −A)
)
. (5.27)
To prove that this approximation holds, we start recalling the Stirling’s approximation for
large values of n
n! '
√
2pin
(n
e
)n
,
so that
log(n!) ' 1
2
log(2pin) + nlog(n)− n
and, consequently,
log
((
m
n
))
' mlog(m)−m+ 1
2
log(2pim)− nlog(n) + n− 1
2
log(2pin)
− (m− n)log(m− n) + (m− n)− 1
2
log(2pi(m− n))
= mlog(m)− nlog(n)− (m− n)log(m− n) + 1
2
log
(
m
2pin(m− n)
)
.
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Thus we can write
log(fTN (A)(t)) ' log(N −A) +N log(N)−Alog(A)− (N −A)log(N −A)
+
1
2
log
(
N
2piA(N −A)
)
+ (N −A− 1)log (1− e−µ˜t)
+ (A+ 1)log(e−µ˜t) + log(µ˜).
This can be written as
log(fTN (A)(t)) ' N log
(
N
N −A
)
+Alog
(
N −A
A
)
+ log(N −A) + 1
2
log
(
N
2piA(N −A)
)
+ (N −A− 1)log (eµ˜t − 1)−Nµ˜t+ log(µ˜).
This concludes the proof. See Figure 5.9 where f˜TN (A)(t) is plotted forN = 50 and different
values of A. See Figure 5.10 for the counterparts obtained by Gillespie simulations of the
process.
Figure 5.9: Plot of f˜TN (A)(t) vs t, for process X(2) an parameter values θ = 2.5 years
−1,
γ = 1.25 years−1, µ = 0.5 years−1, M = 200, and nθ = 4. Different colours correspond to
different values of A.
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Figure 5.10: Approximations of fTN (A)(t) obtained from 10
4 Gillespie simulations of pro-
cess X(2), and parameter values θ = 2.5 years
−1, γ = 1.25 years−1, µ = 0.5 years−1,
M = 200 and nθ = 4. Different colours correspond to different values of A.
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Using (5.26) we find the moment generating function of the random variable TN (A) as
MTN (A)(s) = E
[
esTN (A)
]
=
∫ +∞
0
etsfTN (A)(t)dt
= (N −A)
(
N
A
)
µ˜
∫ +∞
0
(eµ˜t − 1)N−A−1et(s−µ˜N)dt. (5.28)
Defining the new variable p = exp{µ˜t}, we have dp = µ˜ exp{µ˜t} dt and t = log(p)/µ˜.
We can therefore rewrite (5.28) as
MTN (A)(s) = (N −A)
(
N
A
)∫ +∞
1
pk1(p− 1)k2 dp, (5.29)
with
k1 =
s− µ˜(N + 1)
µ˜
,
k2 = N −A− 1.
To find an explicit solution for (5.29), we need to find a solution for the integra∫ +∞
1
pk1(p− 1)k2 dp. (5.30)
To this aim, we apply integration by parts with
du = pk1 dp ⇒ u = p
k1+1
k1 + 1
,
v = (p− 1)k2 ⇒ dv = k2(p− 1)k2−1 dp.
Thus we obtain the recursion∫ +∞
1
pk1(p− 1)k2 dp =
[
pk1+1(p− 1)k2
(k1 + 1)
]+∞
1
− k2
(k1 + 1)
∫ +∞
1
pk1+1(p− 1)k2−1 dp. (5.31)
We can now apply (5.31) recursively to its own right side of the equation. We apply it
(k2 − 1) times until we reach, as part of the right hand side, the integral∫ +∞
1
pk1+k2(p− 1)0 dp,
which can be computed as
[
pk1+k2+1
k1 + k2 + 1
]+∞
1
. Therefore we obtain the solution
∫ +∞
1
pk1(p−1)k2 dp =
[
pk1+1(p− 1)k2
(k1 + 1)
]+∞
1
+
k2+1∑
k=2
(−1)k−1
[
pk1+k(p− 1)k2−(k−1)∏k−2i=0 (k2 − i)∏k
i=1(k1 + i)
]+∞
1
.
(5.32)
We can therefore apply (5.32) to (5.29) finding
MTN (A)(s) = (N−A)
(
N
A
)[
pk1+1(p− 1)k2
(k1 + 1)
+
k2+1∑
k=2
(−1)k−1 p
k1+k(p− 1)k2−(k−1)∏k−2i=0 (k2 − i)∏k
i=1(k1 + i)
]+∞
1
.
(5.33)
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We note that the highest power of p in (5.33) is k1 + k2 + 1, which gives the condition for
the existence of MTN (A)(s), that is
k1 + k2 + 1 < 0 ⇒ s < µ˜(A+ 1).
We also note that, due to this condition, all the elements in (5.33) evaluated in p = +∞
tend to 0. Evaluating in p = 1, everything results in being 0 because of the elements
(p− 1)k2−k+1, except for k = k2 + 1. Thus we can write
MTN (A)(s) = (N −A)
(
N
A
)
(−1)k2+1
∏k2−1
i=0 (k2 − i)∏k2+1
i=1 (k1 + i)
= (N −A)
(
N
A
)
(−1)k2+1B(k1 + 1, k2 + 1), (5.34)
where
B(a, b) =
∫ 1
0
ta−1(1− t)b−1dt = (a− 1)!(b− 1)!
(a+ b− 1)!
represents the Beta function. It is easy to prove that MTN (A)(0) = 1 as should be for
a moment generating function. Higher moments for the random variable TN (A) can be
computed as
E
[
TN (A)
k
]
=
dk
dsk
MTN (A)(s)
∣∣∣∣
s=0
.
However, computation of these moments can also be carried out if we note that TN (A)
is the time to absorption of a pure-death process formed by a sequence of independent
exponentially distributed times, corresponding to death events. Define Ti,j the time for the
process to go from state i to state j. We can then write TN (A) = TN,N−1+TN−1,N−2+· · ·+
TA+1,A, so that E [TN (A)] = E(TN,N−1) + E(TN−1,N−2) + · · ·+ E(TA+1,A). As previously
said, we know that Ti,i−1 is distributed as an exponential random variable with parameter
iµ˜. We recall that, if Z is an exponential random variable with parameter λ, its expected
value is λ−1. This implies (see Figure 5.11)
E(TN (A)) =
1
µ˜
N∑
i=A+1
1
i
=
1
µ˜
(
1
A+ 1
+
1
A+ 2
+ · · ·+ 1
N
)
. (5.35)
As shown in Section (6.7) of [5], we can write
E(TN (A)) ≈ 1
µ˜
log
(
N
A
)
.
In a similar way, recalling that if Z is an exponential random variable with parameter λ,
then its variance is λ−2, we can write
Var(TN (A)) =
1
µ˜2
N∑
i=A+1
1
i2
=
1
µ˜2
(
1
(A+ 1)2
+
1
(A+ 2)2
+ · · ·+ 1
N2
)
. (5.36)
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Figure 5.11: Plot of (5.35) (orange) and simulations of death process (blue). Time until
absorption (years) as a function of the % of original clones removed from the repertoire.
Parameters: θ = 2.5 years−1, γ = 1.25 years−1, µ = 0.5 years−1, M = 200, nθ = 4 and
N = 50.
Let us focus now on the general higher moment E
[
TN (A)
k
]
. We want now to prove that
E
[
TN (A)
k
]
=
k!
µ˜k
∑
k1+k2+...+kN−A=k
[
1
Nk1(N − 1)k2 · · · (A+ 1)kN−A
]
,
where the sum is taken over all possible combinations of non-negative integer indices
k1, k2, . . . , kN−A such that
N−A∑
j=1
kj = k. Let us consider the process Y(1). We recall that
the random variable TN (A), representing the time to reach for the first time a number
A < X(0) of original clonotypes in the repertoire, can be written as TN (A) = TN,N−1 +
TN−1,N−2+· · ·+TA+1,A, where Ti,j amounts to the time spent by the process Y(1) to go from
state i to state j. We are interested in computing the higher moments E
[
TN (A)
k
]
of the
random variable TN (A). We write E
[
TN (A)
k
]
= E
[
(TN,N−1 + TN−1,N−2 + · · ·+ TA+1,A)k
]
.
In order to find a formula for the higher moments of TN (A), we first state an important
theorem of combinatorics: the multinomial theorem. For any positive integer m > 0 and
any integer n ≥ 0, and considering m terms x1, x2, . . . , xm, we can write
(x1 + x2 + . . .+ xm)
n =
∑
k1+k2+...+km=n
(
n
k1, k2, . . . , km
) m∏
j=1
x
kj
j ,
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where the sum is taken over all possible combinations of integer indices k1, k2, . . . , km ≥ 0
such that
m∑
i=1
ki = k and
(
n
k1, k2, . . . , km
)
=
n!
k1!k2! . . . km!
is called multinomial coefficient, so that the case m = 2 represents the famous binomial
theorem. We can therefore write
E
[
TN (A)
k
]
= E
 ∑
k1+k2+...+kN−A=k
(
k
k1, k2, . . . , kN−A
)
T k1N,N−1T
k2
N−1,N−2 · · ·T kN−AA+1,A
 ,
and linearity properties of the expected value can transform this last equality as follows
E
[
TN (A)
k
]
=
∑
k1+k2+...+kN−A=k
[(
k
k1, k2, . . . , kN−A
)
E
[
T k1N,N−1T
k2
N−1,N−2 · · ·T kN−AA+1,A
]]
.
We recall that Ti,i−1 are independent exponentially distributed random variables with
parameter iµ˜, so that E
[
T ki,i−1
]
=
k!
(iµ˜)k
and
E
[
TN (A)
k
]
=
∑
k1+k2+...+kN−A=k
[(
k
k1, k2, . . . , kN−A
)
k1!
(Nµ˜)k1
k2!
((N − 1)µ˜)k2 · · ·
kN−A!
((A+ 1)µ˜)kN−A
]
.
It follows that
E
[
TN (A)
k
]
=
k!
µ˜k
∑
k1+k2+...+kN−A=k
[
1
Nk1(N − 1)k2 · · · (A+ 1)kN−A
]
.
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5.4.2 Explicit competition
We consider here µ
(X)
n,m = µ
(X,2)
n,m = (n−m)(β1 + β2pn) and µ(Y )n,m = µ(Y,2)n,m = m(β1 + β2pn),
so that µ
(X,2)
n,m + µ
(Y,2)
n,m = µ
(2)
n , leading to the process X
aug
(2) ; see Figure 5.12.
(n− 1,m)
(n− 1,m− 1)
(n,m) (n+ 1,m)
(n−m)(β1 + β2pn) θ
m(β1 + β2pn)
Figure 5.12: Bivariate continuous-time birth-and-death process Xaug(2) with µ
(X)
n,m = µ
(X,2)
n,m =
(n−m)(β1 + β2pn) and µ(Y )n,m = µ(Y,2)n,m = m(β1 + β2pn).
Unlike in the previous section, the process Y(2) = {Y (t) : t ≥ 0} cannot be considered
here as a pure-death linear process, since the death rate µ
(Y,2)
n,m depends on both n and
m. Therefore, in order to find the expected value E(TN (A)) of the time TN (A), the
same arguments cannot be applied and a different method has to be followed. We start
by considering the process Xaug(2) defined over the space of states S = {(n,m) : m ∈
{0, 1, . . . , X(0)}, n ≥ m} and with initial conditions (X(0), Y (0)) = u. Once defined u,
and defining A ⊂ S as a set of states reachable from initial state u, we define Tu(A) as
the time at which the process reaches A. A system of equations for the expression of the
expected value τu = E(Tu) is shown. In order to give the general result for the expected
value τu, we define qu′,u′′ as the transition rate from state u
′ to state u′′. We use the
notation u → u′ to define the event describing the first step of the process, from initial
state u to the second state u′. Thus,
τu =
∑
u′∈S
[
E(Tu|u→ u′) · Pr(u→ u′)
]
, (5.37)
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where (see Eq. (5.12) of [5])
Pr(u→ u′) = qu,u′∑
u′′∈S qu,u′′
.
In order to fully understand (5.37) we need to focus on its first factors E(Tu|u→ u′). The
random variable Tu|u→ u′ can be written as
Tu|u→ u′ = (Tu′ + tu→u′)|u→ u′ = (Tu′) + (tu→u′ |u→ u′),
where the random variable tu→u′ represents the time for the process to go from state u
to state u′. The last equality stands because of the independence of the random variable
Tu′ from the past event {u→ u′}, that is because of the Markov property of the process.
Being Xaug(2) a continuous-time Markov chain, the random variable tu→u′ takes non-negative
real values and has an exponential distribution with parameter qu,u′ , that is
tu→u′ ∼ Exp(qu,u′).
We need though to focus on the random variable Ψ = tu→u′ |u→ u′, which is representing
the random variable tu→u′ knowing that the first movement of the process is u→ u′. This
can be read as Ψ = minu′′∈S(tu→u′′), where the minimum is taken over all the possible u′′
first movements from the initial state u. Thus, from the properties of exponential random
variables, it follows
Ψ ∼ Exp
(∑
u′′
qu,u′′
)
.
We can now write
E(Tu|u→ u′) = E(Tu′ + Ψ) = τu′ + 1∑
u′′∈S qu,u′′
,
leading us to
τu = E(Tu) =
∑
u′∈S
[(
τu′ +
1∑
u′′∈S qu,u′′
)
· qu,u′∑
u′′∈S qu,u′′
]
(5.38)
Eq. (5.38) can now be applied to the process Xaug(2) with µ
(X)
n,m = µ
(X,2)
n,m = (n−m)(β1+β2pn)
and µ
(Y )
n,m = µ
(Y,2)
n,m = m(β1 + β2pn). We consider u = (n,m) as the starting point of the
process and we define the set of states A = {(n,m) : m ≡ A} ⊂ S that the augmented
process Xaug(2) has to reach. There are three possible u
′ states reachable from u with one
step: (n−1,m), (n+ 1,m) and (n−1,m−1). The three transition rates are, respectively,
(β1 + β2pn)(n−m), θ and m(β1 + β2pn), giving∑
u′′∈S
qu,u′′ = n(β1 + β2pn) + θ.
126
5.4 Time TN (A) from N to A original clonotypes in the repertoire
Thus, applying (5.38) we obtain
τ(n,m) =
θ · τ(n+1,m) + (β1 + β2pn)(n−m) · τ(n−1,m) +m(β1 + β2pn) · τ(n−1,m−1) + 1
n(β1 + β2pn) + θ
.
(5.39)
To find explicit solutions for the recursive equation (5.39), we start focusing on the par-
ticular states {(n,m) : m = A + 1}. In order to solve the (infinite) system of equations
given by (5.39), we consider a maximum number of total clonotype classes M that the
random variable X(t) cannot exceed, so that (5.39) becomes a finite system of equations
represented by the equality
τ(n,A+1) =
δn<M · θ · τ(n+1,A+1) + (β1 + β2pn)(n− (A+ 1)) · τ(n−1,m)
n(β1 + β2pn) + δn<M · θ
+
(A+ 1)(β1 + β2pn) · τ(n−1,A) + 1
n(β1 + β2pn) + δn<M · θ ,
(5.40)
where δD is defined as
δD =
{
1 if D is satisfied,
0 if not.
We define the functions
v(2)(n) = n(β1 + nβ2p) + δn<M · θ
g(2)(n,m) = (β1 + nβ2p)(n−m).
Note that the notation v(2)(n) and g(2)(n,m) is due to the usage of the second kind of
death rates µ
(X)
n,m = µ
(X,2)
n,m = (n − m)(β1 + β2pn) and µ(Y )n,m = µ(Y,2)n,m = m(β1 + β2pn) in
this section. For the same reason, in the following sections we will also use the notation
v(1)(n) and g(1)(n,m) when dealing with the cases µ
(X)
n,m = µ
(X,1)
n,m = (n−m)(β1 +β2pn) and
µ
(Y )
n,m = µ
(Y,1)
n,m = m(β1 + β2pn). Definitions v
(2)(n) and g(2)(n,m), together with (5.40),
give
τ(M,A+1) =
1
M(β1 +Mβ2p)
+
(β1 +Mβ2p)(M − (A+ 1))
M(β1 +Mβ2p)
· τ(M−1,A+1)
=
1
v(2)(M)
+
g(2)(M,A+ 1)
v(2)(M)
· τ(M−1,A+1). (5.41)
Thus, τ(M,A+1) can be written as
τ(M,A+1) =
aM
bM
+
cM
bM
· τ(M−1,A+1),
where aM = 1; bM = v
(2)(M); cM = g
(2)(M,A + 1). Let us focus now on τ(M−1,A+1).
Following similar arguments as for τ(M,A+1), we have
τ(M−1,A+1) =
θ
v(2)(M − 1) · τ(M,A+1) +
g(2)(M − 1, A+ 1)
v(2)(M − 1) · τ(M−2,A+1) +
1
v(2)(M − 1)
=
θ + v(2)(M)
v(2)(M − 1)v(2)(M) +
θg(2)(M,y) · τ(M−1,A+1)
v(2)(M − 1)v(2)(M) +
g(2)(M − 1, A+ 1) · τ(M−2,A+1)
v(2)(M − 1) ,
(5.42)
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where the last equality is obtained by replacing (5.41) in the first equality. We can now
rearrange (5.42) to obtain
τ(M−1,A+1) =
θ + v(2)(M)
v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)+
v(2)(M)g(2)(M − 1, A+ 1) · τ(M−2,A+1)
v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1) ,
(5.43)
so that
τ(M−1,A+1) =
aM−1
bM−1
+
cM−1
bM−1
· τ(M−2,A+1),
where aM−1 = θ + v(2)(M); bM−1 = v(2)(M − 1)v(2)(M) − θg(2)(M,A + 1); cM−1 =
v(2)(M)g(2)(M − 1, A+ 1). Let us focus now on τ(M−2,A+1). We have
τ(M−2,A+1) =
θ · τ(M−1,A+1)
v(2)(M − 2) +
g(2)(M − 2, A+ 1) · τ(M−3,A+1)
v(2)(M − 2) +
1
v(2)(M − 2)
=
θ[θ + v(2)(M)]
v(2)(M − 2)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)]
+
θv(2)(M)g(2)(M − 1, A+ 1)
v(2)(M − 2)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)] · τ(M−2,A+1)
+
g(2)(M − 2, A+ 1)
v(2)(M − 2) · τ(M−3,A+1) +
1
v(2)(M − 2) , (5.44)
where the last equality is obtained by replacing (5.43) in the first equality. We can now
rearrange (5.44) to obtain
τ(M−2,A+1) =
θ[θ + v(2)(M)] + [v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)]
v(2)(M − 2)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)]− θv(2)(M)g(2)(M − 1, A+ 1)
+
g(2)(M − 2, A+ 1)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)] · τ(M−3,A+1)
v(2)(M − 2)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)]− θv(2)(M)g(2)(M − 1, A+ 1) .
so that
τ(M−2,A+1) =
aM−2
bM−2
+
cM−2
bM−2
· τ(M−3,A+1),
where
aM−2 = θ[θ + v(2)(M)] + [v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)],
bM−2 = v(2)(M − 2)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)]− θv(2)(M)g(2)(M − 1, A+ 1),
cM−2 = g(2)(M − 2, A+ 1)[v(2)(M − 1)v(2)(M)− θg(2)(M,A+ 1)].
Noticing the two first sets of relations
aM−1 = bM + θaM ,
bM−1 = bMv(2)(M − 1)− θcM ,
cM−1 = bMg(2)(M − 1, A+ 1),
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and
aM−2 = bM−1 + θaM−1,
bM−2 = bM−1v(2)(M − 2)− θcM−1,
cM−2 = bM−1g(2)(M − 2, A+ 1),
we can write the general recursive relations
aM−k = bM−k+1 + θaM−k+1,
bM−k = bM−k+1v(2)(M − k)− θcM−k+1, (5.45)
cM−k = bM−k+1g(2)(M − k,A+ 1),
with initial values aM = 1, bM = v
(2)(M), cM = g
(2)(M,A+ 1) and
τ(M−k,A+1) =
aM−k
bM−k
+
cM−k
bM−k
· τ(M−k−1,A+1). (5.46)
In order to obtain explicit solution for the general values τ(n,A+1), an algorithm has to
be followed. Before showing the different steps of the algorithm, it is worth noticing that
(5.39) and (5.46) give, respectively, the two equations of the following system

τ(A+1,A+1) =
θ
v(2)(A+ 1)
τ(A+2,A+1) +
1
v(2)(A+ 1)
,
τ(A+2,A+1) =
aA+2
bA+2
+
cA+2
bA+2
τ(A+1,A+1),
which gives

τ(A+1,A+1) =
θaA+2 + bA+2
bA+2v(2)(A+ 1)− θcA+2
,
τ(A+2,A+1) =
aA+2v
(2)(A+ 1) + cA+2
bA+2v(2)(A+ 1)− θcA+2
.
Given these values τ(A+1,A+1) and τ(A+2,A+1) dependent on aA+2, bA+2 and cA+2, we can
now give the steps of the algorithm:
• Start with aM = 1, bM = v(2)(M), cM = g(2)(M,A+ 1);
• Use the recursive relations (5.45) to find aA+2, bA+2 and cA+2;
• Find τ(A+1,A+1) and τ(A+2,A+1) as explained above;
• Use (5.46) to find all the different values of τ(n,A+1), up to τ(M,A+1).
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We focus now on the more general states {(n,m) : m ∈ {A+ 2, A+ 3, · · · , N}}. We recall
the functions v(2)(n) and g(2)(n,m) and we define the new function q(n,m) as
v(2)(n) = n(β1 + nβ2p) + δn<M · θ
g(2)(n,m) = (β1 + nβ2p)(n−m)
q(n,m) = 1 +m(β1 + nβ2p) · τ(n−1,m−1).
Note that for the function q(n,m) we do not use any index as this function will be
used only in this case for this particular section. These definitions, together with (5.39),
give
τ(M,m) =
q(M,m)
v(2)(M)
+
g(2)(M,m)
v(2)(M)
· τ(M−1,m). (5.47)
With the same techniques used for computing (5.43), we can find
τ(M−1,m) =
θq(M,m) + v(2)(M)q(M − 1,m)
v(2)(M − 1)v(2)(M)− θg(2)(M,m) +
v(2)(M)g(2)(M − 1,m)
v(2)(M − 1)v(2)(M)− θg(2)(M,m) · τ(M−2,m),
obtaining the relationships
aM−1 = bMq(M − 1,m) + θaM ,
bM−1 = bMv(2)(M − 1)− θcM ,
cM−1 = bMg(2)(M − 1,m),
and, recursively, the general ones
aM−k = bM−k+1q(M − k,m) + θaM−k+1,
bM−k = bM−k+1v(2)(M − k)− θcM−k+1, (5.48)
cM−k = bM−k+1g(2)(M − k,m),
with aM = q(M,m), bM = v
(2)(M), cM = g
(2)(M,m) and
τ(M−k,m) =
aM−k
bM−k
+
cM−k
bM−k
· τ(M−k−1,m). (5.49)
In order to obtain explicit solution for the general τ(n,m), similar steps have to be followed
as for the particular case m = A + 1. Thus, we notice that (5.39) and (5.49) give,
respectively, the two equations of the following system
τ(m,m) =
θ
v(2)(m)
τ(m+1,m) +
q(m,m)
v(2)(m)
,
τ(m+1,m) =
am+1
bm+1
+
cm+1
bm+1
τ(m,m),
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which gives

τ(m,m) =
θam+1 + bm+1q(m,m)
bm+1v(2)(m)− θcm+1
,
τ(m+1,m) =
am+1v
(2)(m) + cm+1q(m,m)
bm+1v(2)(m)− θcm+1
.
Given these two values τ(m,m) and τ(m+1,m) dependent on am+1, bm+1 and cm+1, the steps
of the algorithm are as follows:
• Start with aM = q(M,m), bM = v(2)(M), cM = g(2)(M,m);
• Use the recursive relations (5.48) to find am+1, bm+1 and cm+1;
• Find τ(m,m) and τ(m+1,m) as explained above;
• Use (5.49) to find all the different values of τ(n,m), up to τ(M,m).
The reader can find simulations for this algorithm and for a Gillespie code representing
the same biological process in Figures 5.38 and 5.39 respectively. The hitting times are
also plotted for a specific initial state as function of both the β1 and β2p variables, as a
heat map in Figure 5.40.
5.5 Size of the repertoire at time TN(A)
We recall the definition of our augmented process Xaug = {(X(t), Y (t)) : t ≥ 0} defined on
the space of states Saug = {(n,m) : m ∈ {0, 1, 2, . . . , X(0)}, n ≥ m}. We also recall the
definition of TN (A) as the time when, for the first time, the process X
aug reaches the space
of states A = {(n,m) : m = A}, representing thus the first time until only A < X(0) of
the original clonotypes remain in the repertoire. The aim of this section is to analyse the
probability p(n,m)(n¯, A) = Pr(X(TN (A)) = n¯|(X(0), Y (0)) = (n,m)) that the size X(t)
of the repertoire at time TN (A) equals a particular value n¯ ≥ A. As for the previous
section, we consider a maximum number of total clonotype classes M that the random
variable X(t) cannot exceed. We believe this stochastic descriptor represents a significant
aspect of the internal dynamics of a repertoire, as it has the capability to describe the
probability distribution of the size of the renewed part of the repertoire at time TN (A).
The last section focused on the use of a first step argument to find an equation for the
stochastic descriptor TN (A). In the following sections a similar argument will be applied
to the study of the probabilities p(n,m)(n¯, A), known as hitting probabilities.
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5.5.1 Implicit competition
Analytical analysis
We consider the auxiliary random variable Z(t) = X(t)−Y (t) and the process Z = {Z(t) :
t ≥ 0} defined on Sz = {0, 1, 2, . . .}, where Z(t) amounts to the number of newly generated
clonotypes in the repertoire at time t ≥ 0. We note that Z can be seen as a pure-death
linear process with immigration, with death rate µz = µ˜z and immigration rate θ. We
want to analyse the probability, for the process Xaug, to be in the state (z+A,A) at time
TN (A). This is equivalent to analyse the probability that the process Z is in state z at
time TN (A). Thus we want to analyse the following probabilities
Pr (Z(TN (A)) = z) = Pr (X(TN (A)) = z +A) , z = 0, 1, 2, ...
Given the independence between process Y = {Y (t) : t ≥ 0} defined on {0, 1, 2, . . . , X(0)}
and process Z, and given the probability density function fTN (A)(t) of the random variable
TN (A) given by (5.26), we can write
Pr (Z(TN (A)) = z) =
∫ +∞
0
pz(t) · fTN (A)(t) dt, (5.50)
where pz(t) = Pr(Z(t) = z). Therefore, we need to find pz(t). We start writing the
forward Kolmogorov equations for process Z as
dpz(t)
dt
= θpz−1(t) + µ˜(z + 1)pz+1(t)− (θ + µ˜z)pz(t), z = 1, 2, . . . ,
dp0(t)
dt
= µ˜p1(t)− θp0(t).
From these equations, we find now the partial differential equation for the probability gen-
erating function φZ(s, t) of the random variable Z(t), following the arguments of Chapter
6 in [5]. We multiply the differential equations by sz and sum over z. Then
∂φZ(s, t)
∂t
= θ
+∞∑
z=2
pz−1(t)sz + µ˜
+∞∑
z=0
(z + 1)pz+1(t)s
z − θ
+∞∑
z=1
pz(t)s
z − µ˜
+∞∑
z=1
zpz(t)s
z
= θ
+∞∑
z=1
pz(t)s
z+1 + µ˜
+∞∑
z=1
zpz(t)s
z−1 − θ
+∞∑
z=1
pz(t)s
z − µ˜
+∞∑
z=1
zpz(t)s
z
= θs
+∞∑
z=1
pz(t)s
z + µ˜
+∞∑
z=1
zpz(t)s
z−1 − θ
+∞∑
z=1
pz(t)s
z − µ˜s
+∞∑
z=1
zpz(t)s
z−1.
Thus we have 
∂φZ(s, t)
∂t
= µ˜(1− s)∂φZ(s, t)
∂s
+ θ(s− 1)φZ(s, t),
φZ(s, 0) = s
Z(0) = 1.
(5.51)
We notice that this equation agrees with arguments in Section (6.4.4) of [5]. In fact, it
would be sufficient to consider the partial differential equation for the moment generating
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function for the special case λ = 0 and using the substitution θ = log(s) in order to find
our equation (Note that θ in the equation from [5] is not representing our immigration
rate θ, but just the independent variable of the moment generating function). We use
the method of characteristics to find a solution φZ(s, t) for the general initial condition
Z(0) = Z0. We will then apply it to our specific case where Z0 = 0. We start by rewriting
the system as followsµ˜(s− 1)
∂φZ(s, t)
∂s
+
∂φZ(s, t)
∂t
+ θ(1− s)φZ(s, t) = 0,
φZ(s, 0) = s
Z0 .
We write the ODEs system
ds/dw = µ˜(s− 1),
dt/dw = 1,
dφZ(s, t)/dw = θ(s− 1)φZ(s, t).
We solve the first two ODEs of the system, finding{
s(w) = c1e
µ˜w + 1,
t(w) = c2 + w.
(5.52)
We consider the characteristic line (s(w), t(w)), setting (s(0), t(0)) = (s0, 0). Therefore,
substituting in (5.52), we obtain c1 = s0 − 1 and c2 = 0. We can now find{
s(s0, w) = (s0 − 1)eµ˜w + 1,
t(s0, w) = w.
(5.53)
Using the initial condition φZ(s(s0, w), t(s0, w) = 0) = s
Z0 together with (5.53), we can
write the initial condition as φZ(s(s0, w), t(s0, w) = 0) = s
Z0
0 . Thus{
dφZ(s0, w)/dw = θ(s(s0, w)− 1)φZ(s0, w) = θ(s0 − 1)φZ(s0, w),
φZ(s0, 0) = s
Z0
0 .
Therefore we have φZ(s0, w) = c3e
θ(s0−1)eµ˜w
µ˜ ,
φZ(s0, 0) = s
Z0
0 ,
which gives c3 = s
Z0
0 e
− θ(s0−1)
µ˜ . We now use (5.53) to find{
s0(s, t) = (s− 1)e−µ˜t + 1,
w(s, t) = t.
Finally, we obtain
φZ(s, t) = c3(s0(s, t), w(s, t)) · e
θ(s0(s,t)−1)eµ˜w(s,t)
µ˜ ,
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which gives
φZ(s, t) =
[
1 + (s− 1)e−µ˜t]Z0 · exp{θ(s− 1)
µ˜
(
1− e−µ˜t)} . (5.54)
As previously said, we now apply this general solution to our particular case, where Z(0) =
Z0 = 0. Thus we have
φZ(s, t) = exp
{
θ(s− 1)
µ˜
(
1− e−µ˜t)} . (5.55)
Recalling the general property of the probability generating function for which
pz(t) = Pr(Z(t) = z) =
1
z!
∂zφZ(s, t)
∂sz
∣∣∣∣
s=0
,
we can write
pz(t) =
1
z!
(
(1− e−µ˜t)θ
µ˜
)z
e
− (1−e−µ˜t)θ
µ˜ . (5.56)
We substitute pz(t) in (5.50) to obtain
Pr (Z(TN (A)) = z) =
∫ +∞
0
1
z!
(
(1− e−µ˜t)θ
µ˜
)z
e
− (1−e−µ˜t)θ
µ˜ (N −A)
(
N
A
)
(1− e−µ˜t)N
(eµ˜t − 1)A+1 µ˜ dt.
This can be rewritten as
Pr (Z(TN (A)) = z) = Ω
∫ +∞
0
e
− (1−e−µ˜t)θ
µ˜
(
1− e−µ˜t)N+z
(eµ˜t − 1)A+1 dt, (5.57)
where
Ω =
θz(N −A)(NA)µ˜
z! µ˜z
.
We will now find an explicit solution for (5.57). First we define the new variable p =
exp{µ˜t}, which implies dp = µ˜ exp{µ˜t} dt, t = log(p)/µ˜ and
Pr (Z(TN (A)) = z) = Ω1
∫ +∞
1
(
e
a p−1
p
) (p− 1)b
pc
dp, (5.58)
where
Ω1 =
θz(N −A)(NA)
z! µ˜z
,
a = − θ
µ˜
,
b = N −A− 1− z,
c = N + z + 1.
Following similar steps, we define the new variable q = p−1p , which implies dq =
dp
p2
,
p = 11−q and
Pr (Z(TN (A)) = z) = Ω1
∫ 1
0
eaqqb(1− q)A dq. (5.59)
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Solving the integral on the right hand side of (5.59) is possible but requires quite a few
steps. Therefore we focus now on the solution of this integral, coming back only later to
the explicit solution of (5.59). Using integration by parts with
u = qb(1− q)A and
dv = eaqdq,
we obtain the recursive formula∫ 1
0
eaqqb(1−q)A dq = 1
a
[
eaqqb(1− q)A
]1
0
− b
a
∫ 1
0
eaqqb−1(1−q)A dq+A
a
∫ 1
0
eaqqb(1−q)A−1 dq.
(5.60)
It is fundamental at this point to notice that[
eaqqb(1− q)A
]1
0
6= 0 only in the cases b = 0 or A = 0.
For simplicity of notation, define the function
f(b, A) =
[
eaqqb(1− q)A
]1
0
.
Thus, (5.60) becomes∫ 1
0
f(b, A) dq =
1
a
[f(b, A)]10 −
b
a
∫ 1
0
f(b− 1, A) dq + A
a
∫ 1
0
f(b, A− 1) dq, (5.61)
where
[f(b, A)]10 6= 0 only in the cases b = 0 or A = 0. (5.62)
Applying recursively (5.61) to itself and eliminating all the different [f(b− x,A− y)]10 for
x 6= b and y 6= A, it can be proved that each remaining item is of the kind
(−1)x
(
x+ y
x
)
bxAy
ax+y
∫ 1
0
f(b− x,A− y) dq,
where nk = n(n−1)(n−2) . . . (n−k+1). Given (5.62), the only integrals we are interested
in are for y = A and x = b that is, respectively,
(−1)x
(
x+A
x
)
bxA!
ax+A
∫ 1
0
f(b− x, 0) dq,
(−1)b
(
b+ y
b
)
b!Ay
ab+y
∫ 1
0
f(0, A− y) dq.
It can also be proved that all these integrals have to be taken into consideration, that is for
x ∈ {0, 1, . . . , b} and y ∈ {0, 1, . . . , A}, excluding only the case (x, y) = (0, 0) which does
not exist. Therefore, in order to solve (5.59), we need now to focus on the two integrals
I1(x) =
∫ 1
0
eaqqb−x dq,
I2(y) =
∫ 1
0
eaq(1− q)A−y dq.
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First we notice that, defining the new variable w = 1− q, we have
I2(y) = e
a
∫ 1
0
ea˜ttA−y dt,
with a˜ = −a. Thus, to solve both I1 and I2, we focus on finding a solution for the generic
integral ∫ 1
0
ecuun du.
Integrating by parts, it is easy to show that
∫ 1
0
ecuun du =
[
ecu
n∑
i=0
(−1)i n! u
n−i
(n− i)! ci+1
]1
0
= ec
n∑
i=0
(−1)i n!
(n− i)! ci+1 .
Therefore, we can write
I1(x) = e
a
b−x∑
i=0
(−1)i (b− x)!
(b− x− i)! ai+1 ,
I2(y) = e
aea˜
A−y∑
i=0
(−1)i (A− y)!
(A− y − i)! a˜i+1 =
A−y∑
i=0
− (A− y)!
(A− y − i)! ai+1 .
We are now finally able to write an explicit formula for Pr (Z(TN (A)) = z). In fact we
have
Pr (Z(TN (A)) = z) = Ω1
∫ 1
0
f(b, A) dq,
with
Ω1 =
θz(N −A)(NA)
z! µ˜z
, and
∫ 1
0
f(b, A) dq =
b−1∑
x=0
(−1)x
(
x+A
x
)
bxA!
ax+A
I1(x) +
A−1∑
y=0
(−1)b
(
b+ y
b
)
b!Ay
ab+y
I2(y),
where
I1 = e
a
b−x∑
i=0
(−1)i (b− x)!
(b− x− i)! ai+1
I2 =
A−y∑
i=0
− (A− y)!
(A− y − i)! ai+1 .
The next section follows the first step argument analysis to find similar analytical results.
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First step argument analysis
This section focuses on finding a formula for the probabilities p(n,m)(n¯, A), when we con-
sider the death rates µ
(X)
n,m = µ
(X,1)
n,m = µ˜(n−m) and µ(Y )n,m = µ(Y,1)n,m = µ˜m for the augmented
process Xaug. We recall that these probabilities are defined as
p(n,m)(n¯, A) = Pr(u¯ = (n¯, A)|u = (n,m)), (5.63)
where u represents the initial state (X(0), Y (0)) and u¯ represents the state hit by the
process Xaug at time TN (A). The first step argument analysis gives
p(n,m)(n¯, A) =
δn<M · θ · p(n+1,m)(n¯, A) + g(1)(n,m) · p(n−1,m)(n¯, A) + r(1)(n,m)
v(1)(n)
, (5.64)
where we define the functions v(1)(n), g(1)(n,m) and r(1)(n,m) as
v(1)(n) = nµ˜+ δn<M · θ,
g(1)(n,m) = (n−m)µ˜,
r(1)(n,m) = mµ˜ · p(n−1,m−1)(n¯, A).
Note that the notations v(1)(n), g(1)(n,m) and r(1)(n,m) are due to the usage of the first
kind of death rates µ
(X)
n,m = µ
(X,1)
n,m = (n − m)µ˜ and µ(Y )n,m = µ(Y,1)n,m = mµ˜ in this section.
For the same reason, in the following section we will use the notation v(2)(n), g(2)(n,m)
and r(2)(n,m) when dealing with the cases µ
(X)
n,m = µ
(X,2)
n,m = (n − m)(β1 + β2pn) and
µ
(Y )
n,m = µ
(Y,2)
n,m = m(β1 +β2pn). In order to find explicit solutions for the recursive equation
(5.64), we first analyse the particular space of states {(n,m) : m = A+ 1}. The functions
v(1)(n), g(1)(n,m) and r(1)(n,m), together with (5.64) give
p(M,A+1)(n¯, A) =
r(1)(M,A+ 1)
v(1)(M)
+
g(1)(M,A+ 1)
v(1)(M)
p(M−1,A+1)(n¯, A), (5.65)
where r(1)(M,A+ 1) = (A+ 1)µ˜ · p(M−1,A)(n¯, A) and
p(M−1,A)(n¯, A) =
{
1 if n¯ = M − 1,
0 otherwise.,
Let us define
aM = r
(1)(M,A+ 1); bM = v
(1)(M); cM = g
(1)(M,A+ 1),
so that p(M,A+1)(n¯, A) can be written as
p(M,A+1)(n¯, A) =
aM
bM
+
cM
bM
· p(M−1,A+1)(n¯, A). (5.66)
We continue with p(M−1,A+1)(n¯, A). As for p(M,A+1)(n¯, A), it can be written
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p(M−1,A+1)(n¯, A) =
θ · p(M,A+1)(n¯, A)
v(1)(M − 1) +
g(1)(M − 1, A+ 1) · p(M−2,A+1)(n¯, A)
v(1)(M − 1) +
r(1)(M − 1, A+ 1)
v(1)(M − 1)
=
θaM + bMr
(1)(M − 1, A+ 1)
bMv(1)(M − 1)− θcM
+
bMg
(1)(M − 1, A+ 1)
bMv(1)(M − 1)− θcM
· p(M−2,A+1)(n¯, A),
(5.67)
where the last equality is obtained by replacing (5.66) in the first equality. We define
aM−1 = θaM + bMr(1)(M − 1, A+ 1),
bM−1 = bMv(1)(M − 1)− θcM ,
cM−1 = bMg(1)(M − 1, A+ 1),
so that p(M−1,A+1)(n¯, A) can be written as
p(M−1,A+1)(n¯, A) =
aM−1
bM−1
+
cM−1
bM−1
· p(M−2,A+1)(n¯, A).
Thus, the general recursive relations
aM−k = θaM−k+1 + bM−k+1r(1)(M − k,A+ 1),
bM−k = bM−k+1v(1)(M − k)− θcM−k+1, (5.68)
cM−k = bM−k+1g(1)(M − k,A+ 1),
with aM = r
(1)(M,A+ 1), bM = v
(1)(M), cM = g
(1)(M,A+ 1) and
p(M−k,A+1)(n¯, A) =
aM−k
bM−k
+
cM−k
bM−k
· p(M−k−1,A+1)(n¯, A). (5.69)
In order to obtain explicit solution for the general p(n,A+1)(n¯, A), an algorithm has to be
followed, as previously done for the study of the stochastic descriptor TN (A). Before show-
ing the different steps of the algorithm, we notice that (5.64) and (5.69) give, respectively,
the two equations of the following system
p(A+1,A+1)(n¯, A) =
θ
v(1)(A+ 1)
p(A+2,A+1)(n¯, A) +
r(1)(A+ 1, A+ 1)
v(1)(A+ 1)
,
p(A+2,A+1)(n¯, A) =
aA+2
bA+2
+
cA+2
bA+2
p(A+1,A+1)(n¯, A),
which gives

p(A+1,A+1)(n¯, A) =
θaA+2 + bA+2r
(1)(A+ 1, A+ 1)
bA+2v(1)(A+ 1)− θcA+2
,
p(A+2,A+1)(n¯, A) =
aA+2v
(1)(A+ 1) + cA+2r
(1)(A+ 1, A+ 1)
bA+2v(1)(A+ 1)− θcA+2
.
Given the two values p(A+1,A+1)(n¯, A) and p(A+2,A+1)(n¯, A) dependent on aA+2, bA+2 and
cA+2, the steps of the algorithm is as follows:
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• Start with aM = r(1)(M,A+ 1), bM = v(1)(M), cM = g(1)(M,A+ 1);
• Use the recursive relations (5.68) to find aA+2, bA+2 and cA+2;
• Find p(A+1,A+1)(n¯, A) and p(A+2,A+1)(n¯, A);
• Use (5.69) to find all the different values of p(n,A+1)(n¯, A), up to p(M,A+1)(n¯, A).
The same steps are now applied to the more general states {(n,m) : m ∈ {A+ 2, A+ 3, · · · , N}}.
We recall the functions v(1)(n), g(1)(n,m) and r(1)(n,m) as
v(1)(n) = nµ˜+ δn<M · θ,
g(1)(n,m) = (n−m)µ˜,
r(1)(n,m) = mµ˜ · p(n−1,m−1)(n¯, A).
These definitions, together with (5.64), give
p(M,m)(m¯, A) =
r(1)(M,m)
v(1)(M)
+
g(1)(M,m)
v(1)(M)
p(M−1,m)(n¯, A). (5.70)
With the same techniques used for computing (5.67), we can find
p(M−1,m)(n¯, A) =
θ · p(M,m)(n¯, A)
v(1)(M − 1) +
g(1)(M − 1,m)
v(1)(M − 1) · p(M−2,m)(n¯, A) +
r(1)(M − 1,m)
v(1)(M − 1) ,
(5.71)
obtaining the relations
aM−1 = θaM + bMr(1)(M − 1,m),
bM−1 = bMv(1)(M − 1)− θcM ,
cM−1 = bMg(1)(M − 1,m),
and, recursively, the general ones
aM−k = θaM−k+1 + bM−k+1r(1)(M − k,m),
bM−k = bM−k+1v(1)(M − k)− θcM−k+1, (5.72)
cM−k = bM−k+1g(1)(M − k,m),
with aM = r
(1)(M,m), bM = v
(1)(M), cM = g
(1)(M,m) and
p(M−k,m)(n¯, A) =
aM−k
bM−k
+
cM−k
bM−k
· p(M−k−1,m)(n¯, A). (5.73)
To obtain explicit solution for the general p(n,m)(n¯, A), we notice once again that (5.64)
and (5.73) give, respectively, the two equations of the following system
p(m,m)(n¯, A) =
θ
v(1)(m)
p(m+1,m)(n¯, A) +
r(1)(m,m)
v(1)(m)
,
p(m+1,m)(n¯, A) =
am+1
bm+1
+
cm+1
bm+1
p(m,m)(n¯, A),
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which gives

p(m,m)(n¯, A) =
θam+1 + bm+1r
(1)(m,m)
bm+1v(1)(m)− θcm+1
,
p(m+1,m)(n¯, A) =
am+1v
(1)(m) + cm+1r
(1)(m,m)
bm+1v(1)(m)− θcm+1
.
Given these two values p(m,m)(n¯, A) and p(m+1,m)(n¯, A) dependent on am+1, bm+1 and
cm+1, the algorithm is as follows:
• Start with aM = r(1)(M,m), bM = v(1)(M), cM = g(1)(M,m);
• Use the recursive relations (5.72) to find am+1, bm+1 and cm+1;
• Find p(m,m)(n¯, A) and p(m+1,m)(n¯, A);
• Use (5.73) to find all the different values of p(n,m)(n¯, A), up to p(M,m)(n¯, A).
Simulations of this algorithm and numerical results of a Gillespie code representing the
same biological process can be found in Figures 5.13 and 5.14 respectively. The hitting
probabilities of a particular final state are also plotted for a specific initial state as function
of the variables nθ, θ, γ, Mc and µ, as a heat map in Figures 5.15 to 5.24.
5.5.2 Explicit competition
This section focuses on finding a formula for the probabilities p(n,m)(n¯, A), when we con-
sider the death rates µ
(X)
n,m = µ
(X,2)
n,m = (n−m)(β1+β2pn) and µ(Y )n,m = µ(Y,2)n,m = m(β1+β2pn)
for the augmented process Xaug. As for the previous section, probabilities are defined as
p(n,m)(n¯, A) = Pr(u¯ = (n¯, A)|u = (n,m)), (5.74)
where u represents the initial state (X(0), Y (0)) and u¯ represents the first state hit by the
process Xaug at time TN (A). Following a first step argument we obtain the equation
p(n,m)(n¯, A) =
δn<M · θ · p(n+1,m)(n¯, A) + g(2)(n,m) · p(n−1,m)(n¯, A) + r(2)(n,m)
v(2)(n)
, (5.75)
where we define the functions v(2)(n), g(2)(n,m) and r(2)(n,m) as
v(2)(n) = n(β1 + nβ2p) + δn<M · θ,
g(2)(n,m) = (β1 + nβ2p)(n−m),
r(2)(n,m) = m(β1 + nβ2p) · p(n−1,m−1)(n¯, A).
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In order to find explicit solutions for the recursive equation (5.75), we focus on the
particular space of states {(n,m) : m = A+ 1}. The functions v(2)(n), g(2)(n,m) and
r(2)(n,m), together with (5.75) give
p(M,A+1)(n¯, A) =
r(2)(M,A+ 1)
v(2)(M)
+
g(2)(M,A+ 1)
v(2)(M)
p(M−1,A+1)(n¯, A), (5.76)
where r(2)(M,A+ 1) = (A+ 1)(β1 + β2pM) · p(M−1,A)(n¯, A) and
p(M−1,A)(n¯, A) =
{
1 if n¯ = M − 1,
0 otherwise.
Let us define
aM = r
(2)(M,A+ 1); bM = v
(2)(M); cM = g
(2)(M,A+ 1),
so that p(M,A+1)(n¯, A) can be written as
p(M,A+1)(n¯, A) =
aM
bM
+
cM
bM
· p(M−1,A+1)(n¯, A). (5.77)
We consider p(M−1,A+1)(n¯, A). As for p(M,A+1)(n¯, A), it can be written
p(M−1,A+1)(n¯, A) =
θ · p(M,A+1)(n¯, A)
v(2)(M − 1) +
r(2)(M − 1, A+ 1)
v(2)(M − 1)
+
g(2)(M − 1, A+ 1)
v(2)(M − 1) · p(M−2,A+1)(n¯, A),
(5.78)
that is
p(M−1,A+1)(n¯, A) =
θaM + bMr
(2)(M − 1, A+ 1)
bMv(2)(M − 1)− θcM
+
bMg
(2)(M − 1, A+ 1)
bMv(2)(M − 1)− θcM
· p(M−2,A+1)(n¯, A),
(5.79)
where the equality is obtained by replacing (5.77) in (5.78). We define
aM−1 = θaM + bMr(2)(M − 1, A+ 1),
bM−1 = bMv(2)(M − 1)− θcM ,
cM−1 = bMg(2)(M − 1, A+ 1),
so that p(M−1,A+1)(n¯, A) can be written as
p(M−1,A+1)(n¯, A) =
aM−1
bM−1
+
cM−1
bM−1
· p(M−2,A+1)(n¯, A).
The general recursive relations follow
aM−k = θaM−k+1 + bM−k+1r(2)(M − k,A+ 1),
bM−k = bM−k+1v(2)(M − k)− θcM−k+1, (5.80)
cM−k = bM−k+1g(2)(M − k,A+ 1),
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with aM = r(M,A+ 1), bM = v(M), cM = g(M,A+ 1) and
p(M−k,A+1)(n¯, A) =
aM−k
bM−k
+
cM−k
bM−k
· p(M−k−1,A+1)(n¯, A). (5.81)
We notice that (5.75) and (5.81) give, respectively, the two equations of the following
system
p(A+1,A+1)(n¯, A) =
θ
v(2)(A+ 1)
p(A+2,A+1)(n¯, A) +
r(2)(A+ 1, A+ 1)
v(2)(A+ 1)
,
p(A+2,A+1)(n¯, A) =
aA+2
bA+2
+
cA+2
bA+2
p(A+1,A+1)(n¯, A),
which gives
p(A+1,A+1)(n¯, A) =
θaA+2 + bA+2r
(2)(A+ 1, A+ 1)
bA+2v(2)(A+ 1)− θcA+2
,
p(A+2,A+1)(n¯, A) =
aA+2v
(2)(A+ 1) + cA+2r
(2)(A+ 1, A+ 1)
bA+2v(2)(A+ 1)− θcA+2
.
These two values p(A+1,A+1)(n¯, A) and p(A+2,A+1)(n¯, A), dependent on aA+2, bA+2 and
cA+2, are now used as part of the following algorithm:
• Start with aM = r(2)(M,A+ 1), bM = v(2)(M), cM = g(2)(M,A+ 1);
• Use the recursive relations (5.45) to find aA+2, bA+2 and cA+2;
• Find p(A+1,A+1)(n¯, A) and p(A+2,A+1)(n¯, A);
• Use (5.81) to find all the different values of p(n,A+1)(n¯, A), up to p(M,A+1)(n¯, A).
We focus now on the general space of states {(n,m) : m ∈ {A+ 2, A+ 3, · · · , N}}, recall-
ing the functions v(2)(n), g(2)(n,m) and r(2)(n,m)
v(2)(n) = n(β1 + nβ2p) + δn<M · θ,
g(2)(n,m) = (β1 + nβ2p)(n−m),
r(2)(n,m) = m(β1 + nβ2p) · p(n−1,m−1)(n¯, A).
We have from (5.75)
p(M,m)(n¯, A) =
r(2)(M,m)
v(2)(M)
+
g(2)(M,m)
v(2)(M)
p(M−1,m)(n¯, A). (5.82)
With the same techniques used for computing (5.79), we can find
p(M−1,m)(n¯, A) =
θ · p(M,m)(n¯, A)
v(2)(M − 1) +
g(2)(M − 1,m)
v(2)(M − 1) · p(M−2,m)(n¯, A) +
r(2)(M − 1,m)
v(2)(M − 1)
(5.83)
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obtaining the relations
aM−1 = θaM + bMr(2)(M − 1,m),
bM−1 = bMv(2)(M − 1)− θcM ,
cM−1 = bMg(2)(M − 1,m),
and, recursively, the general ones
aM−k = θaM−k+1 + bM−k+1r(2)(M − k,m),
bM−k = bM−k+1v(2)(M − k)− θcM−k+1, (5.84)
cM−k = bM−k+1g(2)(M − k,m),
with aM = r
(2)(M,m), bM = v
(2)(M), cM = g
(2)(M,m) and
p(M−k,m)(n¯, A) =
aM−k
bM−k
+
cM−k
bM−k
· p(M−k−1,m)(n¯, A). (5.85)
Equations (5.75) and (5.85) give, respectively, the two equations of the following system
p(m,m)(n¯, A) =
θ
v(2)(m)
p(m+1,m)(n¯, A) +
r(2)(m,m)
v(2)(m)
,
p(m+1,m)(n¯, A) =
am+1
bm+1
+
cm+1
bm+1
p(m,m)(n¯, A),
which gives 
p(m,m)(n¯, A) =
θam+1 + bm+1r
(2)(m,m)
bm+1v(2)(m)− θcm+1
,
p(m+1,m)(n¯, A) =
am+1v
(2)(m) + cm+1r
(2)(m,m)
bm+1v(2)(m)− θcm+1
.
The final algorithm follows:
• Start with aM = r(2)(M,m), bM = v(2)(M), cM = g(2)(M,m);
• Use the recursive relations (5.84) to find am+1, bm+1 and cm+1;
• Find p(m,m)(n¯, A) and p(n+1,m)(n¯, A);
• Use (5.85) to find all the different values of p(n,m)(n¯, A), up to p(M,m)(n¯, A).
Simulations of this algorithm and numerical results of a Gillespie code representing the
same biological process can be found in Figures 5.41 and 5.42 respectively. The hitting
probabilities of a particular final state are also plotted for a specific initial state as function
of both the β1 and β2p variables, as a heat map in Figure 5.43.
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5.6 Maximum repertoire diversity in [0, TN(A)]
Given the augmented process Xaug = {(X(t), Y (t)) : t ≥ 0} defined on the space of
states Saug = {(n,m) : m ∈ {0, 1, 2, . . . , X(0)}, n ≥ m}, we recall the definition of
TN (A) as the time when, for the first time, the process X
aug reaches the space of states
A = {(n,m) : m = A}. Our goal here is to derive the distribution of the maximum
value of total clonotypes Xmax = max{X(t) : t ∈ [0, TN (A)]} that the augmented process
Xaug = {(X(t), Y (t)) : t ≥ 0}, defined on the space of states Saug = {(n,m) : m ∈
{0, 1, 2, . . . , X(0)}, n ≥ m}, reaches during the period of time [0, TN (A)]. In particular,
we analyse the probabilities φ(n,m) = Pr(X
max ≥ M |(X(0), Y (0)) = (n,m)}) for the
stochastic descriptor Xmax to reach (and maybe overpass) a certain value M > X(0). We
believe this descriptor is an important measure of the renewal dynamics of the repertoire,
as able to describe the overpopulation effects of a population subject to renewal. Such a
descriptor has been previously studied in the literature in relation to a generic two-species
competition process [70]. Other authors apply similar steps to the study of the repertoire
dynamics, not considering though the renewal problem we are focusing on [14]. This
descriptor is also relevant from a technical point for the section on numerical results. In
fact, it is only through the analyses of these probabilities that we can obtain a good idea
of which value of M to use for the simulations of the two previously discussed stochastic
descriptors.
5.6.1 Implicit competition
We find a formula for the probabilities φ(n,m), when we consider the death rates µ
(X)
n,m =
µ
(X,1)
n,m = µ˜(n −m) and µ(Y )n,m = µ(Y,1)n,m = µ˜m for the augmented process Xaug. We recall
that these probabilities are defined as
φ(n,m) = Pr(X
max ≥M |(X(0), Y (0)) = (n,m)}). (5.86)
Using the first step argument as explained in the previous sections, we write
φ(n,m) =
δn<M · θ · φ(n+1,m) + g(1)(n,m) · φ(n−1,m) + w(1)(n,m)
v(1)(n)
, (5.87)
where the functions v(1)(n), g(1)(n,m) and w(1)(n,m) are defined as
v(1)(n) = nµ˜+ δn<M · θ
g(1)(n,m) = (n−m)µ˜
w(1)(n,m) = mµ˜ · φ(n−1,m−1).
Note that the notations v(1)(n), g(1)(n,m) and w(1)(n,m) are due to the use of the first
kind of death rates µ
(X)
n,m = µ
(X,1)
n,m = (n − m)µ˜ and µ(Y )n,m = µ(Y,1)n,m = mµ˜ in this section.
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For the same reason, in the following section we will use the notation v(2)(n), g(2)(n,m)
and w(2)(n,m) when dealing with the cases µ
(X)
n,m = µ
(X,2)
n,m = (n − m)(β1 + β2pn) and
µ
(Y )
n,m = µ
(Y,2)
n,m = m(β1 + β2pn). The boundary conditions for this stochastic descriptor are
φ(M,m) = 1 ∀m ∈ [A,N ], (5.88)
φ(n,A) =
{
1 if n = M,
0 otherwise.
(5.89)
In order to find explicit solutions for the recursive equation (5.87), we focus on the general
space of states {(X(t), Y (t)) : Y (t) = m, m ∈ {A+ 1, A+ 2, . . . Y (0)}}, as shown in the
previous section. Following the same steps of the previous sections, the functions v(n),
g(n,m) and w(n,m), together with (5.87), give (for k ≥ 1)
aM−k = θaM−k+1 + bM−k+1w(1)(M − k,m),
bM−k = bM−k+1v(1)(M − k)− θcM−k+1, (5.90)
cM−k = bM−k+1g(1)(M − k,m),
with aM−1 = θ + w(1)(M − 1,m), bM−1 = v(1)(M − 1), cM−1 = g(1)(M − 1,m) and
φ(M−k,m) =
aM−k
bM−k
+
cM−k
bM−k
· φ(M−k−1,m). (5.91)
In order to obtain explicit solution for the general φ(n,m), an algorithm has to be followed.
Equations (5.87) and (5.91) give, respectively, the two equations of the following system
φ(m,m) =
θ
v(1)(m)
φ(m+1,m) +
w(1)(m,m)
v(1)(m)
,
φ(m+1,m) =
am+1
bm+1
+
cm+1
bm+1
φ(m,m),
which gives

φ(m,m) =
θam+1 + bm+1w
(1)(m,m)
bm+1v(1)(m)− θcm+1
,
φ(m+1,m) =
am+1v
(1)(m) + cm+1w
(1)(m,m)
bm+1v(1)(m)− θcm+1
.
Given these two values φ(m,m) and φ(m+1,m) dependent on am+1, bm+1 and cm+1, we can
now give the steps of the algorithm as follows:
• Start with aM−1 = θ+w(1)(M −1,m), bM−1 = v(1)(M −1), cM−1 = g(1)(M −1,m);
• Use the recursive relations (5.90) to find am+1, bm+1 and cm+1;
• Find φ(m,m) and φ(m+1,m);
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• Use (5.91) to find all the different values of φ(n,m), up to φ(M−1,m).
The reader can find simulations for this algorithm and for a Gillespie code representing the
same biological process in Figures 5.25, 5.26 and 5.27 respectively. The hitting probabilities
of a particular final state are also plotted for a specific initial state as function of the
variables nθ, θ, γ, Mc and µ, as a heat map in Figures 5.28 to 5.37.
5.6.2 Explicit competition
We find a formula for the probabilities φ(n,m), when we consider the death rates µ
(X)
n,m =
µ
(X,2)
n,m = (n−m)(β1 +β2pn) and µ(Y )n,m = µ(Y,2)n,m = m(β1 +β2pn) for the augmented process
Xaug. We recall that these probabilities are defined as
φ(n,m) = Pr(X
max ≥M |(X(0), Y (0)) = (n,m)}). (5.92)
Using the first step argument as explained in the previous sections, we can write
φ(n,m) =
δn<M · θ · φ(n+1,m) + g(2)(n,m) · φ(n−1,m) + w(2)(n,m)
v(2)(n)
, (5.93)
where the functions v(2)(n), g(2)(n,m) and w(2)(n,m) are defined as
v(2)(n) = n(β1 + nβ2p) + δn<M · θ,
g(2)(n,m) = (β1 + nβ2p)(n−m),
w(2)(n,m) = m(β1 + nβ2p) · φ(n−1,m−1).
The boundary conditions for this stochastic descriptor in this process are
φ(M,m) = 1 ∀m ∈ [A,N ], (5.94)
φ(n,A) =
{
1 if n = M,
0 otherwise.
(5.95)
In order to find explicit solutions for the recursive equation (5.93), we focus, as shown
in the previous section, on the general space of states {(X(t), Y (t)) : Y (t) ≡ m}. The
functions v(2)(n), g(2)(n,m) and w(2)(n,m), together with (5.93) give (for k ≥ 1)
aM−k = θaM−k+1 + bM−k+1w(2)(M − k,m),
bM−k = bM−k+1v(2)(M − k)− θcM−k+1, (5.96)
cM−k = bM−k+1g(2)(M − k,m),
with aM−1 = θ + w(2)(M − 1,m), bM−1 = v(2)(M − 1), cM−1 = g(2)(M − 1,m) and
φ(M−k,m) =
aM−k
bM−k
+
cM−k
bM−k
· φ(M−k−1,m). (5.97)
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Equations (5.93) and (5.97) give, respectively, the two equations of the following system
φ(m,m) =
θ
v(2)(m)
φ(m+1,m) +
w(2)(m,m)
v(2)(m)
,
φ(m+1,m) =
am+1
bm+1
+
cm+1
bm+1
φ(m,m),
which gives 
φ(m,m) =
θam+1 + bm+1w
(2)(m,m)
bm+1v(2)(m)− θcm+1
,
φ(m+1,m) =
am+1v
(2)(m) + cm+1w
(2)(m,m)
bm+1v(2)(m)− θcm+1
.
Given these two values φ(m,m) and φ(m+1,m) dependent on am+1, bm+1 and cm+1, we can
now give the steps of the algorithm as follows:
• Start with aM−1 = θ+w(2)(M −1,m), bM−1 = v(2)(M −1), cM−1 = g(2)(M −1,m);
• Use the recursive relations (5.96) to find am+1, bm+1 and cm+1;
• Find φ(m,m) and φ(m+1,m);
• Use (5.97) to find all the different values of φ(n,m), up to φ(M−1,m).
The reader can find simulations for this algorithm and for a Gillespie code representing the
same biological process in Figures 5.44, 5.45 and 5.46 respectively. The hitting probabilities
of a particular final state are also plotted for a specific initial state as function of both the
β1 and β2p variables, as a heat map in Figure 5.47.
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5.7 Numerical results
In this section we display results from small-scale numerical simulations. We decided to
rescale the system with different parameters than those chosen in [100] for computational
reasons. We explain here the reasoning behind the rescaling procedure, and the invariances
maintained from the clonotype perspective. Let us consider a repertoire, in homeostasis
conditions, made of N(0) = 50 initial clonotype classes. The average clonal size equals 10
T cells. Thus, we consider a total of 500 initial T cells. The number of T cells of any new
clonotype coming out of the thymus is nθ = 4. The mean cell death rate is maintained to
µ = 0.5 year−1, as in [100]. The total number of self pMHC subsets is chosen following
the relation Mc = 4N(0) = 200. This relation is kept from the simulations of Figure 7 in
[100]. It is important to notice that we changed the notation of the total number of self
pMHC subsets, from M to Mc, since in our notation M represents the maximum number
of possible clonotype classes in the simulated repertoire. This parameter is important
for the realization of the first step argument analysis, as explained in (5.40). We set
pMc = 10, to maintain an invariance from the clonotype perspective, since pMc is the
mean number of self pMHC recognised by a single TCR clonotype. This gives p=0.05,
which also gives pN(0) = 2.5, that is the mean number of TCR clonotypes that are able
to recongnise a given self pMHC. As explained in [100], we consider to biological case in
which the division of peripheral cells gives the dominant contribution (as it is for adult
humans), therefore approximating the mean number of total T cells in the system with
(γMc)/µ. Thus we have (γMc)/µ = 500, giving γ = 1.25 year
−1. We extrapolate the
relation 50θnθ = (γMc)/µ. Thus we obtain θ = 2.5 year
−1. Sensitivity analysis will
be done on the parameter θ, as well as on the other parameters. To conclude, we note
that the average number of clonotype classes (i.e., 50) equals θ/µ˜, being µ˜ = 0.05 year−1
(see definition of µ˜ explained in Section 5.2.1). This is coherent with the fact that, in
homeostasis conditions, the average number of clonotype classes should be around θ/µ˜.
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5.7.1 Implicit competition
This section presents the numerical results for the stochastic model with implicit compe-
tition, as described in Section 5.2.1. Results are shown for both the stochastic descriptors
defining (i) the size of the repertoire at time TN (A) and (ii) the maximum repertoire di-
versity in [0, TN (A)]. Solutions of the first step argument methods of Section 5.5.1 and
Section 5.6.1 are shown for different initial states, together with Gillespie simulations
which confirm the correctness of the first step argument methods. Sensitivity analysis is
also performed over the different paramenters θ, nθ, Mc, γ and µ.
Size of repertoire at time TN (A)
We present here the results for the stochastic descriptor defining the size of the repertoire
at time TN (A). Parameters are chosen in accordance to Section 5.7. Figure represents
the solution of the system described in Section 5.5.1. The hitting state (35, 25) and the
different initial states {(x, y) : x ∈ {48, . . . , 60}, y ∈ {47, . . . , 50}} have been chosen just
as examples. Numerical (Gillespie) simulations of the same process are shown in Figure
5.14, with hitting state (35, 25) and initial states {(x, 50) : x ∈ {50, . . . , 60}}. Sensitivity
analyses are then presented in Figures 5.15 - 5.24.
Figure 5.13: Parameters: A = 25, M = 60, θ = 2.5 year−1, nθ = 4, Mc = 200, γ = 1.25
year−1 and µ = 0.5 year−1. Different colours represent different values of y. The hitting
probabilities, for a given y, are plotted as functions of x.
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Figure 5.14: Parameters: A = 25, M = 60, θ = 2.5 year−1, nθ = 4, Mc = 200, γ = 1.25
year−1 and µ = 0.5 year−1. The plot represents the hitting probabilities of state (35, 25)
from different states (x, 50). Number of simulations = 105.
Figure 5.15: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both nθ and θ variables. Fixed parameters are Mc = 200,
γ = 1.25 year−1 and µ = 0.5 year−1.
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Figure 5.16: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both nθ and γ variables. Fixed parameters are θ = 2.5
year−1, Mc = 200 and µ = 0.5 year−1.
Figure 5.17: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both nθ and Mc variables. Fixed parameters are θ = 2.5
year−1, γ = 1.25 year−1 and µ = 0.5 year−1.
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Figure 5.18: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both nθ and µ variables. Fixed parameters are θ = 2.5
year−1, Mc = 200 and γ = 1.25 year−1.
Figure 5.19: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both θ and γ variables. Fixed parameters are nθ = 4,
Mc = 200 and µ = 0.5 year
−1.
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Figure 5.20: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both θ and Mc variables. Fixed parameters are nθ = 4,
γ = 1.25 year−1 and µ = 0.5 year−1.
Figure 5.21: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both θ and µ variables. Fixed parameters are nθ = 4,
Mc = 200 and γ = 1.25 year
−1.
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Figure 5.22: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both γ and Mc variables. Fixed parameters are θ = 2.5
year−1, nθ = 4 and µ = 0.5 year−1.
Figure 5.23: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both γ and µ variables. Fixed parameters are θ = 2.5 year−1,
nθ = 4 and Mc = 200.
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Figure 5.24: The plot represents the hitting probabilities of state (35, 25) from the initial
state (50, 50) as a function of both Mc and µ variables. Fixed parameters are θ = 2.5
year−1, nθ = 4 and γ = 1.25 year−1.
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Maximum repertoire diversity in [0, TN (A)]
We present here the results for the stochastic descriptor defining the maximum repertoire
diversity in the time interval [0, TN (A)]. Parameters are chosen in accordance to Section
5.7. Figure represents the solution of the system described in Section 5.6.1, that is the
Pr(Xmax > x¯). The maximum diversity value x¯ = 52 to be exceeded, and the different
initial states {(x, y) : x ∈ {46, . . . , 52}, y ∈ {46, . . . , 50}} have been chosen just as exam-
ples. Figure 5.26 represents the Pr(Xmax = x), while Figure 5.27 represents its Gillespie
counterpart. Sensitivity analyses are then presented in Figures 5.28 - 5.37.
Figure 5.25: Parameters: A = 25, θ = 2.5 year−1, nθ = 4, γ = 1.25 year−1, Mc = 200 and
µ = 0.5 year−1. Different colours represent different values of y. The hitting probabilities,
for a given y, are plotted as functions of x.
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Figure 5.26: Parameters: A = 25, θ = 2.5 year−1, nθ = 4, γ = 1.25 year−1, Mc = 200,
µ = 0.5 year−1 and initial state (50, 50). The plot represents the probabilities for Xmax
being equal to x from the initial state (50, 50).
Figure 5.27: Parameters: A = 25, θ = 2.5 year−1, nθ = 4, γ = 1.25 year−1, Mc = 200,
µ = 0.5 year−1 and initial state (50, 50). The plot represents the probabilities (from
Gillespie algorithm) for Xmax being equal to x from the initial state (50, 50). Number of
simulations = 105.
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Figure 5.28: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both nθ and θ variables. Fixed parameters
are Mc = 200, µ = 0.5 year
−1 and γ = 1.25 year−1.
Figure 5.29: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both nθ and γ variables. Fixed parameters
are θ = 2.5 year−1, Mc = 200 and µ = 0.5 year−1.
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Figure 5.30: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both nθ and Mc variables. Fixed parameters
are θ = 2.5 year−1, µ = 0.5 year−1 and γ = 1.25 year−1.
Figure 5.31: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both nθ and µ variables. Fixed parameters
are θ = 2.5 year−1, Mc = 200 and γ = 1.25 year−1.
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Figure 5.32: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both θ and γ variables. Fixed parameters
are nθ = 4, Mc = 200 and µ = 0.5 year
−1.
Figure 5.33: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both θ and Mc variables. Fixed parameters
are nθ = 4, µ = 0.5 year
−1 and γ = 1.25 year−1.
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Figure 5.34: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both θ and µ variables. Fixed parameters
are nθ = 4, Mc = 200 and γ = 1.25 year
−1.
Figure 5.35: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both γ and Mc variables. Fixed parameters
are θ = 2.5 year−1, nθ = 4 and µ = 0.5 year−1.
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Figure 5.36: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both γ and µ variables. Fixed parameters
are θ = 2.5 year−1, nθ = 4 and Mc = 200.
Figure 5.37: The plot represents the probabilities for Xmax being greater or equal to 52
from the initial state (50, 50), as a function of both Mc and µ variables. Fixed parameters
are θ = 2.5 year−1, nθ = 4 and γ = 1.25 year−1.
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5.7.2 Explicit competition
This section presents the numerical results for the stochastic model with implicit compe-
tition, as described in Section 5.2.2. Results are shown for the three stochastic descriptors
defining (i) the time TN (A) to reach for the first time a number A < X(0) of original clono-
types in the repertoire, (ii) the size of the repertoire at time TN (A) and (iii) the maximum
repertoire diversity in [0, TN (A)]. Solutions of the first step argument methods of Sec-
tions 5.4.2, 5.5.2 and 5.6.2 are shown for different initial states, together with Gillespie
simulations which confirm the correctness of the first step argument methods. Sensitivity
analysis is also performed over the parameter β1 and the product pβ2. The choice to
vary the product pβ2 instead of the single parameter β2 comes from the importance of
the product itself, defined as the environmental pressure due to clonotype competition in
Section 5.2.2.
Time TN (A) to reach for the first time a number A < X(0) of original clonotypes
in the repertoire
We present here the results for the stochastic descriptor defining the time TN (A) to reach
for the first time a number A < X(0) of original clonotypes in the repertoire. Parameters
are chosen in accordance to Section 5.7. Figure 5.38 represents the solution of the system
described in Section 5.4.2. The value A = 25, as well as the initial states {(x, y) : x ∈
{48, . . . , 60}, y ∈ {47, . . . , 50}} have been chosen just as examples. Figure 5.39 represents
the Gillespie counterpart of Figure 5.38, for the particular value y = 50. Sensitivity
analyses are then presented in Figure 5.40.
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Figure 5.38: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the hitting times of level A, that is one of the
general states (x,25), from the different states (x, y). Different colours represent different
values of y. The hitting probabilities, for a given y, are plotted as functions of x.
Figure 5.39: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the hitting times (from Gillespie algorithm) of
level A, that is one of the general states (x,25), from the initial state (50, 50). Number of
simulations = 105.
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Figure 5.40: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the hitting times of level A, that is one of
the general states (x,25), from the initial state (50, 50) as a function of both β1 and β2p
variables.
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Size of repertoire at time TN (A)
We present here the results for the stochastic descriptor defining the size of repertoire at
time TN (A). Parameters are chosen in accordance to Section 5.7. Figure 5.41 represents
the solution of the system described in Section 5.5.2. The hitting state (35, 25), as well
as the initial states {(x, y) : x ∈ {46, . . . , 60}, y ∈ {46 . . . , 50}} have been chosen just as
examples. Figure 5.42 represents the Gillespie counterpart of Figure 5.41, for the particular
value y = 50. Sensitivity analyses are then presented in Figure 5.43.
Figure 5.41: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the hitting probabilities of state (35, 25) from
the different states (x, y). Different colours represent different values of y. The hitting
probabilities, for a given y, are plotted as functions of x.
166
5.7 Numerical results
Figure 5.42: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the hitting probabilities of state (35, 25) from
the initial state (50, 50). Number of simulations = 105.
Figure 5.43: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the hitting probabilities of state (50, 25) from
the initial state (50, 50) as a function of both β1 and β2p variables.
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Maximum repertoire diversity in [0, TN (A)]
We present here the results for the stochastic descriptor defining the maximum repertoire
diversity in the time interval [0, TN (A)]. Parameters are chosen in accordance to Section
5.7. Figure 5.44 represents the solution of the system described in Section 5.6.2, that
is the Pr(Xmax > x¯). The maximum diversity value x¯ = 52 to be exceeded, and the
different initial states {(x, y) : x ∈ {46, . . . , 52}, y ∈ {46, . . . , 50}} have been chosen just
as examples. Figure 5.45 represents the Pr(Xmax = x), while Figure 5.46 represents its
Gillespie counterpart. Sensitivity analyses are then presented in Figure 5.47.
Figure 5.44: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. Different colours represent different values of y. The plot represents
the probabilities for Xmax being greater or equal to 52 from the initial state (x, y).
168
5.7 Numerical results
Figure 5.45: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the probabilities for Xmax being equal to x from
the initial state (50, 50).
Figure 5.46: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the probabilities (Gillespie simulations) for Xmax
being equal to x from the initial state (50, 50). Number of simulations = 105.
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Figure 5.47: Parameters: A = 25, M = 60, θ = 2.5 year−1, β1 = 0.004 year−1, β2 = 0.02
year−1 and p = 0.05. The plot represents the probabilities for Xmax being greater or equal
to 52 from the initial state (50, 50), as a function of both β1 and β2p variables.
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5.8 Discussion
This chapter focused on the biological problem concerning the evolution of diversity in a
CD4+ T-cell repertoire. In particular, we follow the dynamics of both original and new
clonotype classes. The study of these dynamics is of foremost importance to evaluate
the relevance of sampling from a repertoire and trying to estimate its diversity at a given
point in time. To this aim, we built a continuous-time Markov chain (CTMC) representing
the stochastic processes of competition and natural death of the original and new TCR
clonotypes. We then decided to further consider two different types of competitions:
implicit and explicit competition. The implicit case considers a death rate µ
(1)
n = µ˜n,
where n represents the number of different clonotype classes, and µ˜ represents the average
survival time of a clonotype in the repertoire, incorporating competition within its very
definition, as explained in Section 5.2.1. The explicit case considers a death rate µ
(2)
n =
n(β1+β2p(n−1)), where n represents the number of different clonotype classes, p represents
the probability that any given self pMHC is recognised by a randomly-selected TCR
clonotype, β1 represents the average survival time of a clonotype in the repertoire, and
β2 represents the strength of competition among clonotypes competing for the same self
pMHCs, as explained in Section 5.2.2. Three different stochastic descriptors were studied:
(i) the time TN (A) needed for the N original clonotype classes to become A (with A < N),
(ii) the size of the repertoire at time TN (A), and (iii) the maximum repertoire diversity
achieved in the time interval [0, TN (A)].
The first descriptor was analysed analytically for the implicit case, and its density
function was computed, together with the moment generating function. The results were
seen to be very similar to those from the explicit case, which was analysed by the first step
argument analysis. Figure 5.11 and Figures 5.38–5.39 show the average time until half of
the original clonotype classes are lost, starting with N(0) = 50 clonotypes. The time is
around 13.5 years for both implicit and explicit cases.
The second descriptor was analysed with the first step argument technique for both im-
plicit and explicit cases, showing slightly different results. Figures 5.13–5.14 and 5.41–5.42
show the probability of hitting the state (35, 25) from the state (50, 50). The probabilities
are 0.0025 and 0.00075 for the implicit and explicit case respectively.
The third descriptor was also analysed with the first step argument technique for both
implicit and explicit cases, showing very similar results. Figures 5.25 and 5.44 show the
probability for the maximum number of distinct clonotypes to be greater than 52, starting
with N(0) = 50 clonotypes. The probability is around 0.75 for both cases.
Small-scale simulations are of course far from reality, representing a simplified version
of the dynamics of the homeostasis conditions of the immune system. Nevertheless, we
believe these simulations carry two important results. First, they show the power of the
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first step argument for the analysis of stochastic descriptors which cannot be analytically
studied. This is proven by the accuracy of the analyses compared with the Gillespie
simulations. Second, these results show that within a life-time period, the repertoire of
an individual could easily evolve in a way that it could become very different from the
starting one. This enhances the importance of our first question: up to what point does
it really make sense to have an estimate of the actual repertoire diversity of an individual
at a specific point in time?
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Chapter 6
Conclusions
The immune system is a complex machine, whose mechanisms are indispensable to life
itself. Its outstanding power is given by the unique ability of recognising virtually almost
all the possible existing pathogens. This singular characteristic is maintained, among
others, thanks to an incredibly broad army of distinct T-cell classes, characterised by
different T-cell receptors (TCRs), and able to recognise different overlapping groups of
pathogens. Understanding the biological mechanisms behind the creation of the immune
system diversity is one of the central aspects of current research in immunobiology.
The present work tried to shed some light on different facets of this crucial aspect,
producing some interesting quantitative results and suggesting future research areas in
mathematical immunology. Data analysis and stochastic models were the main drivers of
the thesis, together with statistical and probabilistic analysis.
Starting from the probabilistic side of the subject, Chapter 3 studied the relation
between the total (unmeasurable) TCR repertoire diversity, and the observable diversity,
shown by small biological samples. The probability generating function (PGF) of the
distribution of the observed clonal sizes is proven to be the composition of two PGFs
of two distinct random variables: (i) a Bernoulli random variable and (ii) the random
variable of the true clonal size distribution in the repertoire that is being sampled from. In
particular, different clonal size distributions were studied and their sample distributions
were analysed. The expected number of TCR repeats in a sample, and the number of
draws to find the first repeat are also studied, and analytical formulae are given. These
techniques were then used to estimate the clonal size distribution of a subset of the mice
immune system (GP33+ repertoire), following different distribution hypotheses.
Chapter 4 targeted the TCR diversity problem from a data analysis point of view, fo-
cusing on experimental data gathered from a broader study on TCR diversity in na¨ıve and
LCMV (lymphocytic choriomeningitis virus) infected mice. The analyses centered on the
distributions of the V and J gene segments of the TCR β chains. Statistical tests such as
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Wilcoxon-Mann-Whitney U test, Randomization test, and χ2 test were conducted. Simp-
son’s diversity index, which was used to quantify genetic diversity among mice, resulted
to be statistically higher in the na¨ıve mice than in the infected ones. Though, this result
only concerned the diversity at the V-J pair level, and was not found for the single V or J
diversities. The clonal sharing was also studied, trying to distinguish public from private
VJ classes, in both na¨ıve and infected mice. The chapter continued with the development
of a mathematical relation among the observed (gi) and unobserved (fi) frequency of a
given TCR clonotype class (i) of the repertoire. The chapter is concluded with a quick
application of this relation to some of the data taken into consideration: the frequency of
the V1 gene segment is suggested to be around 5.47% in the na¨ıve repertoire of a mice.
Chapter 5 focused on the evolution of diversity in a CD4+ T-cell repertoire. A
continuous-time Markov chain was built, to follow the dynamics of TCR clonotype classes
of a simulated repertoire. Two different cases for inter clonal competition were considered:
implicit and explicit competition. The first case considered the competition intrinsically
defined into the constant µ˜ within the definition of the death rate of each clonotype
class (µ
(1)
n = µ˜n), where n represented the number of different clonotype classes in the
repertoire. The second case considers the competition in an explicit way, through a sec-
ond death rate µ
(2)
n = n(β1 + β2p(n − 1)). Both cases were analysed and three different
stochastic descriptors were taken into consideration: (i) the time TN (A) needed for the
N original clonotype classes to become A (with A < N), (ii) the size of the repertoire
at time TN (A), and (iii) the maximum repertoire diversity achieved in the time interval
[0, TN (A)]. Small-scale simulations were displayed, showing strong similarities between the
two cases for both the first and third stochastic descriptor. The driving question of the
chapter was about the importance of a time-point estimate of the actual TCR diversity,
taking into consideration the renewal process. The simulations, although representing an
overly simplified reality, suggest the existance of a renewal process that should be taken
into consideration when studying the TCR repertoire diversity.
The study of TCR repertoire diversity is of foremost importance for immunology to-
day. Its complexity is such that even the smallest step forward in knowledge could have
incredibly positive repercussions for human and animal health. Difficulties are found at
each level of the research, from genetics up to population studies, from the biological to
the modelling point of view. This work tackled some of these problems from a quantitative
perspective, and the author is well aware that the path to a final understanding of TCR
diversity remains an uphill battle. With this in mind, the author looks at this thesis as
a small step on an ambitious path, with the hope that somehow, someday science will
eventually unravel this unbelievable mystery of the immune system.
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Appendix A
Binomial approximation of
hypergeometric distribution
Let’s define Di as the clonotype class i for i ∈ 1, 2, ..., N . Thus the repertoire will be
D =
⋃N
i=1Di. Let ni be the number of T cells in the clonotype class i, that is ni = |Di|.
Let S =
∑N
i=1 ni be the total number of T cells in the repertoire. Now let us extract a
sample X = (X1, X2, ..., Xm) of size m, where Xj is the j
th extracted T cell. Define Yi as
the number of T cells of type i in the sample X, for i ∈ 1, 2, ..., N . Note that ∑Ni=1 Yi = m.
The distribution of (Y1, Y2, ..., YN ) is called multivariate hypergeometric distribution with
parameters (S, (n1, ..., nN ),m). In particular, the marginal distributions are described by
Pr(Yi = y) =
(
ni
y
) (
S−ni
m−y
)(
S
m
) for y ∈ 0, 1, ...,m. (A.1)
Defining Pr(Yi = y) as pi, we can rewrite this equation as
pi =
(
ni
y
)
m!
(m− y)!
(S −m)!
S!
(S − ni)!
(S − ni − (m− y))!
=
(
ni
y
)
m(m− 1) · · · (m− (y − 1))
S(S − 1) · · · (S − (m− 1))
m−y−1∏
k=0
(S − ni − k)
(A.2)
We now assume ni  m, which in turn implies y  m, obtaining
pi ≈
(
ni
y
)
my
SySm−y
m∏
k=0
(S − ni − k). (A.3)
We also assume that ni  S, therefore approximating pi as
pi ≈
(
ni
y
)
qy
1
Sm−y
(S)(S − 1)(S − 2) · · · (S −m). (A.4)
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We now realize that (A.4) can be rewritten as
pi ≈
(
ni
y
)
qy
1
Sm−y
(S −m+m)(S −m+ (m− 1))(S −m+ (m− 2)) · · · (S −m)), (A.5)
and then approximated by
pi ≈
(
ni
y
)
qy
1
Sm−y
(
(S −m) + m
2
)m−y
. (A.6)
Assuming m S, we obtain
pi ≈
(
ni
y
)
qy
(S −m)m−y
Sm−y
=
(
ni
y
)
qy(1− q)m−y. (A.7)
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Appendix B
V-J data
Tables B.1-B.10 show, for each individual mouse, the number of T cells with a particular
combination of V and J genes.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 1 3 1 0 0 0 0 1 1 0 0 3
V2 2 2 0 0 1 0 1 0 2 0 0 1
V3 2 0 1 0 0 0 0 1 1 0 2 2
V4 0 0 0 0 0 0 0 0 3 1 0 3
V5 2 0 1 1 2 0 0 0 0 1 0 0
V12−1 0 2 2 0 0 0 1 1 1 0 0 2
V12−2 0 1 0 0 0 0 1 0 0 0 4 4
V13−1 2 4 0 3 1 2 4 2 2 2 2 5
V13−2 4 3 0 3 0 1 6 1 3 6 7 8
V13−3 0 2 3 4 0 2 6 2 5 3 6 7
V14 2 0 0 1 0 0 3 0 1 0 1 1
V15 3 0 0 0 0 0 2 1 0 0 0 0
V16 1 2 1 1 0 0 3 0 0 2 0 7
V17 0 0 0 0 0 0 0 0 0 1 1 2
V19 0 0 0 0 0 2 0 1 1 0 4 4
V20 2 2 0 0 0 0 1 1 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 1 0 0 0 1 0 3 0 0 1 1 3
V29 2 0 0 0 0 0 2 1 0 2 2 1
V30 0 0 0 0 0 0 0 0 0 0 1 0
V31 0 0 0 0 0 0 0 0 0 0 3 3
Table B.1: V-J distribution of the 253 T cells of mouse BA1.
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J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 2 0 2 1 0 2 2 0 0
V2 0 1 0 0 1 0 1 0 1 1 3 0
V3 0 1 0 2 0 0 0 0 0 0 0 0
V4 0 1 1 0 0 0 1 0 1 0 0 1
V5 0 0 0 1 0 0 2 0 0 2 1 3
V12−1 0 4 1 0 0 0 1 0 0 1 3 3
V12−2 0 1 0 0 0 0 2 1 0 0 0 1
V13−1 3 2 0 0 0 2 3 2 0 3 2 1
V13−2 3 2 0 0 0 2 0 1 1 1 2 5
V13−3 2 0 0 0 0 1 2 0 1 1 3 2
V14 0 1 0 0 0 0 2 0 1 0 4 3
V15 1 0 0 0 0 0 1 1 0 0 1 2
V16 1 0 0 3 0 0 1 2 1 1 1 1
V17 0 0 0 0 0 0 0 1 1 0 3 4
V19 3 0 1 1 0 0 1 1 1 0 0 4
V20 0 0 0 0 0 0 0 0 0 2 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 1 0 0 0 0 0 0
V24 0 0 0 0 0 0 1 0 0 0 1 0
V26 0 1 0 0 0 0 0 0 0 0 0 1
V29 1 2 0 1 0 1 1 1 1 1 0 0
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 0 0 0 0 1 0 0 0 1 0 0
Table B.2: V-J distribution of the 166 T cells of mouse BA2.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 3 1 0 0 0 0 2 0 0 1 1 1
V2 0 0 0 0 0 0 0 0 0 0 0 3
V3 0 0 0 0 0 0 1 2 1 0 0 3
V4 0 0 1 1 0 0 0 2 0 2 0 1
V5 1 0 0 1 0 0 4 1 1 1 1 2
V12−1 0 0 1 0 0 0 2 0 0 1 0 0
V12−2 0 0 1 0 0 0 1 0 0 0 1 2
V13−1 5 3 1 1 2 0 6 3 2 2 5 6
V13−2 7 4 2 1 0 1 8 1 8 6 7 12
V13−3 5 5 0 0 1 1 5 3 8 5 8 13
V14 2 0 1 0 0 0 2 0 1 2 2 4
V15 0 1 0 0 0 0 0 1 0 0 0 0
V16 1 0 0 1 1 0 3 0 3 5 2 0
V17 0 0 1 0 0 0 2 1 0 1 1 1
V19 10 0 0 2 0 0 1 0 0 1 2 3
V20 0 0 0 0 0 0 0 0 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 1 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 0 0 0 1 1 0 0 0 1
V29 3 0 0 0 0 0 2 0 1 5 4 2
V30 0 0 0 0 0 0 0 0 0 0 0 1
V31 0 0 0 0 0 1 0 0 0 0 0 0
Table B.3: V-J distribution of the 275 T cells of mouse BA3.
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J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 2 0 2 3 0 1 1 0 2 2 0 1
V2 0 0 0 0 0 0 1 0 2 1 1 0
V3 1 0 0 0 0 0 4 0 0 1 1 3
V4 0 0 0 1 0 2 0 0 0 1 0 3
V5 1 0 0 2 0 1 0 0 0 0 2 2
V12−1 0 2 0 0 0 0 1 1 1 0 1 3
V12−2 1 0 0 0 1 0 2 1 1 0 2 0
V13−1 2 0 1 1 0 0 1 0 1 3 2 6
V13−2 1 2 0 0 1 0 2 3 0 4 3 5
V13−3 1 2 1 2 0 3 3 0 1 2 3 3
V14 0 0 1 1 0 0 1 0 0 2 0 2
V15 0 0 0 0 0 0 1 0 0 1 0 3
V16 0 2 1 0 0 0 3 1 5 3 4 3
V17 0 0 0 0 0 0 0 2 0 0 1 0
V19 2 1 1 0 1 1 3 0 1 1 1 3
V20 0 1 0 0 0 0 2 0 1 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 1 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 1 0 0 0 0 0 0 0 1 1 0 1
V29 2 2 0 0 2 0 1 0 0 1 0 3
V30 0 0 0 0 1 0 0 0 0 0 0 0
V31 1 0 0 0 0 1 0 0 0 0 0 0
Table B.4: V-J distribution of the 195 T cells of mouse BA4.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 1 0 0 0 0 1 3 2 0 0 2 1
V2 0 0 0 0 0 0 0 0 0 0 1 1
V3 0 0 0 2 0 0 1 0 1 0 0 0
V4 1 0 0 0 0 0 1 0 0 1 0 0
V5 1 0 0 1 0 0 2 1 0 0 0 1
V12−1 0 1 1 1 0 0 1 2 0 2 0 1
V12−2 0 0 0 0 0 0 0 0 1 1 3 1
V13−1 4 0 0 0 1 0 4 1 1 1 0 3
V13−2 1 1 0 0 1 0 2 3 0 4 4 3
V13−3 3 1 0 1 0 1 2 1 0 1 2 3
V14 2 0 0 1 0 0 4 0 2 0 0 2
V15 1 0 1 1 1 0 0 0 0 0 0 0
V16 2 2 1 1 0 0 0 0 1 0 2 1
V17 1 0 0 1 0 0 0 0 0 0 0 0
V19 0 0 0 1 1 0 0 1 1 0 0 2
V20 0 1 0 0 0 0 0 0 0 0 1 1
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 1 0 0 0 0 0 0 0 0
V26 0 0 0 0 1 0 1 0 0 0 0 0
V29 0 0 0 0 0 0 1 0 0 0 0 1
V30 0 0 0 0 0 0 1 0 0 0 0 0
V31 0 0 0 0 0 0 0 0 0 0 1 1
Table B.5: V-J distribution of the 133 T cells of mouse BA5.
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J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 0 0 0 1 0 0 1 3 0
V2 0 0 0 0 0 0 1 2 0 0 4 0
V3 0 0 1 1 1 0 3 0 0 0 6 0
V4 2 1 0 0 0 0 0 2 1 0 3 1
V5 1 1 1 0 1 1 0 1 4 0 0 0
V12−1 0 1 0 1 0 1 2 0 0 1 0 0
V12−2 0 0 0 0 0 1 0 0 1 2 2 2
V13−1 13 0 0 1 0 1 4 0 3 0 4 3
V13−2 0 2 1 1 0 0 3 1 3 2 1 6
V13−3 1 0 0 0 0 3 0 0 0 1 1 3
V14 0 0 1 0 4 0 1 0 1 0 1 8
V15 0 0 0 0 0 0 2 0 1 0 0 3
V16 9 6 0 0 0 1 3 0 1 4 2 1
V17 4 1 1 1 0 0 4 2 1 1 2 4
V19 2 1 0 1 0 2 4 0 0 1 1 2
V20 0 1 0 0 0 0 0 0 0 0 0 1
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 1 0 0 0 0 0 1 1 0 0 0 3
V29 1 1 3 0 2 2 0 5 0 7 2 0
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 1 0 0 0 0 1 0 0 0 1 0
Table B.6: V-J distribution of the 234 T cells of mouse EF1.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 1 0 0 0 0 1 0 0 2 0
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 0 0 0 1 0 3 0 0 0 0 0 0
V4 0 0 0 0 0 0 0 0 0 1 0 0
V5 1 0 0 0 0 0 0 0 0 0 0 0
V12−1 0 0 0 0 0 0 1 0 0 0 1 0
V12−2 0 0 0 0 0 1 2 0 0 0 0 1
V13−1 0 0 0 0 2 1 3 0 1 0 2 1
V13−2 2 0 0 1 0 0 0 0 0 0 1 1
V13−3 0 0 0 0 0 1 2 1 0 1 0 0
V14 0 0 0 0 0 0 2 0 0 0 0 0
V15 0 0 0 0 1 0 0 0 1 0 0 0
V16 0 0 0 0 0 0 1 0 3 0 0 4
V17 1 0 0 1 0 0 1 0 1 0 0 2
V19 1 0 0 2 0 2 0 0 1 0 1 0
V20 0 0 0 0 0 0 0 0 0 0 1 1
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 2 0 0 0 0 0 0 0 0
V29 1 0 3 1 0 1 0 0 0 2 0 1
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 0 0 0 0 0 0 0 1 0 0 0
Table B.7: V-J distribution of the 75 T cells of mouse EF2.
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J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 0 0 0 0 0 0 0 0 0
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 0 0 0 0 0 0 1 0 0 0 0 0
V4 3 0 0 0 0 0 2 0 0 0 0 11
V5 0 0 0 0 0 0 1 0 0 0 0 0
V12−1 0 0 0 1 0 1 1 0 0 0 0 0
V12−2 0 0 0 0 7 0 0 8 2 1 0 0
V13−1 20 0 1 0 0 0 0 0 0 1 0 0
V13−2 0 0 0 0 0 0 1 0 0 0 0 0
V13−3 10 0 0 0 0 1 2 0 0 0 0 2
V14 0 0 0 0 0 0 1 0 0 0 0 1
V15 0 0 0 0 0 0 0 0 0 0 0 0
V16 0 1 0 0 0 2 13 0 0 0 2 6
V17 1 0 0 0 0 0 3 0 0 0 0 0
V19 2 0 0 0 0 0 2 0 0 0 0 5
V20 0 0 0 0 0 0 0 0 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 0 0 0 0 0 0 0 0 0
V29 7 13 0 25 1 0 23 3 0 5 41 1
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 0 0 0 0 0 0 0 0 0 23 0
Table B.8: V-J distribution of the 258 T cells of mouse EF3.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 1 0 0 0 0 0 0 3 0 0 1
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 2 0 0 0 0 0 0 0 0 0 1 1
V4 0 0 0 0 0 0 0 0 0 0 0 2
V5 0 0 0 0 0 0 0 0 1 1 2 1
V12−1 1 0 0 1 0 0 1 2 1 0 1 1
V12−2 2 3 0 0 0 0 1 0 0 1 12 3
V13−1 13 9 0 1 0 0 1 1 2 3 2 3
V13−2 3 0 2 1 0 1 4 0 8 1 2 0
V13−3 12 4 0 1 4 0 1 1 3 2 1 0
V14 0 0 0 1 0 2 0 0 2 6 0 1
V15 0 0 0 0 1 0 0 0 0 5 3 0
V16 0 0 0 0 0 0 0 0 2 0 0 7
V17 1 0 1 0 1 1 0 0 0 3 6 2
V19 4 0 3 2 0 3 0 2 5 4 0 10
V20 2 6 1 1 0 0 1 0 0 0 0 1
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 1 0 0 0 1 1 0 0 0
V29 4 1 3 5 1 0 3 3 2 0 10 1
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 1 0 0 0 0 0 0 0 0 0 0
Table B.9: V-J distribution of the 259 T cells of mouse EF4.
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B. V-J DATA
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 1 0 0 0 0 0 1 0 0
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 1 0 0 0 0 0 0 0 1 0 1 0
V4 0 0 0 0 0 0 0 0 0 0 0 1
V5 0 0 0 0 0 1 1 0 0 0 0 0
V12−1 0 0 0 0 1 0 3 0 0 0 0 0
V12−2 0 0 0 1 0 0 0 1 0 2 2 0
V13−1 15 1 0 0 0 3 2 0 0 1 0 1
V13−2 5 0 0 0 0 1 3 0 1 0 0 3
V13−3 7 3 0 0 0 0 1 0 0 0 0 10
V14 0 0 0 0 0 0 1 0 0 0 0 4
V15 0 0 0 0 0 0 1 0 1 0 7 1
V16 0 1 0 0 0 0 2 0 2 1 1 55
V17 0 0 0 0 0 0 1 1 0 0 0 0
V19 1 1 4 0 2 0 12 0 0 0 1 4
V20 0 0 0 0 0 0 0 1 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 3 0 0 0 0 0 0 0 1
V29 3 2 0 0 0 0 1 1 4 1 11 2
V30 0 0 0 0 0 0 0 1 0 0 0 0
V31 0 0 0 0 0 0 0 0 0 0 1 1
Table B.10: V-J distribution of the 212 T cells of mouse EF5.
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VJ frequency plots
Figure B.1: V-J frequency plots for the na¨ıve mouse BA1.
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B. V-J DATA
Figure B.2: V-J frequency plots for the na¨ıve mouse BA2.
Figure B.3: V-J frequency plots for the na¨ıve mouse BA3.
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Figure B.4: V-J frequency plots for the na¨ıve mouse BA4.
Figure B.5: V-J frequency plots for the na¨ıve mouse BA5.
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B. V-J DATA
Figure B.6: V-J frequency plots for the infected mouse EF1.
Figure B.7: V-J frequency plots for the infected mouse EF2.
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Figure B.8: V-J frequency plots for the infected mouse EF3.
Figure B.9: V-J frequency plots for the infected mouse EF4.
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B. V-J DATA
Figure B.10: V-J frequency plots for the infected mouse EF5.
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Appendix C
VJ frequencies
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 4 · 10−3 1.2 · 10−2 4 · 10−3 0 0 0 0 4 · 10−3 4 · 10−3 0 0 1.2 · 10−2
V2 7.9 · 10−3 7.9 · 10−3 0 0 4 · 10−3 0 4 · 10−3 0 7.9 · 10−3 0 0 4 · 10−3
V3 7.9 · 10−3 0 4 · 10−3 0 0 0 0 4 · 10−3 4 · 10−3 0 7.9 · 10−3 7.9 · 10−3
V4 0 0 0 0 0 0 0 0 1.2 · 10−2 4 · 10−3 0 1.2 · 10−2
V5 7.9 · 10−3 0 4 · 10−3 4 · 10−3 7.9 · 10−3 0 0 0 0 4 · 10−3 0 0
V12−1 0 7.9 · 10−3 7.9 · 10−3 0 0 0 4 · 10−3 4 · 10−3 4 · 10−3 0 0 7.9 · 10−3
V12−2 0 4 · 10−3 0 0 0 0 4 · 10−3 0 0 0 1.6 · 10−2 1.6 · 10−2
V13−1 7.9 · 10−3 1.6 · 10−2 0 1.2 · 10−2 4 · 10−3 7.9 · 10−3 1.6 · 10−2 7.9 · 10−3 7.9 · 10−3 7.9 · 10−3 7.9 · 10−3 2 · 10−2
V13−2 1.6 · 10−2 1.2 · 10−2 0 1.2 · 10−2 0 4 · 10−3 2.4 · 10−2 4 · 10−3 1.2 · 10−2 2.4 · 10−2 2.8 · 10−2 3.2 · 10−2
V13−3 0 7.9 · 10−3 1.2 · 10−2 1.6 · 10−2 0 7.9 · 10−3 2.4 · 10−2 7.9 · 10−3 2 · 10−2 1.2 · 10−2 2.4 · 10−2 2.8 · 10−2
V14 7.9 · 10−3 0 0 4 · 10−3 0 0 1.2 · 10−2 0 4 · 10−3 0 4 · 10−3 4 · 10−3
V15 1.2 · 10−2 0 0 0 0 0 7.9 · 10−3 4 · 10−3 0 0 0 0
V16 4 · 10−3 7.9 · 10−3 4 · 10−3 4 · 10−3 0 0 1.2 · 10−2 0 0 7.9 · 10−3 0 2.8 · 10−2
V17 0 0 0 0 0 0 0 0 0 4 · 10−3 4 · 10−3 7.9 · 10−3
V19 0 0 0 0 0 7.9 · 10−3 0 4 · 10−3 4 · 10−3 0 1.6 · 10−2 1.6 · 10−2
V20 7.9 · 10−3 7.9 · 10−3 0 0 0 0 4 · 10−3 4 · 10−3 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 4 · 10−3 0 0 0 4 · 10−3 0 1.2 · 10−2 0 0 4 · 10−3 4 · 10−3 1.2 · 10−2
V29 7.9 · 10−3 0 0 0 0 0 7.9 · 10−3 4 · 10−3 0 7.9 · 10−3 7.9 · 10−3 4 · 10−3
V30 0 0 0 0 0 0 0 0 0 0 4 · 10−3 0
V31 0 0 0 0 0 0 0 0 0 0 1.2 · 10−2 1.2 · 10−2
Table C.1: Table for BA1.
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C. VJ FREQUENCIES
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 1.2 · 10−2 0 1.2 · 10−2 6 · 10−3 0 1.2 · 10−2 1.2 · 10−2 0 0
V2 0 6 · 10−3 0 0 6 · 10−3 0 6 · 10−3 0 6 · 10−3 6 · 10−3 1.8 · 10−2 0
V3 0 6 · 10−3 0 1.2 · 10−2 0 0 0 0 0 0 0 0
V4 0 6 · 10−3 6 · 10−3 0 0 0 6 · 10−3 0 6 · 10−3 0 0 6 · 10−3
V5 0 0 0 6 · 10−3 0 0 1.2 · 10−2 0 0 1.2 · 10−2 6 · 10−3 1.8 · 10−2
V12−1 0 2.4 · 10−2 6 · 10−3 0 0 0 6 · 10−3 0 0 6 · 10−3 1.8 · 10−2 1.8 · 10−2
V12−2 0 6 · 10−3 0 0 0 0 1.2 · 10−2 6 · 10−3 0 0 0 6 · 10−3
V13−1 1.8 · 10−2 1.2 · 10−2 0 0 0 1.2 · 10−2 1.8 · 10−2 1.2 · 10−2 0 1.8 · 10−2 1.2 · 10−2 6 · 10−3
V13−2 1.8 · 10−2 1.2 · 10−2 0 0 0 1.2 · 10−2 0 6 · 10−3 6 · 10−3 6 · 10−3 1.2 · 10−2 3 · 10−2
V13−3 1.2 · 10−2 0 0 0 0 6 · 10−3 1.2 · 10−2 0 6 · 10−3 6 · 10−3 1.8 · 10−2 1.2 · 10−2
V14 0 6 · 10−3 0 0 0 0 1.2 · 10−2 0 6 · 10−3 0 2.4 · 10−2 1.8 · 10−2
V15 6 · 10−3 0 0 0 0 0 6 · 10−3 6 · 10−3 0 0 6 · 10−3 1.2 · 10−2
V16 6 · 10−3 0 0 1.8 · 10−2 0 0 6 · 10−3 1.2 · 10−2 6 · 10−3 6 · 10−3 6 · 10−3 6 · 10−3
V17 0 0 0 0 0 0 0 6 · 10−3 6 · 10−3 0 1.8 · 10−2 2.4 · 10−2
V19 1.8 · 10−2 0 6 · 10−3 6 · 10−3 0 0 6 · 10−3 6 · 10−3 6 · 10−3 0 0 2.4 · 10−2
V20 0 0 0 0 0 0 0 0 0 1.2 · 10−2 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 6 · 10−3 0 0 0 0 0 0
V24 0 0 0 0 0 0 6 · 10−3 0 0 0 6 · 10−3 0
V26 0 6 · 10−3 0 0 0 0 0 0 0 0 0 6 · 10−3
V29 6 · 10−3 1.2 · 10−2 0 6 · 10−3 0 6 · 10−3 6 · 10−3 6 · 10−3 6 · 10−3 6 · 10−3 0 0
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 0 0 0 0 6 · 10−3 0 0 0 6 · 10−3 0 0
Table C.2: Table for BA2.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 1.1 · 10−2 3.6 · 10−3 0 0 0 0 7.3 · 10−3 0 0 3.6 · 10−3 3.6 · 10−3 3.6 · 10−3
V2 0 0 0 0 0 0 0 0 0 0 0 1.1 · 10−2
V3 0 0 0 0 0 0 3.6 · 10−3 7.3 · 10−3 3.6 · 10−3 0 0 1.1 · 10−2
V4 0 0 3.6 · 10−3 3.6 · 10−3 0 0 0 7.3 · 10−3 0 7.3 · 10−3 0 3.6 · 10−3
V5 3.6 · 10−3 0 0 3.6 · 10−3 0 0 1.5 · 10−2 3.6 · 10−3 3.6 · 10−3 3.6 · 10−3 3.6 · 10−3 7.3 · 10−3
V12−1 0 0 3.6 · 10−3 0 0 0 7.3 · 10−3 0 0 3.6 · 10−3 0 0
V12−2 0 0 3.6 · 10−3 0 0 0 3.6 · 10−3 0 0 0 3.6 · 10−3 7.3 · 10−3
V13−1 1.8 · 10−2 1.1 · 10−2 3.6 · 10−3 3.6 · 10−3 7.3 · 10−3 0 2.2 · 10−2 1.1 · 10−2 7.3 · 10−3 7.3 · 10−3 1.8 · 10−2 2.2 · 10−2
V13−2 2.5 · 10−2 1.5 · 10−2 7.3 · 10−3 3.6 · 10−3 0 3.6 · 10−3 2.9 · 10−2 3.6 · 10−3 2.9 · 10−2 2.2 · 10−2 2.5 · 10−2 4.4 · 10−2
V13−3 1.8 · 10−2 1.8 · 10−2 0 0 3.6 · 10−3 3.6 · 10−3 1.8 · 10−2 1.1 · 10−2 2.9 · 10−2 1.8 · 10−2 2.9 · 10−2 4.7 · 10−2
V14 7.3 · 10−3 0 3.6 · 10−3 0 0 0 7.3 · 10−3 0 3.6 · 10−3 7.3 · 10−3 7.3 · 10−3 1.5 · 10−2
V15 0 3.6 · 10−3 0 0 0 0 0 3.6 · 10−3 0 0 0 0
V16 3.6 · 10−3 0 0 3.6 · 10−3 3.6 · 10−3 0 1.1 · 10−2 0 1.1 · 10−2 1.8 · 10−2 7.3 · 10−3 0
V17 0 0 3.6 · 10−3 0 0 0 7.3 · 10−3 3.6 · 10−3 0 3.6 · 10−3 3.6 · 10−3 3.6 · 10−3
V19 3.6 · 10−2 0 0 7.3 · 10−3 0 0 3.6 · 10−3 0 0 3.6 · 10−3 7.3 · 10−3 1.1 · 10−2
V20 0 0 0 0 0 0 0 0 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 3.6 · 10−3 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 0 0 0 3.6 · 10−3 3.6 · 10−3 0 0 0 3.6 · 10−3
V29 1.1 · 10−2 0 0 0 0 0 7.3 · 10−3 0 3.6 · 10−3 1.8 · 10−2 1.5 · 10−2 7.3 · 10−3
V30 0 0 0 0 0 0 0 0 0 0 0 3.6 · 10−3
V31 0 0 0 0 0 3.6 · 10−3 0 0 0 0 0 0
Table C.3: Table for BA3.
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J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 1 · 10−2 0 1 · 10−2 1.5 · 10−2 0 5.1 · 10−3 5.1 · 10−3 0 1 · 10−2 1 · 10−2 0 5.1 · 10−3
V2 0 0 0 0 0 0 5.1 · 10−3 0 1 · 10−2 5.1 · 10−3 5.1 · 10−3 0
V3 5.1 · 10−3 0 0 0 0 0 2.1 · 10−2 0 0 5.1 · 10−3 5.1 · 10−3 1.5 · 10−2
V4 0 0 0 5.1 · 10−3 0 1 · 10−2 0 0 0 5.1 · 10−3 0 1.5 · 10−2
V5 5.1 · 10−3 0 0 1 · 10−2 0 5.1 · 10−3 0 0 0 0 1 · 10−2 1 · 10−2
V12−1 0 1 · 10−2 0 0 0 0 5.1 · 10−3 5.1 · 10−3 5.1 · 10−3 0 5.1 · 10−3 1.5 · 10−2
V12−2 5.1 · 10−3 0 0 0 5.1 · 10−3 0 1 · 10−2 5.1 · 10−3 5.1 · 10−3 0 1 · 10−2 0
V13−1 1 · 10−2 0 5.1 · 10−3 5.1 · 10−3 0 0 5.1 · 10−3 0 5.1 · 10−3 1.5 · 10−2 1 · 10−2 3.1 · 10−2
V13−2 5.1 · 10−3 1 · 10−2 0 0 5.1 · 10−3 0 1 · 10−2 1.5 · 10−2 0 2.1 · 10−2 1.5 · 10−2 2.6 · 10−2
V13−3 5.1 · 10−3 1 · 10−2 5.1 · 10−3 1 · 10−2 0 1.5 · 10−2 1.5 · 10−2 0 5.1 · 10−3 1 · 10−2 1.5 · 10−2 1.5 · 10−2
V14 0 0 5.1 · 10−3 5.1 · 10−3 0 0 5.1 · 10−3 0 0 1 · 10−2 0 1 · 10−2
V15 0 0 0 0 0 0 5.1 · 10−3 0 0 5.1 · 10−3 0 1.5 · 10−2
V16 0 1 · 10−2 5.1 · 10−3 0 0 0 1.5 · 10−2 5.1 · 10−3 2.6 · 10−2 1.5 · 10−2 2.1 · 10−2 1.5 · 10−2
V17 0 0 0 0 0 0 0 1 · 10−2 0 0 5.1 · 10−3 0
V19 1 · 10−2 5.1 · 10−3 5.1 · 10−3 0 5.1 · 10−3 5.1 · 10−3 1.5 · 10−2 0 5.1 · 10−3 5.1 · 10−3 5.1 · 10−3 1.5 · 10−2
V20 0 5.1 · 10−3 0 0 0 0 1 · 10−2 0 5.1 · 10−3 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 5.1 · 10−3 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 5.1 · 10−3 0 0 0 0 0 0 0 5.1 · 10−3 5.1 · 10−3 0 5.1 · 10−3
V29 1 · 10−2 1 · 10−2 0 0 1 · 10−2 0 5.1 · 10−3 0 0 5.1 · 10−3 0 1.5 · 10−2
V30 0 0 0 0 5.1 · 10−3 0 0 0 0 0 0 0
V31 5.1 · 10−3 0 0 0 0 5.1 · 10−3 0 0 0 0 0 0
Table C.4: Table for BA4.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 7.5 · 10−3 0 0 0 0 7.5 · 10−3 2.3 · 10−2 1.5 · 10−2 0 0 1.5 · 10−2 7.5 · 10−3
V2 0 0 0 0 0 0 0 0 0 0 7.5 · 10−3 7.5 · 10−3
V3 0 0 0 1.5 · 10−2 0 0 7.5 · 10−3 0 7.5 · 10−3 0 0 0
V4 7.5 · 10−3 0 0 0 0 0 7.5 · 10−3 0 0 7.5 · 10−3 0 0
V5 7.5 · 10−3 0 0 7.5 · 10−3 0 0 1.5 · 10−2 7.5 · 10−3 0 0 0 7.5 · 10−3
V12−1 0 7.5 · 10−3 7.5 · 10−3 7.5 · 10−3 0 0 7.5 · 10−3 1.5 · 10−2 0 1.5 · 10−2 0 7.5 · 10−3
V12−2 0 0 0 0 0 0 0 0 7.5 · 10−3 7.5 · 10−3 2.3 · 10−2 7.5 · 10−3
V13−1 3 · 10−2 0 0 0 7.5 · 10−3 0 3 · 10−2 7.5 · 10−3 7.5 · 10−3 7.5 · 10−3 0 2.3 · 10−2
V13−2 7.5 · 10−3 7.5 · 10−3 0 0 7.5 · 10−3 0 1.5 · 10−2 2.3 · 10−2 0 3 · 10−2 3 · 10−2 2.3 · 10−2
V13−3 2.3 · 10−2 7.5 · 10−3 0 7.5 · 10−3 0 7.5 · 10−3 1.5 · 10−2 7.5 · 10−3 0 7.5 · 10−3 1.5 · 10−2 2.3 · 10−2
V14 1.5 · 10−2 0 0 7.5 · 10−3 0 0 3 · 10−2 0 1.5 · 10−2 0 0 1.5 · 10−2
V15 7.5 · 10−3 0 7.5 · 10−3 7.5 · 10−3 7.5 · 10−3 0 0 0 0 0 0 0
V16 1.5 · 10−2 1.5 · 10−2 7.5 · 10−3 7.5 · 10−3 0 0 0 0 7.5 · 10−3 0 1.5 · 10−2 7.5 · 10−3
V17 7.5 · 10−3 0 0 7.5 · 10−3 0 0 0 0 0 0 0 0
V19 0 0 0 7.5 · 10−3 7.5 · 10−3 0 0 7.5 · 10−3 7.5 · 10−3 0 0 1.5 · 10−2
V20 0 7.5 · 10−3 0 0 0 0 0 0 0 0 7.5 · 10−3 7.5 · 10−3
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 7.5 · 10−3 0 0 0 0 0 0 0 0
V26 0 0 0 0 7.5 · 10−3 0 7.5 · 10−3 0 0 0 0 0
V29 0 0 0 0 0 0 7.5 · 10−3 0 0 0 0 7.5 · 10−3
V30 0 0 0 0 0 0 7.5 · 10−3 0 0 0 0 0
V31 0 0 0 0 0 0 0 0 0 0 7.5 · 10−3 7.5 · 10−3
Table C.5: Table for BA5.
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C. VJ FREQUENCIES
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 0 0 0 4.3 · 10−3 0 0 4.3 · 10−3 1.3 · 10−2 0
V2 0 0 0 0 0 0 4.3 · 10−3 8.5 · 10−3 0 0 1.7 · 10−2 0
V3 0 0 4.3 · 10−3 4.3 · 10−3 4.3 · 10−3 0 1.3 · 10−2 0 0 0 2.6 · 10−2 0
V4 8.5 · 10−3 4.3 · 10−3 0 0 0 0 0 8.5 · 10−3 4.3 · 10−3 0 1.3 · 10−2 4.3 · 10−3
V5 4.3 · 10−3 4.3 · 10−3 4.3 · 10−3 0 4.3 · 10−3 4.3 · 10−3 0 4.3 · 10−3 1.7 · 10−2 0 0 0
V12−1 0 4.3 · 10−3 0 4.3 · 10−3 0 4.3 · 10−3 8.5 · 10−3 0 0 4.3 · 10−3 0 0
V12−2 0 0 0 0 0 4.3 · 10−3 0 0 4.3 · 10−3 8.5 · 10−3 8.5 · 10−3 8.5 · 10−3
V13−1 5.6 · 10−2 0 0 4.3 · 10−3 0 4.3 · 10−3 1.7 · 10−2 0 1.3 · 10−2 0 1.7 · 10−2 1.3 · 10−2
V13−2 0 8.5 · 10−3 4.3 · 10−3 4.3 · 10−3 0 0 1.3 · 10−2 4.3 · 10−3 1.3 · 10−2 8.5 · 10−3 4.3 · 10−3 2.6 · 10−2
V13−3 4.3 · 10−3 0 0 0 0 1.3 · 10−2 0 0 0 4.3 · 10−3 4.3 · 10−3 1.3 · 10−2
V14 0 0 4.3 · 10−3 0 1.7 · 10−2 0 4.3 · 10−3 0 4.3 · 10−3 0 4.3 · 10−3 3.4 · 10−2
V15 0 0 0 0 0 0 8.5 · 10−3 0 4.3 · 10−3 0 0 1.3 · 10−2
V16 3.8 · 10−2 2.6 · 10−2 0 0 0 4.3 · 10−3 1.3 · 10−2 0 4.3 · 10−3 1.7 · 10−2 8.5 · 10−3 4.3 · 10−3
V17 1.7 · 10−2 4.3 · 10−3 4.3 · 10−3 4.3 · 10−3 0 0 1.7 · 10−2 8.5 · 10−3 4.3 · 10−3 4.3 · 10−3 8.5 · 10−3 1.7 · 10−2
V19 8.5 · 10−3 4.3 · 10−3 0 4.3 · 10−3 0 8.5 · 10−3 1.7 · 10−2 0 0 4.3 · 10−3 4.3 · 10−3 8.5 · 10−3
V20 0 4.3 · 10−3 0 0 0 0 0 0 0 0 0 4.3 · 10−3
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 4.3 · 10−3 0 0 0 0 0 4.3 · 10−3 4.3 · 10−3 0 0 0 1.3 · 10−2
V29 4.3 · 10−3 4.3 · 10−3 1.3 · 10−2 0 8.5 · 10−3 8.5 · 10−3 0 2.1 · 10−2 0 3 · 10−2 8.5 · 10−3 0
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 4.3 · 10−3 0 0 0 0 4.3 · 10−3 0 0 0 4.3 · 10−3 0
Table C.6: Table for EF1.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 1.3 · 10−2 0 0 0 0 1.3 · 10−2 0 0 2.7 · 10−2 0
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 0 0 0 1.3 · 10−2 0 4 · 10−2 0 0 0 0 0 0
V4 0 0 0 0 0 0 0 0 0 1.3 · 10−2 0 0
V5 1.3 · 10−2 0 0 0 0 0 0 0 0 0 0 0
V12−1 0 0 0 0 0 0 1.3 · 10−2 0 0 0 1.3 · 10−2 0
V12−2 0 0 0 0 0 1.3 · 10−2 2.7 · 10−2 0 0 0 0 1.3 · 10−2
V13−1 0 0 0 0 2.7 · 10−2 1.3 · 10−2 4 · 10−2 0 1.3 · 10−2 0 2.7 · 10−2 1.3 · 10−2
V13−2 2.7 · 10−2 0 0 1.3 · 10−2 0 0 0 0 0 0 1.3 · 10−2 1.3 · 10−2
V13−3 0 0 0 0 0 1.3 · 10−2 2.7 · 10−2 1.3 · 10−2 0 1.3 · 10−2 0 0
V14 0 0 0 0 0 0 2.7 · 10−2 0 0 0 0 0
V15 0 0 0 0 1.3 · 10−2 0 0 0 1.3 · 10−2 0 0 0
V16 0 0 0 0 0 0 1.3 · 10−2 0 4 · 10−2 0 0 5.3 · 10−2
V17 1.3 · 10−2 0 0 1.3 · 10−2 0 0 1.3 · 10−2 0 1.3 · 10−2 0 0 2.7 · 10−2
V19 1.3 · 10−2 0 0 2.7 · 10−2 0 2.7 · 10−2 0 0 1.3 · 10−2 0 1.3 · 10−2 0
V20 0 0 0 0 0 0 0 0 0 0 1.3 · 10−2 1.3 · 10−2
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 2.7 · 10−2 0 0 0 0 0 0 0 0
V29 1.3 · 10−2 0 4 · 10−2 1.3 · 10−2 0 1.3 · 10−2 0 0 0 2.7 · 10−2 0 1.3 · 10−2
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 0 0 0 0 0 0 0 1.3 · 10−2 0 0 0
Table C.7: Table for EF2.
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J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 0 0 0 0 0 0 0 0 0
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 0 0 0 0 0 0 3.9 · 10−3 0 0 0 0 0
V4 1.2 · 10−2 0 0 0 0 0 7.8 · 10−3 0 0 0 0 4.3 · 10−2
V5 0 0 0 0 0 0 3.9 · 10−3 0 0 0 0 0
V12−1 0 0 0 3.9 · 10−3 0 3.9 · 10−3 3.9 · 10−3 0 0 0 0 0
V12−2 0 0 0 0 2.7 · 10−2 0 0 3.1 · 10−2 7.8 · 10−3 3.9 · 10−3 0 0
V13−1 7.8 · 10−2 0 3.9 · 10−3 0 0 0 0 0 0 3.9 · 10−3 0 0
V13−2 0 0 0 0 0 0 3.9 · 10−3 0 0 0 0 0
V13−3 3.9 · 10−2 0 0 0 0 3.9 · 10−3 7.8 · 10−3 0 0 0 0 7.8 · 10−3
V14 0 0 0 0 0 0 3.9 · 10−3 0 0 0 0 3.9 · 10−3
V15 0 0 0 0 0 0 0 0 0 0 0 0
V16 0 3.9 · 10−3 0 0 0 7.8 · 10−3 5 · 10−2 0 0 0 7.8 · 10−3 2.3 · 10−2
V17 3.9 · 10−3 0 0 0 0 0 1.2 · 10−2 0 0 0 0 0
V19 7.8 · 10−3 0 0 0 0 0 7.8 · 10−3 0 0 0 0 1.9 · 10−2
V20 0 0 0 0 0 0 0 0 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 0 0 0 0 0 0 0 0 0
V29 2.7 · 10−2 5 · 10−2 0 9.7 · 10−2 3.9 · 10−3 0 8.9 · 10−2 1.2 · 10−2 0 1.9 · 10−2 1.6 · 10−1 3.9 · 10−3
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 0 0 0 0 0 0 0 0 0 8.9 · 10−2 0
Table C.8: Table for EF3.
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 3.9 · 10−3 0 0 0 0 0 0 1.2 · 10−2 0 0 3.9 · 10−3
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 7.7 · 10−3 0 0 0 0 0 0 0 0 0 3.9 · 10−3 3.9 · 10−3
V4 0 0 0 0 0 0 0 0 0 0 0 7.7 · 10−3
V5 0 0 0 0 0 0 0 0 3.9 · 10−3 3.9 · 10−3 7.7 · 10−3 3.9 · 10−3
V12−1 3.9 · 10−3 0 0 3.9 · 10−3 0 0 3.9 · 10−3 7.7 · 10−3 3.9 · 10−3 0 3.9 · 10−3 3.9 · 10−3
V12−2 7.7 · 10−3 1.2 · 10−2 0 0 0 0 3.9 · 10−3 0 0 3.9 · 10−3 4.6 · 10−2 1.2 · 10−2
V13−1 5 · 10−2 3.5 · 10−2 0 3.9 · 10−3 0 0 3.9 · 10−3 3.9 · 10−3 7.7 · 10−3 1.2 · 10−2 7.7 · 10−3 1.2 · 10−2
V13−2 1.2 · 10−2 0 7.7 · 10−3 3.9 · 10−3 0 3.9 · 10−3 1.5 · 10−2 0 3.1 · 10−2 3.9 · 10−3 7.7 · 10−3 0
V13−3 4.6 · 10−2 1.5 · 10−2 0 3.9 · 10−3 1.5 · 10−2 0 3.9 · 10−3 3.9 · 10−3 1.2 · 10−2 7.7 · 10−3 3.9 · 10−3 0
V14 0 0 0 3.9 · 10−3 0 7.7 · 10−3 0 0 7.7 · 10−3 2.3 · 10−2 0 3.9 · 10−3
V15 0 0 0 0 3.9 · 10−3 0 0 0 0 1.9 · 10−2 1.2 · 10−2 0
V16 0 0 0 0 0 0 0 0 7.7 · 10−3 0 0 2.7 · 10−2
V17 3.9 · 10−3 0 3.9 · 10−3 0 3.9 · 10−3 3.9 · 10−3 0 0 0 1.2 · 10−2 2.3 · 10−2 7.7 · 10−3
V19 1.5 · 10−2 0 1.2 · 10−2 7.7 · 10−3 0 1.2 · 10−2 0 7.7 · 10−3 1.9 · 10−2 1.5 · 10−2 0 3.9 · 10−2
V20 7.7 · 10−3 2.3 · 10−2 3.9 · 10−3 3.9 · 10−3 0 0 3.9 · 10−3 0 0 0 0 3.9 · 10−3
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 3.9 · 10−3 0 0 0 3.9 · 10−3 3.9 · 10−3 0 0 0
V29 1.5 · 10−2 3.9 · 10−3 1.2 · 10−2 1.9 · 10−2 3.9 · 10−3 0 1.2 · 10−2 1.2 · 10−2 7.7 · 10−3 0 3.9 · 10−2 3.9 · 10−3
V30 0 0 0 0 0 0 0 0 0 0 0 0
V31 0 3.9 · 10−3 0 0 0 0 0 0 0 0 0 0
Table C.9: Table for EF4.
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C. VJ FREQUENCIES
J1−1 J1−2 J1−3 J1−4 J1−5 J1−6 J2−1 J2−2 J2−3 J2−4 J2−5 J2−7
V1 0 0 0 4.7 · 10−3 0 0 0 0 0 4.7 · 10−3 0 0
V2 0 0 0 0 0 0 0 0 0 0 0 0
V3 4.7 · 10−3 0 0 0 0 0 0 0 4.7 · 10−3 0 4.7 · 10−3 0
V4 0 0 0 0 0 0 0 0 0 0 0 4.7 · 10−3
V5 0 0 0 0 0 4.7 · 10−3 4.7 · 10−3 0 0 0 0 0
V12−1 0 0 0 0 4.7 · 10−3 0 1.4 · 10−2 0 0 0 0 0
V12−2 0 0 0 4.7 · 10−3 0 0 0 4.7 · 10−3 0 9.4 · 10−3 9.4 · 10−3 0
V13−1 7.1 · 10−2 4.7 · 10−3 0 0 0 1.4 · 10−2 9.4 · 10−3 0 0 4.7 · 10−3 0 4.7 · 10−3
V13−2 2.4 · 10−2 0 0 0 0 4.7 · 10−3 1.4 · 10−2 0 4.7 · 10−3 0 0 1.4 · 10−2
V13−3 3.3 · 10−2 1.4 · 10−2 0 0 0 0 4.7 · 10−3 0 0 0 0 4.7 · 10−2
V14 0 0 0 0 0 0 4.7 · 10−3 0 0 0 0 1.9 · 10−2
V15 0 0 0 0 0 0 4.7 · 10−3 0 4.7 · 10−3 0 3.3 · 10−2 4.7 · 10−3
V16 0 4.7 · 10−3 0 0 0 0 9.4 · 10−3 0 9.4 · 10−3 4.7 · 10−3 4.7 · 10−3 2.6 · 10−1
V17 0 0 0 0 0 0 4.7 · 10−3 4.7 · 10−3 0 0 0 0
V19 4.7 · 10−3 4.7 · 10−3 1.9 · 10−2 0 9.4 · 10−3 0 5.7 · 10−2 0 0 0 4.7 · 10−3 1.9 · 10−2
V20 0 0 0 0 0 0 0 4.7 · 10−3 0 0 0 0
V21 0 0 0 0 0 0 0 0 0 0 0 0
V23 0 0 0 0 0 0 0 0 0 0 0 0
V24 0 0 0 0 0 0 0 0 0 0 0 0
V26 0 0 0 1.4 · 10−2 0 0 0 0 0 0 0 4.7 · 10−3
V29 1.4 · 10−2 9.4 · 10−3 0 0 0 0 4.7 · 10−3 4.7 · 10−3 1.9 · 10−2 4.7 · 10−3 5.2 · 10−2 9.4 · 10−3
V30 0 0 0 0 0 0 0 4.7 · 10−3 0 0 0 0
V31 0 0 0 0 0 0 0 0 0 0 4.7 · 10−3 4.7 · 10−3
Table C.10: Table for EF5.
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Appendix D
Dependance of T (α, nθ) on its
parameters
We focus here on the dependance of
T (α, nθ) =
1
αµ
(γE − eαnθ · Ei(−αnθ) + log(αnθ)), (D.1)
on the parameters nθ, M , γ, θ and µ. Figures D.1 to D.5 show the dependence of the
equation on the different parameters, while Figures D.6 to D.10 represent the elasticity of
(D.1) with respect to the different parameters, where the elasticity Ef(a) of a function f
in the point x = a is defined as
Ef(a) =
a
f(a)
f ′(a),
with f ′(a) representing the derivative of the function f calculated in the point x = a.
Figure D.1: Parameters: θ = 109, γ = 10, µ = 0.5, M = 1010.
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Figure D.2: Parameters: nθ = 4, γ = 10, µ = 0.5, M = 10
10.
Figure D.3: Parameters: nθ = 4, θ = 10
9, µ = 0.5, M = 1010.
Figure D.4: Parameters: nθ = 4, θ = 10
9, γ = 10, µ = 0.5.
Figure D.5: Parameters: nθ = 4, θ = 10
9, γ = 10, M = 1010.
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Figure D.6: Parameters: θ = 109, γ = 10, µ = 0.5, M = 1010.
Figure D.7: Parameters: nθ = 4, γ = 10, µ = 0.5, M = 10
10.
Figure D.8: Parameters: nθ = 4, θ = 10
9, µ = 0.5, M = 1010.
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Figure D.9: Parameters: nθ = 4, θ = 10
9, γ = 10, µ = 0.5.
Figure D.10: Parameters: nθ = 4, θ = 10
9, γ = 10, M = 1010.
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